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ABSTRACT
Chromatin has a compact organization in which most DNA sequences are
structurally inaccessible and functionally inactive. Reconfiguration of thechromatir
required to activate transcription. This reconfiguration is achieved by the action of
enzymes that covalently modify nucleosomal core histones, and by enzymes that disrupt
histone-DNA interactions via A TP hydrolysis.
TheSWI/SNF family of ATP-dependent chromatin remodeling enzymes has
been implicated not only in gene activation but also in numerous cellular processes
including differentiation , gene repression , cell cycle control , recombination and DNA
repair. PPARy, C/EBPa and C/EBP are transcription factors with well established roles
in adipogenesis Ectopical expression of each of these factors in non-adipogenic cells is
sufficient to convert them to adipocyte-like cells
To determine the requirements of SWI/SNF enzymes in adipocyte differentiation
we introduced PPARy, C/EBPa or C/EBP into fibroblasts thatinducibly express
dominant-negative versions of the Brahma-Related Gene 1 (BRG1) or human Brahma
(BRM), which are the ATPase subunits of the SWI/SNF enzymes. We found that
adipogenesis and expression of adipocyte genes were inhibited in the presence of
mutant SWI/SNF enzymes. Additionally, in cells expressing C/EBPa or C/EBP , PPARy
expression was SWI/SNF dependent. These data indicate the importance of these
remodeling enzymes in both early and late gene activation events.
Subsequently, we examined by chromatinimmunoprecipitation (ChiP) assay the
functional role of SWI/SNF enzymes in the activation of PPARy2, the master regulator of
adipogenesis. Temporal analysis of factors binding to the PPARy2 promoter showed
V1l
that SWIISNF enzymes are required to promote preinitiation complex assembly and
function.
Additionally, our studies concentrated on the role of C/EBP family members in
the activation of early and late genes during. adipocyte differentiation. During
adipogenesis, C/EBP~ and 3 are rapidly and transiently expressed and are involved in
the expression of PPARy and C/EBPa, which together activate the majority of the
adipocyte genes. Our studies determined the temporal recruitment of the C/EBP family
at the promoters of early and late genes by ChiP assay during adipocyte differentiation.
We found that all of the C/EBP members evaluated are present at the promoters of early
and late genes , and the binding correlated with the kinetics of the C/EBPs expression.
Binding of C/EBP and 3 is transient, subsequently being replaced by C/EBPa. These
studies demonstrated that C/EBP~ and 3 are not only involved in the regulation of
PPARy and C/EBPa, but also in the activation of late expressed adipocyte genes.
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CHAPTER I
INTRODUCTION
1) Chromatin structure and transcriptional control
Many biological processes that take place in eukaryotic organisms such as cell
replication , development and cellular differentiation are highly regulated. During these
nuclear processes, precise temporal and spatial expression of specific genes is required.
However, in the nucleus of eukaryotic cells , DNA is inaccessible and compacted into
. I 
chromatin , which is formed by association of the DNA with histones and non histone
proteins. Since DNA needs to be compacted in order to fit into the nucleus , cells face a
repressive environment , a highly packaged chromatin structure, which . is responsible for
controlling the dynamics of DNA dependent processes.
The fundamental repeat unit of chromatin is the nucleosome which consists of
147 base pairs of DNA wrapped around a histone octamer core , which is composed of
two copies of each of the histone proteins H3 and H4 , located at the center of the core,
flanked by two H2A1H2B heterodimers (Fig. 1.1) (Kornberg and Thomas , 1974; Luger
and Hansen, 2005; Luger et aI. , 1997). Each of the core histones has a central domain
and a flexible tail domain located at the amino terminal (N-terminal) region; an additional
carboxy terminal (C-terminal) tail is also found exclusively on histone H2A. The central
domain contributes to histone-histone interactions inside the octamer and the tail
domains allow histones to interact with DNA and other proteins that control nucleosome
folding and function. In addition, these tails are also subjected to a considerable number
of post-translational modifications which are critical for the regulation of the structural
and functional activities of the nucleosome. These enzymatic activities, which include
acetylation , phosphorylation , methylation, ubiquitination , sumoylation , ADP ribosylation
i.4
Figure 1. Nucleosome core particle: the 146 base pair DNA backbones is shown in
light green and light brown , histone protein H3 is shown in blue, H4 in dark green , H2A
in yellow and H2B in pink (Luger et aI., 1997).
glycosylation , biotinylation and carbonylation or some combination of thereof are
important for mediating structural alterations between repressive and active chromatin
states (Reviewed in (Luger and Hansen , 2005; Margueron et aI., 2005) and references
therein). Additional covalent modifications that occur in the central domain of the
histones have recently been identified. A .number of them are located at the lateral
surface of the nucleosome where histone-DNA interactions occur. These modifications
mayaffect histone-DNA interactions and nucleosome positioning (Cosgrove et aI.
: 11004).
The regulation of chromatin structure, as well as the regulatory aspects of
chromatin , is not only influenced by covalent modification of the histones but also by the
presence of specific histone variant proteins (for instance H3.3 and H2AZ , which are H3
and H2A variants , respectively). Even though many aspects of the variant deposition
are still debated , it seems that histone variants contribute to the generation of functional
domains in the chromatin with different properties. For instance, histone H3 variant
CENP-A which is located to centromeres, is essential for the formation of a functional
kinetochore in all eukaryotes (Reviewed in (Cairns , 2005; Jin et aI., 2005; Korber and
Horz , 2004; Peterson and Laniel , 2004; Sarma and Reinberg, 2005)).
DNA wrapped around a series of nucleosome core particles that are separated
by 10-60 base pairs (bp) generates the 1 0 nm fiber , also known as "beads on a string
This constitutes the first level of DNA organization inside the nucleus. At the next level
the nucleosomalarray is subsequently condensed into a secondary structure known as
the 30 nm fiber, which is stabilized by linker histones (e.g. H1 , H5) (Carruthers et aI.
1998). How are the nucleosomes organized within the 30 nm fiber? Although the in vivo
30 nm organization has not been elucidated , a series of studies performed in vitro using
nucleosomal arrays have shown how packaging of the array depends on interactions
between the N-terminal tails of histone H4 from one nucleosome with the H2A1H2B
dimer of the adjacent one. These interactions can direct the connection of nucleosomes
into a zigzag arrangement resulting in a "two-start helix" pattern under physiological
conditions (Dorigo et aI. , 2003; Dorigo et aI. , 2004; Hansen , 2002). Although these
studies are convincing, the possibility exists that other three-dimensional structures
coexist in vivo. Chromosomal architecture beyond the 30 nm fiber is still unclear;
however it is known that chromatin fiber can form loops that allow the connection of two
distal regions of a particular gene. In addition , a number of nucleosome-binding proteins
such as MENT (myeloid and eryhroid nuclear termination stage-specific protein) and
MeCP2 (methyl CpG binding protein 2), are also involved in the formation of secondary
and tertiary chromatin structures that contribute to the further packaging and stabilization
of the DNA (Reviewed in (Luger and Hansen , 2005) and references therein).
In a scenario where the highly condensed DNA is inaccessible to gene regulatory
proteins, cells have developed mechanisms that respond to specific signals that facilitate
the remodeling of the chromatin structure , thus , alleviating the impediment imposed by
chromatin and assuring gene function. In contrast , when repression of a gene is
required , alteration of chromatin occurs ina way that results in a condensed and
inaccessible chromatin structure. Two major classes of chromatin modifying enzymes
have been identified so far , including the histone modifying enzymes that covalently
modify histones , and the A TP-dependent chromatin remodeling enzymes that disrupt
histone DNA contacts in thenucleosomal core using the energy derived from ATP
hydrolysis.
Remodeling that involves covalent modifications , particularly at the Nand C-
termini of histone tails is mediated by a setof enzymes , including histone acetyl
transferases (HATs), histone methyl transferases (HMTs), kinases, ubiquitinylases
sumoylases, and ADP-ribosylases. The covalent modifications of the histone tails not
only alter the chromatin structure , making it more accessible or inaccessible (depending
of the modification(s), but also allow chromatin to recruit regulatory proteins responsible
for the final outcome: gene activation or silencing. The enzymes involved in reversing
histone modifications such as acetylation and methylation have been identified. They
include the well known histone deacetylases (HDACs) and the recently discovered
lysine-specific demethylase (LSD1) (Reviewed in (Margueron et aI. , 2005; Peterson and
Laniel , 2004; Schreiber and Bernstein , 2002; Shietal. , 2004)).
Combinations of these covalent modifications are complex and it is believed that
they might influence the structure of the chromatin or generate binding sites for
regulatory factors that contain specific binding domains. For instance , transcription
factors and chromatin remodeling enzymes containing bromodomains that recognize
acetylated Iysines and those containing some chromodomains recognize methylated
Iysines (Berger , 2002; Brehm et aI. , 2004; Cosgrove et aI. , 2004; Zeng and Zhou, 2002).
The second class of chromatin modifiers alters contacts between DNA and
histones using the energy from ATP hydrolysis. The first A TP-dependent chromatin
remodeling enzyme identified was the yeast SWI/SNF complex (Winston and Carlson
1992). The complex was discovered in S. cerevisiae while studying the regulation of the
gene HO , which is involved in mating type switching and SUC2 , which regulates the
growth on sucrose. The mutations that affected the expression of HO (SWI; for
switching defective mutants) and SUG2 (SNF: sucrose non fermenting mutants) resulted
in a similar phenotype, suggesting that these proteins might work in a complex. The link
between SWI/SNF and chromatin was established when the analysis of mutations that
suppressed SWI and SNF phenotypes resulted in the identification of genes that
encoded histones and chromatin associated proteins. (Reviewed in (Imbalzano , 1998;
Mohrmann andVerrijzer , 2005; Sif, 2004; Smith and Peterson , 2005) and references
therein). The sequence analysis of the Swi2/Snf2 gene, the motor of the complex
showed that the central domain of the protein is homologous to the later identified , SF2
superfamily of helicases (Laurent et aI. , 1992). The Swi2/Snf2 protein and its family
members do not display DNA unwinding activity, however, they all possess DNA-
stimulated ATPase activity that is required for altering DNA-histone core contacts
resulting, at least in in vitro assays , in relocation of nucleosomes, displacement of
histones or alteration of the nuclesome structure (Becker and Horz , 2002; Cote et aI.,
1994; Flaus and Owen-Hughes , 2004; Laurent et aI. , 1993; Narlikar et aI. , 2002;
Peterson , 2002).
2) The SWI/SNF superfamily of ATP-dependent chromatin remodeling enzymes.
The yeast SWI/SNF complex consists of eleven subunits (Table I), and its activity
is required for the regulation of the expression of constitutive and inducible genes.
Analysis of mutations of SWI/SNF have revealed that this complex is not only involved in
gene expression but also in gene repression (Review in (Wang, 2003) and references
therein). Biochemical analyses demonstrated that Swi1 , Swi2 (Snf2), Swi3, Snf5 and
Snf6 and the subsequently identified SWPs (SWI/SNF-associated proteins) were indeed
components of the 1. 14 MDa SWI/SNF complex which alters the structure of the
nucleosome in an A TP dependent manner (Cairns et aI., 1994; Peterson et al. 1994).
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After the discovery of the SWI/SNF complex , a second member of the family was
identified in yeast. The RSC (remodels the structure of chromatin) complex includes
fifteen polypeptides some of which are highly homologous to the SWI/SNF subunits , and
moreover, two of the subunits, Arp7 and Arp9 , are shared in both complexes (Table I)
(Reviewed in (Mohrmann and Verrijzer, 2005) and references therein). Even though the
remodeling activities of both complexes are similar in vitro several subunits of RSC are
essential for viability, including the ATPase subunit (Sth 1). Whole genome analysis has
shown that RSC activates or represses the transcription of genes that are not regulated
by SWI/SNF , thus yeast has two SWI2/SNF2 remodeling complexes, the yeast SWI/SNF
(ySWI/SNF) and RSC (Review in (Mohrmann and Verrijzer , 2005; Wang, 2003)).
Homologues of Swi2/Snf2 have been identified in Drosophila, mouse, frog, and
human (Cairns et aI. , 1994; Wade et al. , 1998). All of them share the same basic
structure , a catalytic subunit that contains an ATPase domain (related to the yeast
Swi2/Snf2), and each is associated with additional subunits that regulate the structure
function , and efficiency of the complex (Table I) (Cote et aI. , 1994; Laurent et aI. , 1993).
To date , the Swi2/Snf2 superfamily has been divided into four families including
SWI/SNF , ISWI , CHD and In080 that were classified based on sequence homology
within the ATPase subunit and also by the presence of different domains outside the
ATPase region , which include the bromodomains , SANT domain , chromodomains , PHD
fingers , and TEL Y/GTIE motifs. These structural and functional domains are not limited
to ATPase subunits; they are also present in a number of the associated subunits in the
remodeling complexes and in a number of chromatin binding proteins.
The additional domains within the catalytic subunit might function by mediating
protein-protein interactions , targeting the remodeling complex to regulatory regions on
the DNA and/or stabilizing the interactions with chromatin , and mediating complex
formation (Fig. 1.2) (Boyer et aI. , 2000; Eisen et aI. , 1995; Fan et aI. , 2005; Sif , 2004;
Smith and Peterson , 2005).
The bromodomains, which are about 110 amino acids in size, are present in the
ATPase subunit of the SWI/SNF family members. This domain permits interaction with
specific acetylated Iysines in histone tails , facilitating the targeting of the ATPase to
chromatin or perhaps allowing the interactions with other proteins that stabilize the
binding to chromatin. The SANT domain present in the ATPase subunit of the ISWI
family members is a small motif of approximately fifty amino acids. There is a high
degree of homology between this domain and the DNA-binding domain of the c-Myb
proteins. This domain is implicated in the targeting of the catalytic subunit to the
regulatory sequences via interactions with the unmodified histone tails , stabilizing the
chromatin-enzyme interactions. Two chromodomains are present in the catalytic subunit
of the CHD family, and these promote interactions with nucleosomal DNA in a histone
tail independent manner (Reviewed in (de la Cruz et aI. , 2005; Mohrmann and Verrijzer
2005; Smith and Peterson , 2005)).
In the next sections of this thesis the characterization of the SWIISNF complex in
Drosophila and human will be presented. Additionally, it will mention the mechanisms of
remodeling, and finally it will be discuss the role of the complex in development and
differentiation.
1) Drosophila SWI/SNF complexes and subunits
After the identification of the SWI/SNF complex in Saccharomyces cerevisiae,
SWI/SNF related complexes were characterized in Drosophila melanogaster and then in
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Figure 1.2. ATPases of the four main families of ATP-dependent SWI/SNF-related
chromatin remodeling enzymes: SWI/SNF, ISWI , CHD and In080. The ATPase domain
and other characteristic domains are shown (Mohrmann and Verrijzer, 2005).
mammals. The Swi2/Snf2 protein in Drosophila is known as Brahma or Brmand was
identified in genetic screens looking for genes essential for embryonic development
(Dingwall etal. , 1995; Tamkun et aI. , 1992). The first purification of the Drosophila Brm
complex (dBrm) revealed that it consists of eight subunits. The Brm associated proteins,
also referred to as HAPs, were named according to their molecular weightas BAP45,
BAP47 , BAP55 , BAL60, BAP74 , BAP111 , and BAP155. At least four of the subunits
Brm , BAP155 (also known as moira), BAP60 (Swp73/Rs6homolog), and BAP45 (also
: Called Snr1 ) are conserved in yeast and human; see below (Table I). In contrast
BAP111 is unique to higher eukaryotes and belongs to the HMG domain family of
proteins (Fig. 1.3). A number of HMG domains contact DNA in a sequence-dependent
manner, although the HMG motifs present in the BAP111 subunit bind DNA
independently of the DNA sequence (Mohrmann and Verrijzer , 2005; Papoulas etal.
2001). Later studies demonstrated that BAP111 interacts with Brm in vivo suggesting a
possible role of this subunit in the functional activity of the Brm and mammalian
complexes (Papoulas et aI. , 2001). BAP74 is a HSP70 equivalent to HSC4chaperone;
BAP55 is an actin-related protein; BAP47 matched conserved regions of th actin-
related proteins ACT1 and ACT2 (Fig. 1.3) (Papoulas et aI. , 1998).
Later, another subunit known as Osa (closest homolog to the yeast Swi1) was
identified as a component of the dBrm complex. Osa encodes a large protein of
approximately 300 kDa that contains two domains , a putative DNA binding domain
(ARID: AT-rich interaction domain) which is also present in the yeast Swi1 subunit, and a
:.'1
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C,.terminal domain with highly conserved regions , HRI and HRIL In addition , Osa
contains variant LXLL motifs (L: leucine; X: any amino acid), which are characteristic of
protein domains involved in ligand-dependent binding of hormone receptors to their co-
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Figure 1.3. Domain architecture of Drosophila BAP and PBAP subunits. Proteins and
their structural modules are showed approximately to scale (Mohrmann and Verrijzer
2005).
activators (Fig. 1.3) (Collins et aI. , 1999; Inoue et aI. , 2002; Mohrmann and Verrijzer
2005).
Recently, two novel subunits of the Drosophila Brm complex were purified and
characterized by mass spectrometry: Polybromo and BAP170. The Polybromo subunit
contains 6 bromodomains , 2 BAH (bromo-adjacent homology) domains, a HMG box
and 2 putative C zinc fingers (Fig. 1.3). The presence of numerous bromo domains
possibly controls targeting ofthe complex to regions of hyperacetylated chromatin.
: Nevertheless, it is not possible to generalize since there are SWI/SNF complexes that 
not contain polybromo subunits and these still localize to the same regions (Mohrmann
et aI., 2004; Mohrmann and Verrijzer, 2005). BAH domains have also been identified in
Rsc1 and Rsc2 , in DNA methyltransferases , and in other proteins implicated in gene
regulation. The function of both domains in the polybromo subunits has not been
determined. The C zinc fingers are known to mediate sequence-dependent DNA
interactions as well as protein-protein interactions (Mohrmann and Verrijzer, 2005).
The BAP170 subunit is present in many species. Structurally the protein
contains an N-terminus with an ARID domain , an LXXLL (L: leucine; X: any amino acid)
motifs which contributes to protein-protein interactions , a region rich in the amino acids
proline and glutamine , a region rich in serine , and a C-terminus including two C zinc
finger motifs(Fig. 1.3). As in the Polybromo subunit, BAF170 contains multiple conserved
motifs that might be important function in targeting. Biochemical analysis of the dBrm
associated subunits revealed that in Drosophila there are two complexes one including
the Osa subunit , known as SAP (Brahma Associated Proteins) and the other one
containing a polybromo or PBAP (Polybromo Brahma-Associated Proteins) which is also
characterized by the presence of BAP170 subunit (Table 1) (Mohrmann etal. , 2004;
Mohrmann and Verrijzer, 2005; Smith and Peterson , 2005). Furthermore , the
composition of the dBrm complexes might vary in different stages during development.
Using indirect immunofluorescence the distribution of BAP and PBAP complexes
was determined in polytene chromosomes. The complexes exhibited an overlapping but
a different distribution pattern which suggests specific gene regulation by each complex
(Mohrmann et aI. , 2004). It has not been reported yet how both complexes regulate
genes in vivo.
2) Human SWI/SNF complexes and subunits
Afterthe discovery of yeast Swi2/Snf2 and the Drosophila Brahma ATPase
subunits , two human homologues , BRG1 and hBRM , were identified. BRG1 (Brahma
related gene 1) was isolated by screening a human HeLa cell cDNA library with the
Brahma cDNA probe (Khavari et aI. , 1993). Likewise , hBRM (human Brahma) was
isolated by screening a human livercDNA library with a Drosophila Brm probe.
Simultaneously with the hBRM isolation , the mouse counterpart (mBrm) was obtained
from a lung cDNA library probed with a fragment of the ATPase domain from hBRM
(Muchardt and Yaniv, 1993).
Initially the human SWI/SNF complexes were partially purified as two multi-
protein complexes (A and B), each containing 7 peptides, and ATP-dependent
nucleosome disruption activity that facilitated the binding of transcription factors and the
TBP (TAT A-binding protein) to nucleosomal DNA (Imbalzano et aI. , 1994; Kwon et aI.
1994). Subsequent purifications demonstrated that the human complexes contained
either BRG1 or hBRM and consisted of 9 to 12 subunits depending on the cell type used
in the purification (Wang et aI. , 1996b). Like dBrm complexes , BRG1 is found as a
component of two complexes , in human referred to as complex BAF (BRG1-Associated
Factors) or hSWI/SNF-A and in complex PBAF (Polybromo-BRG1-Associated Factors)
or hSWI/SNF-B; BRM is found as a component in one complex , the BAF (Table I).
The human subunits BAF170 and BAF155 , which are highly homologous , were
purified, sequenced and cloned. The alignment of both genes with the yeast Swi3
revealed that all of them have 4 conserved regions in the proteins including a
hydrophobic region, a tryptophan-repeat domain or SANT , a leucine-zipper or coiled-coil
: region (identified as dimerization domain) and a SWIRM (Swi3 , Rsc8 , and Moira)
domain. The SWIRM domain is a conserved domain of about 85 residues present in
Swi3, Rsc8 and Moira as well as other chromosomal proteins involved in chromatin
remodeling (Aravind and Iyer, 2002; Qian et aI. , 2005). BAF170 and BAF155 form hetero
or homodimers.
The mouse BAF60 (mBAFa) was purified and sequenced before the human.
counterpart, and confirmed to be the homolog of the yeast Swp 73 subunit. This subunit
contains the SWIB domain which is similar to the p53-binding domain of MDM2 and a
region present in some topoisomerases (Mohrmann and Verrijzer , 2005). The human
BAF60 includes 3 members, BAF60a , band c , differing at the N-terminal regions which
are expressed differentially in tissues. The human BAF60a, which is ubiquitously
expressed, is highly homologoustothe mouse (mBAF60a), and it has been shown to
copurify with BRG1. BAF60b is expressed in many tissues , but more so in pancreas
whereas BAF60c is expressed particularly in muscle (Wang et aI. , 1996b). Recently, a
newisoform of BAF60c , BAF60c2 , was identified. Both isoforms are expressed in a
number of tissues , and it has been found that they bind to several nuclear receptors and
transcription factors and enhance their activities (Debril et aI. , 2004).
Another subunit, BAF47 , obtained from rat liver, is the counterpart from the
previously identified human INI1 (integrase interactor 1), the homolog ofthe yeast SNF5
gene (Kalpana et aI. , 1994; Wang et aI. , 1996a; Wang et aI. , 1996b). BAF47 contains a
highly conserved domain with 2 direct repeats and a coiled-coil region. The human
BAF47 interacts directly with BRG1 and hBRM and these interactions mediate the
ATPase motor activity (Kalpana et aI. , 1994; Muchardt et aI. , 1995).
BAF45 and BAF53 were identified as ~-actin and actin-related proteins
respectively. It has been proposed that BAF45 and BAF53 are required for the
association of the SWI/SNF complex with chromatin/nuclear matrix. However, further
studies will be necessary to establish this directly (Zhao et aI. , 1998).
The cloning of the human and mouse BAF57 subunit (BAP111 in Drosophila)
revealed that it contains 4 domains. At the N-terminus are present a proline-rich region
and a high-mobility-group (HMG) domain. At the C-terminus is found a kinesin- like
coiled-coil domain and an acidic region. The BAF57 subunit does not have a yeast
homologue but it is a component of all mammalian SWI/SNF complexes (Papoulas et
aI. , 1998; Wang et aI. , 1998).
The human BAF180 subunit, which is the homologue of the Drosophila
polybromo, was purified and cloned. BAF180 together with BAF200 (see below) are
specific subunits of the PBAF complex. BAF180 contains the highly conserved
structural domains , already described in Drosophila. Because the yeast Rsc1 , 2 and 4
from the yeast Rsc complex contain two bromodomains and a BAH (Bromo Adjacent
Homology) region homologous to BAF180, it was proposed that Rsc1 , 2 and 4 are the
closest relatives ofthe human BAF180 (Xue et aI. , 2000). Xue and colleagues proposed
that the presence of BAF180 and the absence of BAF250 (see below) in the PBAF
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complex gives a structural and a functional specificity to the complex (Xue et aI. , 2000).
Therefore , BAF180 and BAF200 in PBAF and BAF250 in BAF might be critical
components that functionally discriminate BAF from PBAF. It would be interesting to
determine if BAF180 and BAF200 are responsible for targeting PBAF to specific genes
in vivo.
Recently, BAF200 subunit was isolated by improved immunopurifications
procedures using antibodies against BRG1 , BAF180 and hSNF5. BAF200 is the
homologue of the Drosophila BAP170 and it is an integral component of PBAF complex
(Wang et aI. , 1996a; Xue et aI. , 2000). BAF200 contains in addition, a putative
sequence-specific DNA binding region that is not present in BAP170. Similar to
BAF180, BAF200 contains various domains involved in DNA and protein-protein
interactions , which might permit the PBAF complex to be targeted to specific regions
(Yan et aI. , 2005).
In reference to the Osa subunit , the cloning of two human Osa , hOsa1 and
hOsa2 was reported. hOsa1 and hOsa2 are the largest subunits present in the human
SWI/SNF-A (PBAF) complex. hOsa1 and hOsa2 are approximately 60% identical and
contain the AT-rich DNA binding domain and a C-terminal region known as Osa
homology domain that confers the abilty to interact with nuclear hormone receptors
(Inoue etal. , 2002; Kozmik et aI. , 2001). Likewise , the C-terminal domain is involved in
the interaction of hOsa1 and hOsa2 with BRG1 and hBRM. Immunoprecipitations using
HeLa nuclear extracts showed that hOsa1 and hOsa2 antibodies were able to precipitate
BRG1 , hBRM and other subunits , indicating that both hOsa1 and hOsa2 interact with
BRG1 and hBRM (Inoue et aI. , 2002).
In summary, SWI/SNF complexes not only consist of many subunits but they also
exhibit significant variation in composition. We have seen that almost all of the subunits
have been structurally characterized in different organisms. The presence of conserved
structural domains in these subunits establishes the functional properties of the complex
they form part of (Mohrmann and Verrijzer, 2005). Diverse roles for the SWI/SNF
subunits have been proposed; one potential function may be to regulate the motor
activity of the ATPase subunit. In fact , at least four subunits are needed to stimulate the
BRG1 ATPase activity in vitro to levels comparable to the intact complex. These
subunits, Ini1 , BAF155 and BAF170 form , together with BRG1 , a functional catalytic
core (Phelan et aI. , 1999). It is interesting that these minimal subunits are highly
conserved from yeast through humans (see Table I) (Marenda et aI. , 2004; Phelan etal.
1999). It has been proposed that the subunits of the catalytic core might be assisting the
ATPase subunit either by increasing the affinity of the ATPase for nucleosomes
stabilizing . a particular conformation that is more active , and/or assisting remodeling
(Phelan etal. , 1999). Do these minimal subunits also constitute a catalytic core in vivo?
This question does not have a complete answer yet. Knockout mice for Brg1 , Ini1 and
BAF155 were generated , showing that all are critical for development (See section 2.4).
Furthermore , some subunits of the complex have independent functions and it is
possible that they are involved in functions other than remodeling, such as specific
targeting through regulators or repressors , complex assembling, and/or controlling
complex functions (Lusser and Kadonaga , 2003; Marenda et aI. , 2004). Moreover
different mammalian tissues contain SWI/SNF complexes that are heterogeneous in
subunit composition , indicative of specialized function (Reviewed in (Chi , 2004;
Sudarsanam and Winston , 2000)). Thus , further investigations are required in order to
precisely establish the role of each subunit within different complexes.
3) Mechanism of ATP-dependent chromatin remodeling
Even though there is clear involvement of ATP-dependent chromatin remodeling
enzymes in a variety of nuclear functions , the DNA-histone remodeling process has not
been completely revealed (lmbalzano and Xiao , 2004; Johnson et aI. , 2005; Smith and
Peterson , 2005). The studies of chromatin remodeling have been concentrated to 
vitro systems since in vivo studies are technically restricted.
The mechanism of remodeling is demonstrated by changes in the structure
and/or position of the nucleosomal DNA on the nucleosome that could be brought about
by disruption , sliding, dinucleosome formation or transfer of individual nucleosomes (Fig.
1.4) (Reviewed in (Imbalzano and Xiao , 2004; Johnson et aI. , 2005; Smith and Peterson
2005) and references therein). In addition , remodeling can cause removal or
replacement of histone dimers between nucleosomes (Review in (Flaus and Owen-
Hughes , 2004)). How are these structural changes generated? A number of potential
mechanisms have been proposed to explain chromatin remodeling, however two major
models have been preferred , the twisting and the bulging or spooling models (Flaus
and Owen-Hughes , 2004; Smith and Peterson , 2005).
In the twisting model a small local twist disrupts histone-DNA contacts and
propagates through the length of the nucleosomal DNA , generating a change in the DNA
position in respect to the core histone. This model is consistent with the capacity of the
TP-chromatin remodeling enzymes to create superhelical torsion. The bulge or looping
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Figure 1.4. Models for changes in chromatin structure mediated by A TP-dependent
chromatin remodeling enzymes (Imbalzano and Xiao , 2004).
model suggests that a region of the DNA is released as a loop from the nucleosome and
it is propagated along the surface of the nucleosome (Imbalzano and Xiao , 2004; Smith
and Peterson , 2005). Recently, Fan and colleagues proposed an alternative model
where the remodeler slides the histone octamer to a different position , via intermediates
that contain DNA loops on the histone surface. This occur, even though the remodeled
nucleosome is constrained by adjacent ones , indicating that a particular nucleosome can
be remodeled without affecting the structure of the surrounding ones (Fan et aI. , 2003).
Although experimental data support these models , there is some discrepancy.
Further investigations are necessary to clarify the mechanism of remodeling, specially
determining how remodeling occurs in vivo.
4) The mammalian SWIISNF subunits in development and differentiation.
In order to determine the role in vivo of the SWI/SNF complexes in development,
targeted disruption of specific subunits has been generated in mice. In the next
subsections these results are presented.
BRG1 and BRM
Initial studies were focused on determining the pattern of expression of mBrg1
and mBrm during early mouse development at preimplantation stages. In mature
oocytes both genes are expressed , indicative of maternal contribution. Levels of mBrg1
mRNA continued to be high during the preimplantation period. Levels of mBrm instead
showed a decline from the oocyte to the 4-cell stage and an increase from the 8 cells to
the blastocyst stage and mBrm protein was limited to the inner cell mass at the
blastocyst stage. From this study it was evident that mBrg1 and mBrm likely have
different roles regulating gene expression during early development of mammalian cells
(LeGouy et aI. , 1998). To determine the levels of expression at later stages in mouse
development, embryos and extraembryonic tissues (yolk sack and alantoid) were
evaluated from 7.5 to 18 days. mBrg1 protein was present at high concentrations in
both embryonic and extraembryonic tissues , however the levels of rrBrm were 20 to 30
fold lower than the levels of mBrg1. After birth levels of hBrm protein exceeded those of
mBrg1 in a number of organs (Reyes et aI. , 1998)
Later, the mBrm gene was inactivated by homologous recombination with the
purpose of determining the role of the mBrm-containing SWI/SNF complexes in vivo and
investigating the functional differences between mBrg1 and mBrm. Surprising, mBrm
null mice were viable and developed and reproduced normally. However, these mice
expressed high levels of mBrg1 protein in different organs compared to wild type mice,
indicating that possibly a compensatory mechanism operated. In fact, it was found that
a post-transcriptional mechanism of regulation was involved since the mRNA levels of
mBrg1 in homozygotes, heterozygotes and wild-type mice were similar. These results
indicated that mBrm and mBrg 1 functions are in part redundant (Reyes et al. , 1998).
Although null mBrm mice seemed normal , they showed some different
characteristics than the wild type mice. mBrm (-/-) mice were heavier than wild type,
and proliferation of cells in liver was higher as well. Cultures of mouse embryonic
fibroblasts (MEFs) obtained from null mice did not arrest after confluence. Certain
observations have suggested a role of mBRM in GO arrested cells. These include the
high expression in adult mice in post-mitotic cell types, cell cycle arrested cells show
more Brm than exponentially growing cells , and downregulation of Brm expression has
been observed in transformed cell lines. These observations may point to a role for Brm
in the control of cell proliferation and terminal differentiation that cannot be compensated
by mBrg1 (Reyes et aI. , 1998).
In contrast with mBrm, a mBrg1 null mutation in mice is lethaland embryos die at
the peri-implantation stage. The in vitro culture of recovered null blastocysts at day 3.
(E3.5) showed that they failed to hatch from their zona peHucidae or to stay alive 
culture. The absence of mBrg1 causes a more general effect to the embryo than the
failure to hatch. In fact, the death of the embryos at early stages and the failure of the
: it-mer cell mass (ICM) and the trophectoderm (TE) to survive was suggestive of the
requirement of mBrg1 beyond the peri- implantation stage. This result indicates that
mBrg1 is essential for early embryogenesis , but, it is not a general cell viability factor
since mBrg1 deficient fibroblasts proliferate as well as control cells (Bultman etal.
2000).
Although mBrg1 (+/-) mice are viable and seen normal , 15% of them show
exencephaly and they are susceptible to developing tumors at low frequency. The
tumors were epithelial in origin , contained glandular structures , and occurred in
subcutaneous tissues. Tumor formation in mBrg 1 (+/-) mice has been ascribed to haplo
insufficiency since loss of heterozygosity has not been revealed in tumors (Bultman et
aI. , 2000; Roberts and Orkin , 2004). In contrast , Brm (-/-)mice did not develop tumors
(Reyes et aI. , 1998).
Both mBrm and mBrg1 null mutations surprisingly generated different
phenotypes. What would be expected , considering the main function of these ATPases
is the inactivation of the whole complex and the generation of the same phenotype
(Roberts and Orkin; 2004). One possible explanation is that complexes containing Brm
or Brg1 might be recruited to different downstream target genes (Bultman et aI. , 2005).
In order to answer to this question a new mBrg1 mutation was obtained. This mutation
avoided the early embryonic lethality produced in the Brg1 null mice (Bultman et aI.
2005). Mice containing a Brg1 hypomorph allele in the ATPase domain were isolated
from an N-ethyl-N-nitrosourea (ENU) mutagenesis screen. The allele contained a point
mutation where amino acid glutamine was substituted to glycine at the putative helicase
motifs IV and Vof the catalytic ATPase domain. This region is conserved from yeast to
human and it is involved in coupling the energy from A TP hydrolysis to chromatin
remodeling (Bultman et aI. , 2005). The mutant mBrg1 protein was stable, assembled
into the SWI/SNF complex and exhibited normal ATPase activity, but the nucleosome
remodeling properties was reduced. mBrg1 null/ENU mice developed normally until E11.
to E14.5 stages, dying because of anemia caused by a blockage in the development of
the erythroid lineage. The normal development of the mBrg1 null/ENU mice raises the
possibility that mBrm could functionally compensate for mBrg1 activities in many cell
types where it is expressed; however, it could not compensate for mBgr1 activity in the
erythroid lineage , where it is absent.
These results indicate that the ATPase activity of Brg1 needs to be coupled with
chromatin remodeling activity in order for this energy to be connected to a change in
conformation and position of the nucleosomes (Bultman et aI. , 2005).
Ini1/Snf5
Investigations in malignant rhabdoid tumors and atypical teratoid tumors (also
refer as atypical teratoid/rhabdoid tumors), which are aggressive and highly lethal
cancers of early childhood , have revealed that these tumors carry specific , biallelic
inactivating mutations in the SNF5/lni1 gene (Review in (Gibbons , 2005; Mohrmann and
Verrijzer , 2005; Roberts and Orkin , 2004) and references therein). In order to
investigate the mechanism by which Ini1 is involved in tumorigenesis , and its possible
role as a tumor suppressor , three independent groups simultaneously generated , by
differenttargeting strategies , Ini1 knockout mice. Disruption of Ini1 expression is
embryonic lethal and occurs during the periimplantation stage , between 3.5 and 5.5 days
(Guidi et aI. , 2001; Klochendler-Yeivin et aI. , 2000; Robertset aI. , 2000). Analysis of Ini1
expression during embryogenesis confirmed the presence of the protein in fertilzed
: 60cytes and.twocell embryos, due to maternal stores. Ini1 expressionstartsat the 4
cell stage and is maintained during all subsequent developmental periods. Ini1 protein is
present in embryos ubiquitously, but predominantly concentrated in the headfolds
neural folds , first branchialarch and hindlimb bud (Guidi et aI. , 2001; Klochendler-Yeivin
etal., 2000; Roberts eta!. , 2000).
The in vitro culture of recovered nulllni1 blastocysts at day 3.5 (E3.5) showed
two different results. Klochendler-Yeivin and colleagues found that one third of the Ini1-
null embryos failed to hatch from the zona pellucida , while the rest of them emerged , but
the trophectoderm did hot spread , suggestive of a trophectoderm defect (Klochendler-
Yeivin et aI. , 2000). However, Guidi and colleagues showed that 100% of the null
blastocysts in culture did not hatch and expand in culture , which is indicative of hatching
defect. Even more, manual disruption of the zona pellucida from null blastocysts
showed a failure ofthe inner cell mass and the trophectoderm to expand. As was the
case of mBrg1 knockout mice, this result indicates that Ini1 was required beyond the
peri- implantation stage (Guidi et aI. , 2001).
Ini1 heterozygous mice developed normally but are highly susceptible to tumor
formation in the head or neck regions of the mice , predominantly in the soft tissue of the
face. The analysis of the expression of Ini1 protein from tumors showed the absence of
Inii1, indicative of loss of heterozygosity (LOH) at the Ini1 locus. LOH is the main reason
for the tumor development in the heterozygote mice , a characteristic of classical tumor
suppressors (Guidi et aI. , 2001; Klochendler- Yeivin et aI. , 2000; Roberts et aI. , 2000).
In order to understand the molecular mechanisms by which INI1 suppresses
tumor formation , several groups have investigated the effect of reintroduction of the INI1
gene in INl1-deficient cancer cell lines. The results have shown that cells undergo cell
cycle arrest in GO/G1 , which indicates that INI1 function limits cell division. However, the
mechanisms differ indifferent tumor cell lines (Roberts and Orkin , 2004).
Is the tumor suppressor activity ofl N 11 mediated via effect on the integrity of the
SWIISNF complex? The answer should be yes if we extrapolate from results obtained
from the yeast SWI/SNF complex. Deletions and/or mutation of any subunit causes
disassembly of the complex (Peterson et aI. , 1994). However , it was shown that the
assembly of the SWI/SNF complex in human cells can occur independently of INI1
subunit. Moreover , some genes that require BRG1 do not require INI1 (Doan et aI.
2004). Therefore, it is possible that the mechanism of tumor suppression by INI1 is not
related to the integrity of a functionalSWIlSNF complex , but instead to an independent
activity (Doan et aI. , 2004).
BAF155 ISrg3
Srg3 is the mouse homolog of the yeast Swi3 , the Drosophila Moira/BAP155
and the human BAF155. As it was mentioned previously, this subunit is a component of
the catalytic core of SWI/SNF complexes. To examine the in vivo function of Srg3, Kim
and colleagues generated knockout mice for Srg3 (Kim et aI. , 2001). As was
demonstrated for mBrg1 and mlni1 , absence of Srg3 in mice resulted also in early
embryonic lethality. The expression pattern of this subunit during mouse development
from E7.5 to E10.5 embryos, showed that Srg3 protein was present constitutively in all of
the stages. Following stages from E12.5 to E18. 5 were evaluated with in situ
hybridization. Srg3 expression pattern coincided with that of mBrg1 , but with some
differences. Embryos at E12.5 and E14.5 expressed high levels of Srg3 in almost all
organs, excluding heart and liver; mBrg1 was found in spinal cord , brain and thymus. At
: E16. 5 Srg3 was evidenced in lung, intestine , thymus and central nervous system. As
the embryos developed further, expression of Srg3 changed , becoming restricted to the
thymus and central nervous system (Kim et aI. , 2001). Since Srg3 is expressed in
additional regions of the embryos, the authors suggested that Srg3 may have alternative
and independent function exclusive of its role in SWI/SNF remodeling activity. However
pattern of expression of mBRM was not determined in these embryos; therefore it may
be possible that Srg3 is present in mBRM complex.
Blastocysts from null embryos at E3. 5 cultured in vitro undergo hatching,
adherence , and formation of trophoblast giant cells , although the inner mass
degenerate. Levels of Brg1 Were stable during these experiments (Kim et aI. , 2001).
Although heterozygous mice looked normal , around 20% of them developed
exencephaly a condition that includes defects in brain growth and organization (Kim et
aI. , 2001). Exencephaly was also seen in heterozygous Brg1 mice (Bultman et aI.
2000). It has not been confirmed if Srg3 heterozygotes are susceptible to spontaneous
neoplasia , as was demonstrated for mBrg1 and Ini1 (Kimet aI. , 2001).
Polybromo/BAF180
As mentioned in a previous section , BAF180 represents a specific subunit of the
SWI/SNF (PBAF) complex (Table I). In order to determine its role in the PBAF complex
. BAF180 knockout mice were generated (Wang et aI. , 2004). The expression of BAF180
is ubiquitous during mouse embryogenesis and also in extraembryonic tissues , such as
the yolk sac and placenta. Disruption ofBAF180 is embryonic lethal and mice embryos
die between E12.5 and E15.5 of gestation. Examination of null embryos showed that
the majority of the organs were present , but liver and lung were smaller and hearts
exhibited incomplete development of the cardiac ventricular free walls and ventricular
septa. Analysis of the nature of the heart defects showed that it was not a consequence
of apoptosis but instead a failure in cell growth and differentiation (Wang et aI.
, 2004).
Because BAF180 is expressed also in placenta , examination for defects was performed.
Placentas were abnormal at the labyrinthine layer, where groups of trophoblasts
replaced maternal and fetal blood space, putting at risk the maternal-fetal exchange. In
order to determine that the defect in heart development was due to a direct effect of
BAF180 disruption , Wang and colleagues performed tetraploid aggregation experiments
to rescue the placenta and complementary fusion experiments. The results confirmed a
direct role for BAF180 in the heart development and not an indirect effect caused by
the placenta (Wang et aI. , 2004).
Gene expression profiles of the wild type and mutant hearts where obtained by
microarray analysis. Potential target genes involved in heart development were
identified and the presence of BAF180 was found on the promoters of some of these
genes. Therefore , these studies demonstrated a contribution of BAF180 in the
maturation of the cardiac chamber by mediating the expression of genes involved in cell
1 ,
growth and proliferation. This function is specific to this subunit and differs from the
roles ofBrg1, BAF155, and Ini1 subunits in early embryogenesis.
BAF60c
Another subunit of the mammalian SWI/SNF BAF complexes examined during
mouse development was BAF60c. Levels of BAF60c mRNA and protein are detected
starting at day 7.5 during development , being concentrated in the lateral mesoderm
: (LPM) that wil contribute to the heart. As development progresses , BAF60c is found in
the heart at the looping heart tube, in somites and in the midline of the neural tube
(Debril et aI. , 2004; Lickert et aI., 2004). The role of BAF60c in developing mice was
determined by Lickert and colleagues using an embryonic stem cell-mediated transgenic
RNA interference strategy: Knockdown of BAF60c caused cardiac malformations with
lethality at E1 0.0 to E11.0. The heart contained a single ventricle connected to an
abnormal outflow tract and the myocardial wall looked rougher. Additionally, the
silencing of BAF60c caused failure of forebrain closure and disordered somites. The
analysis of markers of primary and anterior/secondary heart fields were delayed in the
knockdown mice, but the expression of primary and secondary heart fields was normal
(Lickert et aI. , 2004).
The transcriptional activity of BAF60c was demonstrated in vitro by transient
reporter assays. BAF60c overexpressed in cell culture mediated interactions between
specific heart transcription factors and SWI/SNF through Brg1 , potentiating the
expression of the target genes. The tissue-specific expression of BAF60c is a good
example of how the interactions of transcription factors and remodeling enzymes are
established specifically to regulate particular genes during tissue morphogenesis.
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Disruption of the core subunits in the SWIISNF complex , including Brg1 , Ini1 and
BAF155 , produced early lethality at the peri-implantation stage. Disruption of other
subunits , like BAF180 , which distinguishes BAF from PBAF complexes, and BAF60c
which is expressed in a tissue specific manner, resulted in lethality, but at later stages
where they affect a particular organ/tissue. Individual subunits have differential functions
within a cell type. There are isoforms of BAF subunits that are thought to mediate the
functions of the SWI/SNF complexes in a tissue specific manner, such as the neuron-
specific BAF53b (Olave et aI. , 2002). Detailed structural and functional analysis of the
unique and distinguishing subunits in the SWI/SNF complexes will ultimately help us
better understand how these complex chromatin remodeling cofactors work individually
or in concert to guide expression , cell growth , and organ development (Wang et aI.
2004).
We have seen the involvement of SWI/SNF in early and middle development and
its role in tumor suppression. The following will summarized the differentiation events in
which SWI/SNF remodeling enzymes participate. These studies not only have
demonstrated the contribution of SWI/SNF in cellular differentiation , but also have
defined the mechanisms by which SWI/SNF activity promotes gene expression. To
perform these studies the use of tissue culture models of differentiation has been pivotal.
SWI/SNF and cellular differentiation
Myeloid differentiation
The first endogenous mammalian genes shown to be controlled by SWI/SNF
complexes were the myeloid specific genes (Kowenz-Leutz and Leutz , 1999). During
" ,
myeloid differentiation two major transcription factors , C/EBP~ and Myb , collaborate to
activate specific myeloid genes. In fact , overexpression of both activators in
heterologous cell lines , such as fibroblasts, induces the expression of odginally silent
myeloid-specific genes. It was demonstrated that transcriptional activation mediated by
C/EBP~-Myb involves the recruitment of SWI/SNF complex , via direct interaction of Brm
with the N-terminal region of the C/EBPB activator. If this C/EBP~ domain is transferred
to Myb , the resulting chimera is able to activate myeloid genes in the absence of
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C/EBP~ (Kowenz-Leutz and Leutz , 1999). Thus , interaction of C/EBP~ and SWI/SNF is
crucial for activating a subgroup of genes involved in myeloid differentiation.
Enterocyte differentiation
The human epithelial cell line CaCo-2 spontaneously differentiates from a
cryptlketo a villous like enterocyte and expresses several markers, including the well
characterized a1-antitrypsin gene. The a1-'antitrypsin gene is regulated by the
hepatocyte nuclear factors HNF-1 a and HNF-4a that function synergistically (Hu and
Perlmutter, 1999). In an analysis of the temporal recruitment of factors to the human a1-
antitrypsin promoter during enterocyte differentiation , transient binding of hBRM
occurred. The major events during differentiation included the stable association of
HNF-4a and hBRM at the promoter, the remodeling of one of the two nuclesomes (the
one containing the TAT A box and the transcription start site) and transcription initiation
(Soutoglou and Talianidis, 2002). Therefore , chromatin remodeling by the SWI/SNF
complex is crucial for the activation of the a1-antitrypsin gene expression.
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Muscle differentiation
Skeletal muscle differentiation involves the activation of specific genes by the
action of two families of transcription factors: the myogenic basic helix loop helix (bHLH)
family, which includes MyoD , Myf5 , myogenin , and MRF4 and the myocyte enhancer
factor 2 (MEF2) family (Berkes and Tapscott , 2005). Each ofthe members of the
myogenic family of transcription factors is able to initiate the muscle differentiation
program when they are ectopically expressed in different cell lines. Activation of muscle
specific genes in fibroblasts overexpressing any of the members of the myogenic family,
is abrogated by the presence of dominant negative versions of hBRG1 or hBRM (see
below) (de la Serna et aI. , 2001 b; Roy etal. , 2002). Induction of the muscle-specific
genes required SWI/SNFactivity to facilitate chromatin remodeling at the endogenous
specific promoter (de la Serna et aI. , 2001b). Consequently, these studies demonstrated
the crucial role of SWI/SNF enzymes in the initiation of the muscle differentiation
program. Furthermore , a recent study using microarray analysis of cells differentiated by
MyoD in the presence or absence of dominant-negative BRG1
, showed that one-third of
the MyoD- induced genes were dependent on SWI/SNF enzyme activity (dela Serna et
a/. , 2005) Chromatin immunoprecipitation (ChiP) at the myogenin promoter confirmed
the presence of BRG1 during differentiation. In the presence Of dominant-negative
BRG1 , the recruitment of MyoD transcription factor was prevented and transcription was
prevented (de la Serna et aI., 2005).
Adipocyte differentiation
The main goal of this thesis was to determine the role of SWI/SNFchromatin
remodeling enzymes in adipocyte differentiation. Prior to this work there were not
I' 
publications on the role of chromatin remodeling enzymes during adipocyte
differentiation.
After the isolation and characterization of the human SWI/SNFcomplexes as
A TP dependent chromatin remodeling machines that alter nucleosome structure
(Imbalzano et aI. , 1994; Kwon et aI. , 1994), Anthony Imbalzano s laboratory major aim
was the identification of endogenous cellular loci whose activation and expression is
. dependent on chromatin remodeling by the mammalian SWI/SNF complexes. In order
: to determine the role ofthe mammalianSWI/SNF complexes, Imbalzano and colleagues
generated cell lines that inducibly express either hBRG1 or hBRM subunits that are
. mutated in theATP binding site and FLAG tag. The purpose was to create non-
functional hSWI/SNF complexes via sequestration of BAF subunits into complexes with
the mutated hBRG10r BRM Thus, genes which activation requires SWI/SNF activity
would be impaired in cells expressing dominant negative version of the complexes (de
La Serna et aI. , 2000). .
Conditional expression was performed using the Tet repressor system. Briefly,
NIH3T3 cells were stably transfected with the vector that encodes a Tet-VP16 regulatory
protein (Fig. 1.5), which is a fusion of the DNA binding domain of the Tet repressor with
the activation domain of the herpes simplex virus activator VP16 , and a vector encoding
drug resistance. The fusion protein is active in the absence of tetracycline and can
promote expression from promoters containing a binding site for Tet repressor.
Subsequently, the cells were transfected with the Tet responsive vector containing an
epitope (FLAG) tagged dominant versions of the hBRG1 or BRM (Fig. 1.5). The cell lines
generated that inducibly express FLAG tagged dominant negative hBRM were named
, I
Figure 1.5. Generation of dominant negative BRG1 and hBRM cell lines.
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H" lines and the cell lines that inducibly express FLAG tagged dominant negative
BRG1 were named"B" lines. The parental cell line Tet-VP16 which contains the Tet
regulator was used as control. Initially, these cells lines were used to demonstrate that
dominant negative SWI/SNFenzymes inhibits the activation of the cellular stress
response when activated by environmental stresses (de La Serna et aI. , 2000).
Subsequently, de la Serna and colleagues demonstrated that hSWI/SNF ezymes. are
required for muscle differentiation (see above) (de la Serna et aI. , 2001a). Because
oomponentsof the mammalian SWI/SNF complexes were required for the initiation of
skeletal muscle differentiation , we ask ifthese' remodelingenzymes were also involved
in adipocyte differentiation.
Why are adipocyte differentiation studies important? Adipogenesis is the
process by which mature fat cells are formed from preadipocytes. Adipose tissue 
considered as a global regulator of energy metabolism. Excessive development of
adipocyte tissue causes pathologies , including obesity. Adipocyte related diseases
including diabetes type II and atherosclerosis have been established as serious health
problems. Consequently, all aspects of adipocyte biology, including adipogenesis , and
the sequence of transcriptional events during adipogenesis have become targets of
intense scientific investigation.
Abrief summary of this thesis research is presented here. In chapter II this work
will be discussed thoroughly.
The main transcription factors involved in adipocyte differentiation are members
of the basic leucine zipper (bZIP) family of CCAAT/enhancer binding proteins (C/EBPs),
specifically C/EBP~, and a and the nuclear hormone receptor peroxisome proliferator-
activated receptor (PPARy). Any of these activators , except for C/EBPb, when
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ectopically expressed in non-adipocyte cell lines is sufficient to drive the complete
program of adipogenesis (Tontonoz et aI. , 1994b; Wu et aI. , 1995a; Yeh et aI. , 1995).
We found that adipogenesis and induction of PPARy forced by overexpression of
the adipogenic activators was blocked upon expression of dominant negative hBRG1 or
hBRM. The recruitment of BRG1 , BRM , and Ini1 to adipocyte specific promoters
indicated that SWI/SNF enzymes were involved in the activation of these genes during
adipocyte differentiation (Salma et aI. , 2004).
During this thesis work , using a different approach , Pedersen and colleagues
showed that the capacity of C/EBPa to mediate adipocyte differentiation depends on a
domain present in C/EBPa which is responsible for establishing the interaction with
SWI/SNF components Brm and BAF155. Therefore, SWI/SNF recruitment is critical for
C/EBPa-mediated adipogenesis (Pedersen et aI., 2001).
In the following sections of this thesis , general aspects of adipogenesis , including
adipocyte tissue and development , sequence of events during adipocyte differentiation
and transcription factors involved in adipogenesis will be covered.
3) Adipogenesis
To study the molecular events and the involvement of SWI/SNF function during
adipocyte differentiation, a well established cell model was chosen. Adipocyte
differentiation can be examined when immortalized preadipocytes undergo differentiation
to adipocytes after hormonal stimulation. These adipocytes exhibit a typical
morphological and biochemical characteristic of fat cells found in situ (Green and
Kehinde , 1975; Green and Meuth , 1974; Hwang et aI. , 1997). Adipogenesis can also be
assessed using non-adipogenic cell lines (such as dominant negative BRG1, BRM and
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Tet-VP16 cell lines) by forcing them to differentiate by ectopic expression of specific
adipocyte transcription factors.
1) Adipose tissue
Adipose tissue isa specialized connective tissue that functions as the main
storage place for fat in the form of triglycerides during times when caloric input exceeds
expenditure. In contrast , when caloric expenditure exceeds intake, the reserves are
: mobilized to supply energy in the form of fatty acids or heat. Thereare two kinds of
adipose tissue found in mammals , the white adipose tissue (W A T) and the brown
adipose tissue (BAT). Adipose tissue is found distributed at sites rich in loose
connective tissues such as subcutaneous layers. It is also found in fat depots through
the body and is divided in subcutaneous and visceral depots (Fig. 1.6). In small
mammals BAT is primarily found in the intercapsular, subcapsular, axillary, intercostal
perineal and periaortic regions. In humans and in larger mammals , BAT is found during
development but after birth the BAT become more like WAT. In small mammals , both
WAT and BAT are found in the same depots (Cinti , 2005; Sell et aI. , 2004).
Brown adipose tissue differs in structure and function from the white adipose.
Structurally, brown adipose cells contain small multilocular lipid droplets whereas the
white adipose cell is composed of larger unilocular lipid droplets. In addition , brown
adipose cells are rich in large mitochondrias that express the unique uncoupling protein-
1 (UCP-1). The UCP-1 gives the cells mitochondria the ability to uncouple oxidative
phosphorylation and use the substrates to generate heat. Exposure to cold stimulates
the sympathetic nervous system , releasing norepinephrine , which in turn promotes the
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Figure 1.6. The adipose organ of an adult mouse. The organ is made up of two
subcutaneous and several visceral depots. The most representative visceral depots are
shown. White areas made up of WAT and brown areas of BAT are indicated (Cinti
2005).
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oxidation of fatty acids in the mitochondria and the consequent release of heat. On the
other hand , sympathetic stimulation on white fat promotes the hydrolysis of triglycerides,
and the release of fatty acid and glycerol (Cinti , 2005; Klaus, 1997; Kuroshima, 1993).
Adipose tissue is no longer considered a passive reservoir of energy. Numerous
studies indicate that adipocytes play an active role in the control of the whole body
metabolism and homeostasis through the secretion of paracrine and endocrine factors in
addition to other regulatory factors (Fig. 1.7) (Kershaw and Flier, 2004; MacDougald and
:Mandrup, 2002; Morrison and Farmer, 2000; Otto and Lane , 2005). Understanding the
development and mechanisms that regulate adipogenesis , adipocyte growth and
metabolism as well as the identification of adipose-secreted factors has been the focus
of many investigations since adipose tissue is involved in a number of pathologies
associated with obesity and its related disorders (Morrison and Farmer, 2000).
Lastly, it is important to mention that different adipose depots exhibit significant
heterogeneity. It has been proposed that the observed difference is possibly the result 
variation of their endocrine function. Adipose depots show particular adipokine
(bioactive peptides expressed by adipose tissue) expression and an exclusive receptor
expression , which gives them the capacity to respond appropriately. All of these
differences between adipose depots indicate that this tissue not only function as an
endocrine organ , but also as group of "distinctive organs" (Kershaw and Flier , 2004).
2) Adipose development
In vivo
Mammalian adipose cells originate from multipotent mesenchymal stem cells
(MSC) in the mesoderm during mid to late gestation. In the emergent fat pad , MSC
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metabolism in the storage of free fatt acid and in glucose metabolism through
expression of the insulin.;dependent glucose transporter, Glut 4. Endocrine functions
include secretion of tumor necrosis factor a, interleukin- , adipsin and adiponectin
(Morrison and Farmer, 2000).
become committed to the adipocyte lineage under the control of factors still unidentified
in vivo. The process that converts MSC into preadipocytes is known as determination.
The time of adipose development varies between species and the adipose depot. After
birth , adipocytes expand as a result of an increase in adipocyte size and in the number
of preadipocytes. New adipocytes are continually generated and expand even in the
adult stage (Fig. 1.8) (Reviewed in (Gregoire et aI. , 1998; Novakofski , 2004; Rosen
2002) and references therein).
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In vitro
Since the development of immortal preadipocyte cell lines by Green and
colleagues in the1970s, the study of adipocyte development and physiology has been
possible. Even though there are some disadvantages of the in vitro system , fat
differentiation in vitro is reliable and valid, since it recapitulates almost all of the
characteristics during the adipogenesis process in vivo, including morphological changes
and expression ofadipocyte genes such as those involved in lipid metabolisms
, glucose
metabolism , as well as those involved in insulin sensitivity (Rosen
, 2002). All in vitro
systems have limitations; with increasing culture passages
, the proliferative capacity and
the differentiation potential decreases (Feve , 2005).
Cell culture models of differentiation
Various cell lines have been used to study the molecular and cellular events that
take place during the adipocyte differentiation process. These include the multipotent
stem cells 1 OT1/2 that can undergo differentiation into adipocytes
, myocytes or
l:.
chondrocyte and the well characterized preadipocyte cell line 3T3-L1 that are
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Figure 1.8. Adipose tissue development.
(htt ://ciasses.aces.uiuc.edu/AnSci312/Adi ose/Adi lect.htm 
' '
111
commitment to differentiate into adipocytes. 1 OT1/2 cells represent an early stage in the
adipose development and 3T3-L1 a late stage (Fig. 1.9) (Cornelius et aI. , 1994; Feve,
2005). Preadipocyte cell lines such as 3T3-L 1 and 3T3-F442A were isolated from
disaggregated mouse embryo cells and selected for their ability to accumulate fat (Green
and Kehinde , 1975; Green and Meuth , 1974). When preadipocyte cell lines are treated
with external inducers, they differentiate into cells that are morphologically,
biochemically, and functionally identical to mature adipocytes. Evidence indicate that
: these cell systems recapitulate the whole differentiation process in vivo in fact
transplantation of these preadipocyte cell lines into mice results in development of
normal fat pads indistinguishable from the adipose pad (Reviewed in (Cornelius et aI.
1994 )).
Non-adipogenic fibroblasts can be forced to differentiate into adipocytes when
master regulators of adipocyte differentiation , such as C/EBPa or PPARy are ectopically
overexpressed in these cells. After overexpression of regulators , the cells are treated
with the same differentiation cocktail used to differentiate preadypocytes.
Protocols that allow a highly efficient differentiation of preadipocytes in culture
have been developed. For 3T3-L 1 cell lines , the well established differentiation cocktail
consists of dexamethasone , a synthetic glucocorticoid agonist, insulin , a hormone that
acts through the insulin- like factor 1 (IGF-1) receptor in preadipocytes
methylisobutylxanthine (MIX), a cAMP phosphodiesterase inhibitor, and fetal calf serum
(Cornelius et aI. , 1994; Student etal. , 1980).
How do these differentiation inducers activate adipocyte differentiation? The
insulin/insulin- like growth factor (IGF-1) signaling pathway contributes to adipocyte
differentiation through complex signaling networks that playa significant role during
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adipogenesis. Insulin exerts its effect on differentiation through the insulin-like growth
factor (IGF-1 R) receptor at high concentrations and not through the insulin receptor (IR),
whose concentration is low in preadipocytes. During adipogenesis , IR levels increase.
The participation of IGF-1 R in adipocyte differentiation implies that a tyrosine kinase-
mediated signaling pathway is involved. Data support the idea that the tyrosine kinase
involved may be the IGF- 1 R tyrosine kinase. Insulin effects include the activation of the
extracellular signal-regulated kinase (ERK) pathway, which is important at the
: proliferative phase. ERK activity is also necessary for the expression of the adipogenic
activators C/EBPa, ~, and 0 and PPARy (Reviewed in (Bost et aI. , 2005)1.
Glucocorticoidsare another inducer required for preadipocytes to progress
through clonal expansion and terminal differentiation. The role of glucocorticoid receptor
during adipogenesis is still not clear at molecular level; evidence suggest that
adipogenesis stimulated by glucocorticoids may be mediated by its capacity to reduce
the levels of preadipocyte factor- , an antiadipogenic epidermal growth factor that is
expressed in preadipocytes (Rangwala and Lazar, 2000). It is known that
glucocorticoids activate phospholipase A2, which triggers the release of arachidonic acid
for prostaglandin (PGI2 and PGF2a) synthesis. The increase of PGI2 causes an
increase in cAMP and Ca + levels , which then regulate differentiation (MacDougald and
Lane, 1995b). Glucocorticoid activity though its receptor is also involved in the activation
of the expression ofthe adipogenic regulators, C/EBPo and PPARy (Cao et aI., 1991;
Wu et aI. , 1996); Methylisobutylxanthine (MIX) is other component of the differentiation
cocktail. It is a synthetic organic chemical that inhibits phosphodiesterases , causing an
increase in the intracellular level of cAMP(Wu et aI. , 1996; Wu et aI. , 1995b). The
cellular target of cAMP is the protein kinase A, which catalyzes the phosphorylation of
the cAMP response element binding protein (CREB) at serine 133 , and its ability to
activate the transcription of C/EBP~. Additionally, CREB can be phosphorylated by
insulin action. The transcription factor Sp1 negatively regulates C/EBPa through a Sp1
site on the C/EBPa promoter. The levels of Sp1 decrease by the action of (MIX)
(Rangwala and Lazar, 2000; Zhang et aI. , 2004a). Fatty acids and peroxisome
proliferators are also activators of adipogenesis , acting synergistically with other
inducers (MacDougald and Lane , 1995a).
The use of preadipocyte cell lines has allowed the characterization of the
sequence of events during adipogenesis as well as the identification of the master
regulatory proteins that control the process (Hwang et aI. , 1997).
3) Sequence of events during differentiation in vitro
The developmental program in vitro can be defined by four stages , preconfluent
proliferation , confluence/growth arrest, hormonal induction/mitotic clonal expansion
(MCE) and terminal differentiation. Each stage is characterized by the coordinated
expression of specific genes. Preconfluent preadipocytes express the preadipocyte
factor 1 (Pref-1) which is responsible for maintaining the undifferentiated state. Once
confluence is reached , cells arrest at the GO/G1 phase of the cell cycle. At this stage
occurs early expression of genes such as lipoprotein lipase (LPL), a2 chain type VI
collagen , and fatty acid activated receptor (FAAR). The induction of these genes is
regulated byautocrine/paracrine mechanism(s) and mediated by cell-cell contacts.
(Review in (Amri et aI. , 1986; Gregoire et aI. , 1998; MacDougald and Lane , 1995b)).
When cells are exposed to adipogenic inducers , they synchronously enter S phase of
the cell cycle and undergo one or two rounds of mitosis. Early changes that occur
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during clonal expansion include the early expression of two regulators, the CCAA 
enhancer binding proteins C/EBP~ and C/EBP3, which are induceq by the effects of
IBMX and dexamethasone , respectively (Rangwala and Lazar , 2000; Yeh et aI. , 1995).
After clonal expansion , expression of both regulators decreases and is replaced by
C/EBPa (see below) (Cao etal. , 1991; Yeh et aI. , 1995).
It is important to emphasize that MCE is required for the progression of the
differentiation program , ahd thatC/EBP~ participation is essential (Tang et aI., 2003a;
. i-
fang et al. 2003b; Zhang et aI. , 2004b). To demonstrate the role ofC/EBP~ in MCE,
Tang and colleagues examined the effect of C/EBP deficiency in mouse embryo
fibroblasts (MEFs). They found that C/EBP~ (-/-) MEFs formed neither mitotic foci nor
adipocyte cells. Reintroduction of CIEBP~ LAP or LIP isoforms (described later) in the
deficient MEFs showed that the C/EBP LAP (active form) re-established both MCE and
adipogenesis. In contrast C/EBP~ LIP (dominant negative) was not able to restore these
functions. These results indicate that C/EBP~ has a dual role in adipogenesis, as a
transcriptional activator involved in the expression of PPARy and C/EBPa (both gene
promoters contain C/EBP sites) and playing a role during MCE (Tang et aI., 2003a).
Experiments that support C/EBP function in MCE were performed by Zhang and
colleagues using a dominant negative A-zip C/EBP , which contains the leucine zipper
but lacks functional DNA-binding and transactivation domains. This protein
heterodimerizes with the bZip region of C/EBP~ and generate a stable coiled-coil
complex unable to bind DNA. Forced expression of the A-zip C/EBP prevented C/EBP~
translocation to the nucleus , resulting in a block to MCE and adipogenesis (Zhang et aI.
2004b ).
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During the terminal phase of differentiation, cells exit the cell cycle and express
the master regulators of adipogenesis, peroxisome proliferator-activated receptor-
(PPARy) and C/EBPa, which then activate a large number of adipocyte genes.
Expression of both genes is maintained in mature adipocytes (Rangwala and Lazar
2000). In addition to C/EBPs and PPARyexpression, other regulators are involved (see
below).
C/EBPa is responsible for the maintenance of the terminal differentiated state in
adipocytes, since it functions by blocking mitosis (Christy et aI., 1989; Umeket aI.
1991). PPARy is also involved in growth arrest , and acts cooperatively in this activity
with C/EBPa (Altiok et aI. , 1997). C/EBPa has the capacity toautoregulate its own
expression due to the presence of a C/EBP binding in the proximal promoter (Christy et
aI. , 1991; Lin and Lane, 1992). Also , C/EBPa and PPARy regulate each others
expression (Hamm et aI., 1999; Shao and Lazar , 1997).
4) Transcription factors involved in adipogenesis
Many molecular aspects of adipogenesis can be illustrated as a cascade of gene
expression regulated by a set of transcription factors. At least four transcription factors
playa significant regulatory role during adipocyte differentiation. These include the
already mentioned master regulators C/EBPs and PPARy, and also the SREBP1/ADD1
and the STAT proteins (Fig. 1,10) (Kim and Spiegelman , 1996; Kim etaL , 1995;
Stephens et aI., 1996). Because this thesis concentrated in the role of C/EBPs and
PPARy proteins, in the following sections the role of these factors during adipogenesis
will be discussed.
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Figure 1. 10. Molecular pathway of transcriptional events mediating adipocyte
differentiation. Direct or indirect transcriptional events are indicated in solid lines.
Broken lines represent interactions that are less understood. Abbreviations: ADD1 
adipocyte determination and differentiation dependent factor 1; C/EBP , CCAA T
enhancer binding protein; PPARy, peroxisome proliferator activated receptor y, RXR , In
the retinoic X receptor; SREBP , sterol regulatory element binding proteins; STAT , signal
transducers and activators of transcription (Morrison and Farmer, 2000).
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1) C/EBPs
CCMT/enhancer-binding protein (C/EBP) was discovered as a heat stable
protein in rat liver nuclei able to bind to a CCM T box motif present in a number of
cellular gene promoters and in the "core homology" sequence of viral enhancers
(Landschulz et aI. , 1988). The cloning of the C/EBP gene (later designated C/EBPa) led
to the discovery of the basic-leucine zipper (bZIP) class of DNA-binding and dimerization
domain present in a number of transcription factors (Review in (McKnight, 2001; Ramji
and Foka, 2002)). Later on , other members of the family were cloned and sequenced
and they were called C/EBPa, C/EBP~, C/EBP3 , C/EBPy C/EBPE, and C/EBPs (also
known as CHOP-10) (Otto and Lane , 2005; Schrem etal. , 2004). These transcription
factors are involved in a number of cellular processes like cell cycle control, liver
regeneration and liver specific gene regulation , apoptosis, immune and inflammatory
processes, circadian gene regulation and in the control of a number of differentiation
processes (Ramji and Foka, 2002; Schrem et aI. , 2004). The isoforms involved in
adipocyte differentiation are: C/EBPa, C/EBP~, C/EBP3, and CHOP10.
The protein structure of all of the members of the family consist of three structural
components including a C-terminalleucine-zipper (consisting of a heptad repeat offour
or five leucine residues), a basic DNA-binding region , and an N-terminal transactivating
region (Fig. 1.11) (Reviewed in (Otto and Lane , 2005; Ramji and Foka , 2002; Schrem et
aI. , 2004)). Electrostatic interactions between amino acids along the dimerization
domain (leucine-zipper) establish the specificity of dimer formation (Reviewed in (Ramji
and Foka , 2002)). Dimerization of the C- terminal region is highly conserved and confers
the ability to bind DNA and to form homo or heterodimers with other members of the
family. C/EBP dimerization is a requirement for DNA binding (Landschulz et aI. , 1988).
':!.,:
CIEBPu p42
p30
ClEBPJ3 1.AP*
1.AP
Cl1: 0 ".
ClEO'"/)
ClEBPr. p32
1)30
p27
pl4
C/I-:Pl;
11'
RD AD ZII
I!nl
, . , '. , ;: .
Dlun
i :; ;, ;
nnn
Figure 1.11. Schematic representation of the C/EBP family members. The leucine
zipper is shown in yellow , with black vertical lines indicating the leucine residues, and
the basic region is colored red. The position of the activation domains (AD) and negative
regulatory domains (RD) are shown in green and blue respectively (Ramji and Foka,
2002).
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In the case of CHOP- 1 0 , the DNA-binding domain is not functional; as a consequence
heterodimers formed with this isoform cannot bind to the C/EBP site in the promoter of
target genes, thus acting as a dominant negative of C/EBP function. However, CHOP-
10/CEBP heterodimers can recognize a distinct DNA sequence when cells are exposed
to stress (Otto and Lane , 2005; Ramji and Foka, 2002). The basic DNA-binding region
of the C/EBP proteins determines the DNA binding specificity (Reviewed in (Lekstrom-
Himes and Xanthopoulos , 1998)).
The N-termini of the C/EBPs are more divergent , although there are three
separated subregions , also termed transactivation elements that are conserved in most
of the members. These subregions are important to establish direct or indirect
interaction with components of the basal transcription machinery (Ramji and Foka,
2002). In fact , the transactivation elements in C/EBPa activate transcription and
cooperatively mediate in vitro binding of C/EBPa to TBP and TFIIB (Nerlov and Ziff
1994; Nerlov and Ziff, 1 995). Functional interaction of transactivation elements with
components of the SWI/SNF complex has been demonstrated (Pedersen et aI. , 2001).
Furthermore , it was shown in vitro that C/EBPa , C/EBP~ and C/EBPo interact with p300
and CREB-binding protein (CBP) coactivator. These interactions potentiate C/EBP
transactivation (Erickson et aI. , 2001; Kovacs et aI. , 2003; Schwartz et aI. , 2003). The
terminus also contain one or two regulatory domains , involved in DNA binding
inhibition in a cell type specific manner (Lekstrom-Himes and Xanthopoulos, 1998).
Some of the C/EBP members produce N-terminal truncated proteins, which are
products of alternative usage of translation initiation codons in the same mRNA due to
leaky ribosomal scanning or by regulated proteolysis. C/EBPa produces two isoforms of
42 kDa and 30kDa. The smaller isoform is a less potent transcriptional activator.
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C/EBP~ mRNA produces three isoforms: the 38 kDa and 35 kDa species termed liver
activating protein (LAP), and the 20 kDa liver inhibitory protein (LI P). LIP does not
contain the N-terminal domain , and it functions as a dominant-negative regulator
(Reviewed in (Otto and Lane; 2005; Ramji and Foka , 2002) and references therein).
The expression of the C/EBP family members differs in different tissues.
C/EBPa is highly expressed in adipose tissue , liver , intestine , lung, adrenal gland , blood
mononuclear cells and placenta. In liver and adipose tissue , significant levels of
e/EBPa are detected in differentiated tissue (Lekstrom-Himes and Xanthopoulos , 1998).
CIEBP~ is present in liver, intestine , lung, adipocyte tissue , spleen, kidney, and
myelomonocytic cells. C/EBPb is expressed in adipose tissue , lung and intestine.
C/EBPyand CHOP-10 are present in all tissues, and C/EBPE is only present in myeloid
and lymphoid cells (Reviewed in (Schrem et aI. , 2004)).
C/EBP deficient animal models
Disruption of C/EBPa
Mice homozygous for the targeted deletion of the C/EBPa gene appear normal to
wild mice, but they die 8 hours after birth. The levels of blood glucose were significantly
low , a sign of hypoglycemia. Analysis of embryo (E18) and newborn livers showed the
absence of glycogen , which is indicative of interference of hepatic glycogen synthesis.
The analysis of subcutaneous inguinal WAT and BAT confirmed their absence in the null
animals. In contrast, the intercapsular regions presented the same amount of immature
BAT as the control mice at seven hours after birth; however , by 32 hours postpartum the
volume of BAT did not increase. Analysis of the brown adipocytes indicated that null
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mice failed to accumulate fat in BAT. Molecular analysis of the adipocyte markers
showed a reduction in the expression of UCP1 , but no affects on the expression of Glut
4and aP2 (Wang et aI. , 1995). In conclusion , C/EPBa null mice show significant
reduction in lipid accumulation in both W AT and BAT depots and failure of
gluconeogenesis in the liver. Mice die very early after birth as a result of a severe
metabolic disorder that causes hypoglycemia. C/EBP~ and 8 were not able to
compensate for the lack of C/EBPa, since the levels of both proteins are normal in those
mice. However , normal levels of Glut 4 and aP2 could be explained by C/EBP~ and/or 0
transactivation activities (Rangwala and Lazar , 2000).
Disruption of C/EBP~ and C/EBP8
To investigate the role of C/EBP~ and C/EBPo during adipocyte differentiation
in vivo Tanaka and colleagues generated mice lacking the C/EBP~ and/or C/EBPo by
gene targeting. C/EBPo (-/-) mice did not die, BAT was only slightly impaired
intracytoplasmic lipid content is almost the same or to some extent reduced compared
with wild-type mice and C/EBPa and PPARy mRNA levels in the intercapsular BAT were
similar with that in wild-type mice (Tanaka et aI., 1997). On the other hand , 35% of the
C/EBP~ (-/-) knockout mice die at early neonatal stage , BAT was considerably reduced
compare with that of wild-type mice, the distribution of the intracytoplasmatic lipid
droplets was sparsely distributed and small in size and as in the C/EBP8 (-/-) mice, the
levels of C/EBPa and PPARy mRNA were normal. UCP1 expression in the C/EBPo (-
/-)
or C/EBP~ (-/-) mice was reduced compared with the wild type mice (Tanaka et aI.
1997).
In contrast, disruption of bothC/EBP~ (-/-) and 0 (-/-) produced a more severe
phenotype: 85% of the double knockout mice died at perinatal or early postnatal stage of
unknown reasons; the remaining mice (15%) showed a significant reduction of lipid
accumulation at the intercapsular BAT and minor decrease in WAT (due to a decreased
in the cell number). The analysis of BAT demonstrated the absence of fat droplets
(Tanaka et aI. , 1997). Expression of adipocyte genes in the double knockout mice
showed that most of the genes evaluated were not altered in WAT and BAT, but UCP1
: revels were significantly reduced. Levels of PPARy and C/EBPa in these mice were not
affected in BAT or WAT even though contradictory in vitro results were obtained from
embryonic fibroblasts. Fibroblasts isolated from C/EBP~ (-/-) and 0 (-/-) double
knockout mice did not express PPARyand C/EBPa and they did not differentiate. 
vivo some kind of mechanism may be involved regulating the expression of PPARyand
C/EBPa in the absence of upstream regulators (Rangwala and Lazar , 2000; Tanaka et
aI. , 1997).
Thus , these results demonstrated C/EBP and C/EBPo work together in terminal
fat differentiation. Even though PPARy and C/EBPa are normally expressed in the
double knockout mice , adipogenesis was impaired. Additionally, expression of PPARy
and C/EBPa at least in vivo does not require C/EBP~ and C/EBPo, but induction of the
master regulators PPARy and C/EBPa does not completely compensate the absence of
C/EBP~ and C/EBPo.
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Role of C/EBP in adipogenesis
The essential role of the C/EBP proteins in adipocyte differentiation has been
well established using cell culture models. Ectopic expression of C/EBP~ or C/EBPa is
able to force non-adipogenic cell lines to differentiate into adipocytes (Freytag et aI.
1994; Wu et aI., 1995b; Yeh et aI., 1995). Expression of antisense C/EBPa RNA in
preadipocyte cell lines prevents the differentiation program (Lin and Lane, 1992). The
analysis of promoter regions of adipogenic genes as well as studies of knockout mice
have demonstrated the involvement of this family of transcription factors in regulating
adipogenesis and other important physiological processes (reviewed in (Cornelius et aI.
1994; Darlington et aI., 1998; Gregoire et aI. , 1998; Lane et aI. , 1999; MacDougald and
Lane , 1995b; Ramji and Foka , 2002; Rangwala and Lazar , 2000; Tanaka et aI. , 1997)).
A number of adipocyte genes contain C/EBP binding sites in their proximal promoter and
they are transactivated by C/EBP factors.
C/EBP~ and 3 are the first transcription factors induced after exposure to the
inducers of differentiation; this implies that both factors direct the first steps ofthe
differentiation process. In vitro results have shown that lack of C/EBP~ and
C/EBP3 cause a block in differentiation and inhibition of PPARy and C/EBPa expression,
which then affects adipocytegene expression. Reintroduction of C/EBP~ rescues the
differentiation process but not the overexpression ofC/EBP3. C/EBP3 is not sufficient
by itself, but does accelerate the differentiation process together with C/EBP~ (Yeh et
aI. , 1995). This is indicative that C/EBP3 activity has a minor role , and C/EBP~ is a key
in the cascade promoting adipogenesis. The ability of C/EBP~ to replace C/EBPa
activity suggests a dual role for C/EBP~ as stimulator of cell determination as well as a
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promoter of differentiation (Darlingtonet aI. , 1998; Rosen, 2002; Wu et aI. , 1995b). The
same role is also applicable to C/EBPa (Freytag et aI. , 1994; Lin and Lane, 1994).
To establish the role of C/EBPa and PPARy in adipocyte differentiation , Wu and
colleagues studied the patterns of adipocyte gene expression after ectopic expression of
these regulators using fibroblasts derived from C/EBPa knockout mice. These cells go
through differentiation when PPARy is overexpressed , however the levels of adipocyte
genes expression involved in lipid storage were lower compared to control. This
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reduction could explain the smaller lipid droplets within the cytoplasm of these cells.
Also , these cells overexpressing PPARy did not show insulin dependent glucose intake
compared to C/EBPa. These results defined an additional role for C/EBPa in
adipogenesis. Overexpression of both activators in the C/EBP (-/-) cells clearly
demonstrated full activation of the differentiation program. This study clearly showed
that PPARy activates expression ofC/EBPa, and C/EBPa is necessary to activate
PPARy. Cross-regulation of C/EBPa and PPARyexpression is essential to maintain the
differentiation state (Wu et aI. , 1999).
We have already seen a number of studies that have established the key role for
C/EBP transcription factors in adipogenesis. Nevertheless some aspects have remained
unresolved and require further investigation. One issue came from the studies of the
C/EBP~ and C/EBPo double knockout mice. Itis clear that both activators are involved
in BAT and in WAT differentiation. In general , expression of most adipocyte markers
evaluated looked normal , except that aP2 showed reduced levels , and the BAT marker
UCP1 was almost absent. Since PPARyand C/EBPa are expressed at high levels in
those mice , it is not surprising to observe expression of some of the late adipocyte
genes. However, some genes were not fully induced in the double knockout even
though the presence of the master regulators was indicative of a possible role of C/EBP~
and C/EBP8 in activating late adipocyte genes. Another aspect that has remained
ambiguous is the binding of these transcription factors at the promoter of genes early
during differentiation. In order to determine the role of C/EBP~ and 8 in the regulation of
late gene markers we examined the kinetic of C/EBPa
, ~ and 8 binding to early and late
adipocyte genes in differentiating 3T3-L 1 by chromatin immunoprecipitations. The
results of these studies are presented in chapter III of this Thesis.
2) PPARy
Peroxisome proliferators are a structurally varied group of substances
, including
some clinically tested hypolipidemic agents , herbicides , etc. , that activate hepatic
peroxisomal proliferation and the expression of enzymes of the fatty acid ~-oxidation
pathway (Tontonoz et aI. , 1995). They control gene expression through the activation of
a member of the steroid hormone receptor family. The activity of nuclear receptors is
regulated by interaction with small lipophilc ligands. The receptor was isolated for the
first time and cloned from a mouse liver cDNA library and named peroxisome proliferator
activated receptor (PPAR) (Issemann and Green
, 1990). Subsequently, the human
PPAR gene was cloned (Sher et aI. , 1993). Then , three related PPAR genes were
isolated in Xenopus named a, ~ and 
y, 
and in mouse they were referred as PPARa, y,
and 8 or NUC- I isoforms. Many cell types express more than one PPAR isoform
(Tontonoz et aI. , 1995).
The PPARs bind to DNA sequences called PPAR response elements (PPREs).
The analysis of these target sequences showed they consist of direct repeats of
AGGNCA- like motifs spaced by one nucleotide (DR-1). In addition , it was found that
PPARs form heterodimers with thea second member of the nuclear receptor family, the
retinoid X receptors (RXR)a (Brun et aI. , 1996; Tontonoz et aI. , 1995).
The patternof expression of different PPARs in tissues differs. PPARa is found
in liver , heart, kidney, skeletal muscle, small intestine, and BAT. PPARo is expressed in
many tissues , but markedly in the brain , WAT , and muscle , and PPARy is highly
expressed in adipose tissue (both BAT and WAT), placenta, large intestine , and
macrophages (Grimaldi , 2001; Tontonoz et aI. , 1995).
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The first study that demonstrated the involvement of PPARy in adipocyte
differentiation was performed with the preadipocyte cell line 3T3-L 1. Treatment of 3T3-
L 1 with different peroxisome proliferators caused adipocyte differentiation and the
induction of PPARy (Chawla et aI., 1994). These results and the presence of PPARy in
adipose tissue were indicative of a role for this activator in adipocyte differentiation
(Tontonoz et aI. , 1995). Later, it was showed that ectopic expression of PPARy in
different fibroblast cells lines enabled them to differentiate into adipoocytes (Tontonoz et
al. 1994c).
The role of PPARy as a master key regulator was later verified by studies using
immortalized fibroblasts lacking PPARy. Overexpression of C/EBPa in those cells did not
stimulate adipogenesis , however , reintroduction of PPARy reestablished the
differentiation process (Rosen et aI. , 2002).
PPARy is activated by polyunsaturated fatty acids , and in response to these
lipids, PPARy regulates the induction of adipocyte genes. Earlier findings demonstrated
that the antidiabetic thiazolidinediones (TZDs) were capable of initiating adipogenesis
and were later linked to PPARy by Lehmann and colleagues. These investigators
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reported that TZDs selectively and efficiently activated PPARy transcription factor
(Lehmann et aI. , 1995). After their discovery, TZDs have been used extensively in 
vitro differentiation protocols.
PPARy protein structure
The isolation and cloning of the mouse PPARy (later named PPARy1) was
reported by Zhu and colleagues (Zhu et aI. , 1993). Simultaneously, another isoform of
the receptor, PPARy2, which showed expression largely confined to adipocytes, was
isolated and cloned (Tontonoz et aI., 1994a). PPARy1 and PPARy2 proteins are
produced from differential promoter usage and alternative splicing at the 5' end. The
transcription of PPARy1 is controlled by the promoter P1 , which generates messenger
RNA (mRNA) containing two untranslated exons , A1 and A2 , which are specific to
PPARy1 (Fig, 1.12). The 5' untranslated sequence and the extra thirty N-terminal amino
acids of PPARy2 are encoded by exon B , which is located between the second and the
third exons that encode PPARy1. Exons one to exon 6 encode the same sequences in
both isoforms (Fig. 1.12). The cDNA of PPARy2 encodes an extra thirty amino acids 
terminal to the first ATG codon of thePPARy1 and shows a distinct 5' -untranslated
sequence (Fajas et aI. , 1997; Zhu et aI. , 1995). PPARy1 is expressed in adipose tissue
but also in colon , macrophages and cell of the vasculature. PPARy2 is specifically
expressed in adipose tissue.
PPARy conforms tothe established domain structure that is present in the
superfamily of nuclear hormone receptors. The N-terminal region contains the
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Figure 1.12. Organization of mPPARygene. The eight exons (AI , A2 , and 1-6) encoding
the mPPARy1 (solid boxes) as well as the seven exons (B1 and 1-6) encoding
mPPARy2 are shown in the genomic DNA. yPl and yP2 represent the promoter of
mPPARy1 and mPPARy2, respectively. The corresponding positions of the exons with
respect to mPPARy1 and mPPARy2 cDNAs are shown above. Exons numbered 1-
code for identical sequences in both isoforms starting at the ATG. The mPPARy2 cDNA
encodes an additional 30 amino acids N-terminal to the first ATG of mPPARyl from an
upstream ATG (indicated by * ) from exon B1 shown on the genomic DNA. At the top,
the location of 5'and 3' untranslated regions (UTR) and the DNA and ligand-binding
domains are shown (Zhu et aI., 1995).
transcriptional activation function 1 (AF-1) that functions independently of ligand. This
region contains a mitogen-activated protein kinase (MAPK) phosphorylation site that
when phosphorylated decreases the transcriptional activity of PPAR. The central
domain contains the DNA binding motif, which includes two zinc fingers. The C-terminal
domain includes the dimerization and the ligand binding domain (AF-2) (Rosen and
Spiegelman , 2001; Willson et aI. , 2001).
Functional roles of PPARy1 and PPARy2
The functional role of the extra thirty amino acids present on PPARy2 is unclear.
Experimental data have suggested that the extra amino acids in PPARy2 contribute to
transcriptional activation function and insulin increases that effect (Werman et aI. , 1997).
To access the specific functions of PPARy1 and PPARy2, these factors were
independently overexpressed in PPARy null fibroblasts. The results showed that both
proteins have the capacity to stimulate adipogenesis. However , at low ligand
concentrations , PPARy2 was more adipogenic than PPARy1. Analysis of coactivator
binding and transcriptional analysis showed that PPARy2 has an increased capacity to
interact with cofactors essential in adipocyte differentiation (Mueller et aI. , 2002).
Contradictory results were obtained when endogenous expression of PPARy1 and
PPARy2 was abrogated by targeting a zinc finger repressor protein to specific regions on
the PPARy gene promoter. Adipogenesis was rescued only by overexpression of
PPARy2 and not by PPARy1 (Ren et aI. , 2002).
Additionally, it is important to point out that PPARy2 seems to control the
expression of the PPARy1 in WAT. In a time course of differentiation , PPARy1 induction
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followed PPARy2 expression. This was demonstrated previously by Ren and colleagues
and Saladin and colleagues (Ren et aI., 2002; Saladin et aI. , 1999), and confirmed later
in vivo by Koutnikova and colleagues (Koutnikova et aI., 2003)
PPARy deficient animals
The use of genetically modified mice has confirmed the role of PPARy in
adipogenesis and also has been a tool to examine the role of PPARy in metabolic
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. responses (Gray et aI., 2005).
The complete absence of PPARy is embryonic lethal affecting trophoblast
differentiation and placental vascularization. The defects in placental vascularization
cause myocardial thinning and consequently death at E10 stage. The placental defects
were rescued by generation of tetraploid embryos , allowing the recovery of one moUse
bornPPARy (-/-). All the tetraploid chimeras between E10.0 and term survived
demonstrating that PPARy is not vital during embryogenesis. Analysis of the null pup
demonstrated total absence ofWAT and BAT, confirming the essential role of PPARy in
adipogenesis in vivo (Barak et aI. , 1999). Likewise , through use of a different approach
Rosen et al demonstrated the pivotal role of PPARy in adipocyte differentiation both 
vivo and in vitro. The authors designed a chimeric mouse using wild type and PPARy
/-) embryonic stem (ES) cells. Because PPARy (-/-) ES cells contributed weakly to the
to adipose depots formation and not at all to the sebaceous glands of the skin , they
concluded that PPARy is involved in the development and maturation of fat cells (Rosen
et aI. , 1999).
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Regulation of PPARy expression
The sequence analysis of the mouse PPARy2 promoter identified the TAT A- like
element (T A TT A) located 49 base pair upstream of the transcription start site and
consensus binding sites for HNF3, C/EBP , and Ap1 transcription factors (Fig. 1.13) (Zhu
et a\., 1995). The role of the C/EBP sites in PPARy2 promoter was established in co-
transfection studies arid demonstrated that the C/EBP proteins are involved in the
activation ofPPARy2 expression (Clarke et aI. , 1997; Elberg et aI., 2000; Zhu et aI.
1995).
Another transcription factor involved in adipogenesis through regulation of the
PPARy2 expression is GATA. GATA family members share highly conserved zinc-finger
DNA binding domains and bind specifically to a consensus DNA sequence (Af)
GATA(AlG) (Tong et aI. , 2000). The proximal PPARy2 promoter region contains two
GATA sites. GATA2 and GATA 3, which are expressed in preadipocytes , bind directly to
both GATA sites on the PPARy2 promoter to negatively regulate its basal transcriptional
activity (Tong et aI. , 2000).
In addition to GATA, STAT proteins also negatively regulate PPARy2 expression.
Interferon-y (INFy) is a potent activator of STAT1 and treatment of 3T3-L 1 with INFy has
been shown to inhibit adipogenesis. The mechanism by which INFy performs its effect is
through regulation of the PPARy2 expression. PPARy2 promoter contains a STAT site
at -222 from the start site. This site specifically binds ST A T1 and negatively regulates
PPARy2 expression (Hogan and Stephens , 2001).
Kruppel- like factors (KLF) are also involved in the regulation of the PPARy2
expression. KLF are zinc finger proteins that constitute an important class
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Figure 1.13. The mouse PPAHy2 promoter.
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of transcription regulators. They are characterized to contain multiple zinc fingers at the
terminus of the protein and at the N-terminus , which is implicated in transcriptional
activation and/or repression a protein-protein interactions domain. This family of
transcription factor is involved in the regulation of cellular differentiation (Bieker, 2001;
Segre et aI. , 1999). KLF5 is highly expressed in adipose tissue and KLF2 is highly
expressed in preadipocytes. It has been demonstrated that KLF2 negatively regulates
PPARy2 expression. The KLF2 inhibitory effect on PPARy2 expression is mediated by
direct binding to the promoter as was demonstrated in transient transfection studies
(Banerjee et aI. , 2003). In contrast , the other member of the family, KLF5, positively
regulates adipocyte differentiation (Oishi et aI. , 2005). It has been demonstrated using
reporter assays that KLF controls PPARy2 expression in concert with C/EBP~ and 3.
The proximity of one of the KLF sites at -278 to the C/EBP sites on the PPARy2
promoter suggested a possible interaction between KLF factor and C/EBP~ and 3. This
interaction was later confirmed to occur in vivo. ChiP analysis demonstrated the
presence of KLF5 at early time points during differentiation. Mechanisms by which KLF
proteins modulate PPARy2 expression are still unknown.
While studying, the role of SWI/SNF in adipogenesis, we observed that PPARy2
expression was affected by the presence of dominant negative BRG1. To study the
mechanisms by which SWI/SNF modulate PPARy2 expression, a series of chromatin
immunoprecipitations were performed to temporally characterize pivotal protein
interactions at the PPARy2 promoter. The results and analysis of these experiments are
presented in the following Chapter of this thesis.
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The work presented in this chapter was published in Molecular and Cellular Biology
(2004) volume 24: 4651-4663. Data presented in figure 11.7 was generated by Hengyi
Xiao, Ph.
CHAPTER II
TEMPORAL RECRUITMENT OF TRANSCRIPTION FACTORS AND SWI/SNF
CHROMATIN REMODELING ENZYMES DURING ADIPOGENIC INDUCTION OF THE
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR Y NUCLEAR HORMONE
RECEPTOR
Abstract
The peroxisome proliferator activated receptor gamma (PPARy) regulates adipogenesis,
lipid metabolism, and glucose homeostasis, and roles have emerged for this receptor in
the pathogenesis and treatment of diabetes , atherosclerosis , and cancer. We report
here that induction of the PPARy activator and adipogenesis forced by overexpression of
adipogenic regulatory proteins is blocked upon expression of dominant negative BRG1
or hBRM , the ATPase subunits of distinct SWI/SNF chromatin remodeling enzymes. We
demonstrate that histone hyperacetylation and the binding ofC/EBP activators , RNA
polymerase II , and general transcription factors initially occurred at the inducible PPARy2
promoter in the absence of SWI/SNF function. However , the RNA polymerase and
general transcription factors were subsequently lost from the promoter in cells
expressing dominant negative SWI/SNF , explaining the inhibition of PPARy2 expression.
To corroborate these data, we analyzed interactions atthe PPARy2 promoter in
differentiating pre-adipocytes. Changes in promoter structure , histone hyperacetylation
and binding of C/EBP activators , RNA polymerase II, and most general transcription
factors preceded the interaction of SWI/SNF enzymes with the PPARy2 promoter.
However , transcription of the PPARy2 gene occurred only upon subsequent association
of SWI/SNF and TFIIH with the promoter. Thus induction of the PPARy nuclear
hormone receptor during adipogenesis requires SWI/SNF enzymes to faciltate pre-
initiation complex function.
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Introduction
Differentiation of adipocytes , as with all differentiation events , involves
programmatic changes in gene expression patterns. Genes specifically expressed in
adipocytes must be activated; the concerted action of several transcriptional regulators,
including C/EBPa, C/EBP , andthe nuclear hormone receptor PPARy; controls these
activation events via direct interaction with PPARy and C/EBP binding sites in adipocyte-
specific gene regulatory sequences (reviewed in (Debril et aI. , 2001; Rangwala and
Lazar, 2000; Rosen and Spiegelman , 2000)). Each of these regulators is expressed with
different kinetics during adipocyte differentiation in culture , yet forced overexpression of
any is sufficient to initiate adipogenic differentiation in fibroblast cells (Freytag et aI.
1994; TontorlOz et al. , 1994c; Wu et a\. , 1995b; Yeh et aI. , 1995). Function of the PPARy
regulator is especially critical , as many of the genes involved in adipogenesis as well as
glucose homeostasis are activated by this nuclear hormone receptor. Since adipocyte
specific genes are not expressed prior to differentiation , it is likely that the regulatory
sequences controllng the expression of these genes are incorporated into a repressive
chromatin structure that is refractory to gene expression. Eukaryotic cells have evolved
two classes of enzymes that can alter chromatin structure to control accessibility to the
transcriptional machinery. These include histone modifying enzymes , which post-
translationally modify the N-and C-terminal domains oftheindividual histone proteins
that comprise the nucleosome, and ATP-dependent chromatin remodeling enzymes
which alter structure by disrupting the histone:DNA contacts of the nucleosome, thereby
altering nucleosome conformation and, in some cases , altering the position of the
histone octamer along the DNA (reviewed in (Narlikar et aI., 2002; Strahl and Alls , 2000;
Turner, 2002)).
The mammalian SWI/SNF family of A TP-dependent chromatin remodeling
enzymes includes members containing either the Brg1 or Brm ATPase. Although the
mammalian SWI/SNF enzymes share most of the same subunits , multiple forms of these
enzymes exist; these are distinguished by the ATPase present, the presence of unique
subunits, and/or the presence of tissue specific isoforms of common subunits (Olave et
:al., 2002; Sifet aI. , 2001; Wang et aI. , 1996a; Wang et aI. , 1996b). In vitro analyses of
hBRM and different BRG1 containing enzymes reveal many similarities in chromatin
remodeling assays (Sif et aI., 2001). In vivo, however , clear differences in function likely
exist. Brg1 knockout mice .are embryonic lethal and heterozygotes are predisposed to
tumors (Bultman et aI. , 2000). Brm knockout mice and cells, in contrast, show only
modest proliferation differences compared to wild type (Reyes et aI. , 1998). Additionally,
at the molecular level , chromatinimmunoprecipitation (ChiP) analyses have revealed
that Brg1 and Brm can be present on different promoters (Kadam and Emerson , 2003;
Soutoglou and Talianidis, 2002), supporting the idea of differential functions.
Collectively, the literature reveals that Brg1 and/or Brm can physically interact
with a number of different transcriptional regulatory proteins and these proteins have
been localized by ChiP studies to the promoter sequences of a number of inducible
genes during transcriptional activation. In particular, previous work has indicated a
requirement for or a contribution by SWI/SNF enzymes for activation of cellular
differentiation genes. Myeloid , eryhrocyte , enterocyte , muscle and adipose cell
differentiation events have been linked to the presence of functional SWI/SNF enzymes
(Armstrong et aI. , 1998; de la Serna et aI. , 2001a; Kowenz-Leutz and Leutz , 1999;
Pedersen et aI. , 2001; Soutoglou and Talianidis , 2002) and , in a more limited number of
cases, to the ability of SWI/SNF enzymes to alter chromatin structure at or near
inducible promoters. In the case of adipogenesis, the factor C/EBPa, already known to
physically interact with the RNA polymerase II associated general transcription factors
TBP and TFIIB(Nerlov andZiff, 1995), was shown to have the capability to interact with
hBRM (Pedersen et aL , 2001). Moreover, the domain mediating this interaction was
critically required for the ability of C/EBPa to trans-differentiate fibroblasts into adipocyte-
like cells. In vitro, the competency of PPARy to activate 
in vitro transcriptiontemplates
assembled into chromatin was dependent on a specific BRG1-containingSWI/SNF
enzyme (Lemon et aL , 2001). However, the nature of the role that SWI/SNF enzymes
play in facilitating adipogenenic gene expression remains to be determined.
Here , we explore the functional role of SWI/SNFenzymes during adipocyte
differentiation ,by examining the activation of the PPARy regulator itself. PPARy mRNA
is expressed from two distinct promoters that give rise to two distinct isoforms, termed
PPARy1 and PPARy2 (Zhu et aI. , 1995). We focused on PPARy2 expression because in
differentiating pre-adipocytes, PPARy2 is highly induced and is the predominant isoform
in differentiated adipocytes (Saladin et aI. , 1999; Tontonoz et aL, 1994a), while in
undifferentiated and differentiated fibroblasts, PPARy1 expression was not observed
(see below). We found that the SWI/SNF enzymes are critically required for trans-
differentiation of fibroblasts along the adipogenic pathway. Temporal analyses of factor
binding to the PPARy2 promoterrevealed that the BRG1-based SWI/SNF enzymes did
not facilitate activator binding to the promoter, but instead promoted pre-initiation
complex function. Examination of PPARy2 activation during differentiation of committed
pre-adipocyte cells confirmed that changes in chromatin structure , activator binding, and
assembly of multiple components of the preinitiation complex did not require$WI/SNF
function. Nevertheless, activation of PPARy2 transcription did not occur until SWI/SNF
and TFIIH subsequently were brought to the promoter. Thus, using two different cellular
models for adipocyte differentiation , we demonstrate that activation of the PPARy
. regulator critically depends upon SWI/SNF enzymes, most likely by facilitating
preinitiation complex assembly and function.
i;.
Materials and Methods
Plasmids. The retrovirus encoding mouse PPARy2 (Tontonoz et aI. , 1994c) and
cDNAsencoding rat C/EBPa (Landschulz et al. 1988) and mouse C/EBP~ (Cao et aI.
1991) were kindly provided by Dr. Bruce Spiegelman. C/EBPa and C/EBP~ were
subcloned into pBabe':Puro (Morgenstern and Land, 1990).
Cell lines and differentiation methods. The derivation and maintenance of the cell
lines that express dominant-negative human BRG1 (B22 and B24), dominant negative
human BRM (H17), and the Tet-VP16 regulator (Tet-VP16) were described (de La Serna
et aI., 2000). To infect cell lines , BOSC23 cells were cultured in 100 mmdishes and
transfectedat 80% confluence by FUGENE (Roche) with 10 Ilg of pBabe-PPARy2,
pBabe-C/EBPa, pBabe-C/EBP~ or the empty vector as described (Pear et aI., 1993).
Viral supernatants were harvested 48 hrs after transfection. Dishes (60mm) of B22,
B24 , H17, or Tet-VP16 cells at50% confluence were infected with virus in DMEM
containing ,1 0% calf serum , 4 1l9/ml of polybrene and 2 1l9/ml tetracycline ina final
volume of 5 ml. The corresponding cell lines were split 1:3 48 hrs after infection and
placed under selection with 2 1l9/ml puromycin in the presence of tetracycline.
Subsequently, each virally infected cell line was split 1 :4 into media containing or lacking
tetracycline. After 96 hours the media was changed. Plates designated to be un-
differentiated received and continued to be maintained in DMEM plus 10% calf serum in
the presence or absence of tetracycline while the plates designated for differentiation
received DMEM plus 10% fetal calf serum plus cocktail containing 0. 5 mM
methylisobutylxanthine (Sigma), 1 IlM dexamethasone (Sigma), 5llg/ml insulin and 10
11M troglitazone (Biomol)in the presence or absence of tetracycline for 48 hrs.. The cells
were subsequently maintained in DMEM plus 10% FCS with 5 Ilg /ml insulin and re-fed
every two days for up t08 days.
3T3-L 1 preadipocytes were purChased from A TTC and maintained in growth
medium consisting of DMEM containing 10% calf serum and were induced to .
differentiate as described (Wu et aI., 1995b).
bilRedOstaining. 60 mm dishes were washed twice with PBS and fixed with 10%
buffered formalin for 30 min. The formalin was aspirated and the cells were stained for 
hr in freshly diluted Oil Red 0 solution (Sigma), prepared by mixing 6 parts Oil Red 0
stock solution (0.5% Oil Red Oil in isopropanol) and 4 parts distilled water. The stain
was rem()ved; cells were washed 3 times with distilled water, and photographed.
RNA Analysis. RNA isolation and analysis by Northern blot was described (dela Serna
et aI. , 2001c). Probes were derived from plasm ids containing PPARy, aP2 , or adipsin
cDNA (provided by B. Spiegelman) and were labeled by random priming. Washed blots
were exposed to a Phosphorlmager (Molecular Dynamics).
For RT-PCR , total RNA (3 micrograms) was reverse transcribed with MoMLV RT
(Invitrogen). cDNA was amplified by PCR with Taq polymerase (Invitrogen; 2.
units/reaction), 0.2 mM dNTPs , 8 ng/Ill of each primer, and either 1 mM (C/EBPa), 1.
mM (PPARy), or 2.5 mM (HPRT) MgCI . The initial denaturation step was at 95 oC for 5
min and was followed by 25 cycles (PPARy and C/EBPa)or 27 cycles (HPRT). A cycle
for PPARy PCR consisted of denaturation for 30 see , annealing for 40 see at 68 oC , and
extension at 72 oC for 30 sec. For C/EBPa it consisted of denaturation for 50 see
off 'I
annealing for 55 see at 66 QC, and extension at 72 QC for 50 sec. The final round of
extension was for 5 min. The sequence of the primers were: 5'
GCATGGTGCCTTCGCTGATGC-3' and 5' AGGCCTGTTGTAGAGCTGGGT-3' for
PPARy2 (340 bp product); 5' CCGGCCGCCTTCAACGAC-3' and 5'
CTCCTCGCGGGGCTCTTGTTT-3' for C/EBPa (288 bp prodUct). HPRT and PPARy1
RT-PCRs were described (de laSerna etal. , 2001c; Zhu et aI. , 1995).
Nuclear run-on analysis was performed as described previously by Schubeler
and Bode (http://juergenbode.gmxhome.de/t01176. htm) on nuclei isolated from -4x10
differentiating 3T3-L 1 preadipocyte cells that were collected at days 0 , 2, , 5, 6, and 7
after induction of differentiation. Hybond N+ membranes (Amersham) were prepared for
hybridization as described (Ausubel et aI. , 1996). Immobilized DNAs included 0. 1 flgof
genomic DNA from 3T3-L 1 pre-adipocytes, 3 fl9 EcoR1- linearized pBABE and pBABE-
PPARy2, or 3 fl9 of PCR product corresponding to nucleotides 181-531 of the mouse
36B4 eDNA , to nucleotides 111-641 of mouse Gapdh or to Hprt. The HPRT PCR
product was described (de la Serna et aI. , 2001c).
Protein extracts and western analysis. Isolation of protein and western blotting were
described (de La Serna et aI. , 2000). Antibodies utilized included C/EBP~ (Santa Cruz
sc-7962), M2 anti-FLAG (Sigma), and PI-3 Kinase (Upstate, 06-496). Determination of
the total Brg1 levels in Fig. 11.4 was performed by scanning multiple fim exposures and
quantifying in ImageQuant (Molecular Dynamics).
Accessibility assays. Restriction enzyme and DNAse I accessibility assays were
performed as described (de la Serna et aI. , 2001 a), except that buffer M contained 0.
mM spermine and 0.5 mM spermidine. DNAse I was purchased from Promega. Probes
P1 and P2 were PCR fragments corresponding to -1579 to -1187 and -105 to +138
from the mouse PPARy2 promoter (Zhu et aI. , 1995).
Chromatin Immunoprecipitation (ChiPs). The procedure was adopted from the Upstate
protocol. Cells at the indicated time points were fixed by adding 37% formaldehyde to a final
: boncentration oft% and incubated at 37 C for 10 minutes. Cross- linking was stopped by
adding glycine to a final concentration of 0. 125M. Cells were washed twice with cold PBS and
collected in 1 ml PBS containing protease inhibitors. After centrifugation , the pellet of cells were
resuspended in SDS-Iysis buffer (1 % SDS , 10mM EDT A , 50mM Tris-HCI , pH 8. 1) containing
protease inhibitOrs and incubated on ice for 10 minutes. Ceillysates were sheared extensively
by sonication (Ultrasonic processor from Cole and Parmer, 3mm tip at 80 Watts) on ice to obtain
fragments from 200 to 600 bp, as revealed by ethidium bromide staining of aliquots run on
agarose gels. Samples were centrifuged to pellet debris and an aliquot was taken for gel
analysis and inputs. 100 Ilg of soluble chromatin was diluted 10 times with IP buffer (0.01 %
SDS , 1. 1% Triton X- 100 , 1.2 mM EDTA , 16.7 mMTris , pH 8. , 167mM NaCI) containing
protease inhibitors and precleared for 3 hours at 4 C with 50% slurryof protein A , G or L in TE
(depending on the isotype of the antibody used) in the presence of 20 Ilg sonicated salmon
sperm DNA and 1 mg/ml BSA. After incubation , the beads were pelleted and the supernatant
immunoprecipitated with antibodies of interest (see below) at 4 C overnight. Immune
complexes were collected with 50% slurry of protein A, Gor L containing 20 Ilg sonicated
salmon sperm DNA , and 1 mg/ml BSA in TE by incubating at 4 C for 1 hour. Sepharose beads
were washed sequentially for 5 minutes at 4 C with wash 1 (0. 1 % SDS , 1 % Triton X- 1 00 , 2 mM
EDTA, 20 mM Tris-HCI, pH8. , 150 mM NaCI), wash 2 (wash 1 containing 500 mM NaCI),
wash 3 (0.25M LiCI , 1 % NP40 , 1 % sodium deoxycolate , 1 mM EDT A , 10 mM Tris-HCI , pH 8.
and finally twice with TE , pH 8.0. Immune complexes were eluted from the beads with 1 % SDS
in TE, pH 8.0, and protein-DNA cross- links were reversed by adding 200 mM NaCI and heating
at 65 C overnight. After treatment with proteinase K , the samples were purified with QIAquick
PCR purification Kit (Qiagen). One tenth of the immunoprecipitated DNA and 1 % of the inputs
DNA were analyzed by PCR.
Antibodies used included Brg1 , Brm and Ini 1 (de La Serna et aI., 2000), di-
acetylated (K9K14) H3 (Upstate, 06-599), tetra-acetylated H4 (Upstate, 06-866), Pol-
CTD-Ser-5P (Covance), and the following Santa Cruz antibodies: C/EBPa (sc-9314),
C/EBP~ (sc-7962), C/EBP8 (sc-151), TFIIB (sc-274), TBP (sc-273), TFIIH (sc-293).
When RNA polymerase II antibody was used , 10mM NaF was added to all buffers. PCRs
were performed with Qiagen HotStart Taq master mix in the presence of ,2/lCi a- p dATP
under the following conditions: 94 , 15 minutes , followed by 26 cycles (~-actin) or 27
cycles (PPARy2) of 94 C for 30 see , then either 65 C for 40 see (~-actin) or49. C for 40
see (PPARy2), then 72 C for 30 see , followed by a 72 C extension for 5 min. PCR
products were resolved in 8% polyacrilamide-1X TBE gels, dried and exposed to a
Phospho Imager. Primers used were: ~-actin: 5' (+31 )GCTTCTTTGCAGCTCCTTCGT
TG-3' and 5' (+135)TTTGCACATGCCGGAGCCGTTGT, 3' and PPARy2 promoter 5' (-
413) TACGTTTATCGGTGTTTCAT-3' and 5' (-247) TCTCGCCAGTGACCC-
Experiments utiizing RNA polymerase II or general transcription factor antibodies were
also performed using primers spanning -216 to -20 of the PPARy2 promoter with
identical results.
Results
SWI/SNF enzymes are required for differentiation of fibroblasts along the
adipogenic pathway
We previously described the B22 and H17 fibroblast cell lines that utiize the tet-
regulatory system to inducibly express an ATPase-deficient , FLAG-tagged human allele
of BRG1 (B22) or an ATPase-deficient, FLAG-tagged human allele of hBRM (H17). The
parent for these cell lines , termed Tet-VP16 , inducibly expresses only the tet:'VP16
transactivator and thus serves as a control for our experiments. The mutant BRG 1 and
hBRM protein expressed in B22 and H17 cells are competent to associate with other
endogenous subunits 'of SWI/SNF chromatin remodeling enzymes and can act as
dominant negatives with regard to different inducible gene activation events (de La
Serna et aI. , 2000; de la Serna et aI. , 2001a).
To determine the requirement for BRG1- and hBRM-based SWI/SNF enzymes in
adipogenesis , we forced the differentiation of these cells in the presence (dominant
negative OFF) or absence (dominant negative ON) of tetracycline by infection with
retroviral vectors encoding the PPARy nuclear hormone receptor or the C/EBPaor
C/EBP~ activators. Cells infected with empty retroviral vector served as a control. Cells
then were split into media containing or lacking tetracycline for 96 hours and
subsequently were cultured for 7 days in the presence or absence of a differentiation
regiment that included exposure to a differentiation cocktail (see methods) containing
troglitazone , a synthetic PPARy ligand. Adipocyte differentiation was shown by staining
with Oil Red O, a lipophilic dye. In our hands, approximately 15-20% of the PPARy
infected cells stained with Oil Red 0 , which is similar to previous data for un-modified
NIH3T3 cells infected with PPARy (Tontonoz et aI.
, 1994c), Tet-VP16 control cells
stained positively when infected with the PPARy retrovirus but not when infected with the
empty vector (data not shown), and differentiation into adipocytes was dependent on
exposure to the differentiation cocktail (Fig. 11.1). The presence or absence of
tetracycline made no difference , as expected. In contrast, B22 and H17 cells infected
with the PPARy retrovirus and cultured in the absence of tetracycline did not differentiate
(Fig. 11.1), suggesting that the expression of dominant negative BRG1 or hBRM
interfered with the differentiation process. The same results were obtained for cells
infected with either the C/EBPa or the C/EBP~ virus (data not shown).
SWI/SNF enzymes are required for the activation of adipogenic genes as well as
for activation of PPARy
We analyzed the mRNA levels of two adipogenic marker genes
, aP2 and adipsin
in cells expressing PPARy, C/EBPa, or C/EBP . Cells infected with the PPARy
retrovirus and cultured in the presence of tetracycline and differentiation cocktail
expressed both genes , while cells cultured in the absence of tetracycline produced
dominant negative BRG1 and inhibited the expression of both genes (Fig. 11.2A - right
panel). Expression of PPARy in each of the samples was monitored by RT -PCR (Fig.
11.2B - right panel) and induction of dominant negative BRG1 was monitored by FLAG
expression (Fig. 11.2C - right panel). Other experiments demonstrated that the related
B24 cell line , which also inducibly expresses dominant negative BRG1
, and H17 cells
which inducibly express dominant negative hBRM
, similarly inhibited expression of
adipogenic marker genes in the presence of dominant negative protein (data not shown).
Control Tet-VP16 cells infected with PPARyencoding virus showed accumulation of both
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Figure 11.1. Expression of dominant-negative BRG1 or hBRM blocks the ability of
PPAR)' to induce adipogenesis in fibroblast cells. B22 and H17cells, which inducibly
express ATPase-deficient, dominant-negative BRG1 or hBRM , respectively, upon
removal of tetracycline, or Tet-VP16 cells, which induce only the Tet-VP16 regulator
were infected with a retroviral vector encoding PPAR)', grown in the presence or
absence of tetracycline , and differentiated for 7 days in the presence or absence of
differentiation cocktail (see Materials and Methods). Cells were fixed , stained with Oil
Red 0 , and photographed.
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Figure 11.2. Expression of dominant-negative BRG1 blocks the ability of PPARy2,
C/EBPa, or C/EBP~ to induce adipogenesis in fibroblast cells. B22 cells were infected
with retroviral vectors encoding PPARy2, C/EBPa, or C/EBP~, grown in the presence or
absence of tetracycline , and differentiated for 7 days in the presence or absence of
differentiation cocktail. Samples in lanes marked Adipocyte were taken from 3T3-L 1
preadipocytes differentiated for 7 days. (A) Northern blot showing levels of aP2 and
adipsin mRNA. Ethidium bromide staining of rRNA is shown as a control. (B) RT-PCR
showing levels of PPARy2 and C/EBP mRNA. HPRT mRNA levels are shown as a
control. (C) Western blot showing levels of FLAG-tagged dominant-negative BRG1
C/EBP~, and PI3-kinase.
aP2 and adipsin mRNAs, regardless ofthe presence or absence of tetracycline (Fig. 11.3
lanes 9-10). The results demonstrate that expression of dominant negative BRG1 or
hBRM interfered with the differentiation process by preventing expression of adipogenic
genes. Since BRG1 and hBRM have only been found in cells in a large molecular
weight complex associated with the other SWI/SNF subunits; presumably adipogenesis
is also dependent on the activity of the SWI/SNF chromatin remodeling enzymes.
Adipogenesis also can be induced in culture via ectopic expression of the cellular
:franscriptionfactors C/EBPa or C/EBP~ (Freytag et aI. , 1994; Wu et aI. , 1995b; Yeh et
aI. , 1995). When B22 cells were infected with retrovirus expressing either C/EBPaor
C/EBP~, a similar block to aP2 and adipsin gene expression was observed in the
presence of dominant-negative BRG1 , though in cells expressing C/EBPa, the aP2 and
adipsin mRNA levels were reduced 85-90% and were not completely absent (Fig. 11.2A-
left panel). Expression levels of C/EBPa (Fig. 11.2B - left panel), C/EBP~ and dominant
negative-BRG1 (Fig. 11.2C - left panel) in these samples were monitored by RT-PCR or
western blot Similar results were obtained in H17 cells expressing dominant negative
hBRM (data not shown). As anticipated , Tet-VP16 cells infected with C/EBPa or
C/EBP~ encoding virus expressed both aP2 and adipsin mRNAs in both the presence
and absence oftetracycline (Fig. 11.3, lanes 13-14 and 17-18). Thus SWI/SNF
chromatin remodeling enzymes also are required for activation of the adipogenic gene
program by CIEBPa or C/EBP~.
- Interestingly, cells induced to differentiate via expression of C/EBPa or C/EBP~
activated PPARyexpression in a SWI/SNF dependent manner (Fig. 11.2B- left panel).
This suggests that during differentiation promoted by C/EBPa or C/EBP~, induction of
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Figure 11.3. PPARy2, C/EBPa, and C/EBP~ induce adipogenesis in Tet-VP16 control
fibroblasts. Tet-VP16 cells were infected and manipulated as describedfor Fig. 2. (A)
Northern blot showing levels of aP2 and adipsin mRNA. Ethidium bromide staining of
rRNA is shown as a control. (B) RT-PCR showing levels of PPARy2 and C/EBPa
mRNA. HPRT mRNA is shown as a control. (C) Western blot showing levels of FLAG-
tagged dominant-negative BRG1 , C/EBP~, and PI3-kinase.
PPARy - one of the earliest steps in differentiation - is dependent on the activity of
BRG1 or BRM. This explains the significant decrease in aP2 and adipsin expression in
these cells. However, the data presented here also indicate that SWI/SNF enzymes
playa broader role in adipogenesis than just promoting induction of PPARy, because
when the induction of PPARy is bypassed by providing PPARy via retroviral infection
expression of the downstream adipogenic marker genes remained SWI/SNF dependent
(Fig. 11.2 - right panels). Thus the data indicate thatSWI/SNF enzymes are required for
: 60th early and late gene activation events during adipocyte differentiation.
Kinetics of PPARy2 expression in differentiating cells
To further analyze the molecular events controlling activation of the adipogenic
pathway, we initiated differentiation by infecting cells with C/EBPa, as in our hands we
could observe that nearly 70% of cells differentiated and accumulated lipid droplets (data
not shown). RT-PCR analysis of PPARy2 mRNA levels in cells grown in the presence of
tetracycline showed a detectable accumulation on day 1 of differentiation , with robust
levels present from days 2-7 (Fig. 11.4). Low levels of PPARy2 transcripts were observed
in cells grown in the absence of tetracycline. We could not detect PPARy1 mRNA in
these cells. Western analyses confirmed that C/EBPa was present at equivalent levels
in each sample (Fig. 11.4). Analysis of FLAG-tagged protein levels indicated expression
of the mutant BRG1 protein occurred in all samples grown in the absence of tetracycline.
Re-probing of this blot for total Brg1 levels revealed only a 1.5 - 2.0 fold increase in
levels of Brg1 in the cells expressing the dominant negative BRG1. This suggests that
the levels of mutant Brg1 are only a fraction of the total Brg1 present in the cells yet still
Days
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PPARy1 mRNA
C/EBPa
BRG1
PI3 kinase
Figure 11.4. Expression levels of adipogenic regulators during differentiation of fibroblast
cells along the adipogenic pathway. B22 cells were infected with a retroviral vector
encoding C/EBPa, grown in the presence or absence of tetracycline , and differentiated.
Expression levels of adipogenic regulators are given asa function of time of
differentiation. PPARy2 and PPARy1 transcript levels were measured by RT-PCR. HPRT
levels are shown as a control. The lane marked C is a positive control from day 7
differentiated 3T3-L 1 preadipocytes. C/EBPa , total Brg1 , dominant negative , FLAG-
tagged BRG1 , and Pl3-kinase levels were measured by Western blotting.
function as dominant negative proteins. Alternatively, expression of the mutant Brg1
reduces expression from the endogenous locus , perhaps for the purpose of maintaining
a specific overall level of Brg1 protein. In either case, the results indicate that high levels
of Brg 1 overexpression are not occurring in the differentiating cells.
Histone hyperacetylation and binding of C/EBP factors to the PPARy2 promoter is
independent of Brg1-based SWI/SNF activity
. I 
The mouse PPARy2 promoter has been defined but not well characterized
functionally. Of interest , however , is the presence of multiple C/EBP binding sites in the
promoter, including two half-consensus sites around -325 relative to the mRNA start site
that contribute to activation of PPARy2 reporter genes (Elberg et aI. , 2000). To
temporally analyze factor interactions at the endogenous PPARy2 promoter , we
performed chromatin immunoprecipitation (ChiP) experiments and amplified either
PPARy2 promoter sequences or -actin sequences as a control. Because we forced
differentiation by ectopically expressing C/EBPa before inducing differentiation , we were
not surprised to see interaction of C/EBPa with the PPARy2 promoter at the initiation of
the differentiation process and throughout the time course. This observation likely
reflects and explains the capacity of C/EBPa to initiate the adipogenic gene expression
program in non-adipogenic cells. The presence of dominant negative BRG1 had no or
litte effect on C/EBPa interactions (Fig. 11.5A). In differentiatingadipocytes , there is a
temporal order to expression of the C/EBP family members , where C/EBP~ and C/EBP8
are rapidly induced , then are shut off over the first few days of differentiation.
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Figure 11.5. ChiP analysis of interactions on the PPARy2 promoter as a function of time
of differentiation. B22 cells were infected with a retroviral vector encoding C/EBPa,
grown in the presence or absence of tetracycline, and differentiated. One percent of
input is shown for each experiment. Portions of the PPARy2 promoter or the ~-actin 5'
untranslated region and coding sequence were amplified from each sample. (A) Levels
of interactions with C/EBPa, ~, and D. (B) Levels of interactions with tetra-acetylated H4
and K9 , K14-diacetylated H3. (C) Levels of interactions with total Brg1 , dominant-
, i
negative, FLAG tagged BRG1, and Ini 1. (D) Levels of interactions with TBP , TFIIB
TFIIH , p89 , and RNA polymerase II phosphorylated on Ser-5 of the CTD. Inset: linearity
controls for PCR amplifications. Each ChiP was repeated in two to five independent
experiments. The data shown in parts A, B , and C derive from a single differentiation
experiment. ChiPs in part 0 derive from a different differentiation experiment.
Subsequently, C/EBPa is induced at about day 2-3 and is maintained during
differentiation (reviewed in (Lane et aI. , 1999)). We therefore examined interactions of
C/EBP~ and C/EBP8 at the PPARy2 promoter. Somewhat surprisingly, both C/EBP~
andC/EBP8 showed a robust induction of occupancy of the promoter at days 1-2 of
differentiation , despite the presence of ectopic C/EBPa
, and regardless of the presence
of dominant negative BRG1 (Fig. 1I.5A). Thus there appears to be a preference during
the early stages of differentiation for interaction with C/EBP~ and C/EBP8. In addition
binding of these factors does not require functional SWI/SNF enzymes.
There are a multitude of histone modifications and other ATP-dependent
chromatin remodeling activities that may mediate C/EBP factor binding in the presence
of mutant SWI/SNF enzymes. We examined di-acetylation of histone H30n Iysines 9
and 14 as well as tetra-acetylation of H4 (Fig. 11.5B). Levels of tetra-acetylated H4 were
high at the beginning of the differentiation process and remained constant throughout.
In contrast , there was induction of di-acetylated H3 at day 1
, concurrent with occupancy
of the promoter by the C/EBP~and C/EBP8 factors. Acetylation of H3 and H4 was
unaffected by the presence of dominant negative BRG1.
C/EBP factors initiate recruitment of SWI/SNF and RNA polymerase II associated
general transcription factors to the promoter
Previous work has demonstrated that both C/EBPa and C/EBP~ can physically
interact with the SWI/SNF component hBRM in cells overexpressing both proteins
(Kowenz-Leutz and Leutz, 1999; Pedersen et aL , 2001). Additionally, C/EBPa interacts
with the RNA polymerase II associated general transcription factors TFIIB and TBP
(Nerlov and Ziff, 1995). These data have been used to argue that the C/EBP factors can
recruit SWI/SNF and general transcription factors to facilitate transcription. ChiP
experiments against the FLAG-tagged ATPase-deficient BRG1 produced in B22 cells
revealed that the mutant ATPase, when expressed , was present on thePPARy2
promoter as early as day 0 and maximally from day 1 through day 7 of differentiation
(Fig. 11.5C). Thus the presence of C/EBPa may be recruiting SWI/SNF to the promoter
at or before the onset of differentiation , possibly reflecting the ability of these proteins to
physically interact. ChlPanalysisof Brg1 and the SWI/SNF component Ini1 revealed
inetics of promoter occupancy that were similar to each other and to FLAG-tagged
mutant BRG1. Promoter occupancy in cells not expressing the dominant negative
BRG1 (plus tetracycline) differed in that interaction of SWI/SNF components peaked at
day 2 , which coincides with full induction of PPARy2 transcription (Fig. 11.4). The
observed interaction of the mutant BRG1 with the promoter on day 0 may be due to the
modest overexpression of total Brg1 in the cells expressing mutant BRG1 (Fig. 11.4).
Analyses of phosphorylated RNA polymerase II and its associated general
transcription factors, TBP , TFIIB , and TFIIH , indicated that each of these factors is
present on the PPARy2 promoter on day 0 , and occupancy in the presence of the
dominant negative SWI/SNF complex is essentially unaffected on days 0 and 1 (Fig.
11.50). Thus SWI/SNF function is not required to assemble these factors onto the
promoter in the presence of ectopic C/EBPa. However, the presence of the C/EBP
factors , Brg1-based SWI/SNFenzyme , and these GTFs on the promoter are not
sufficient to initiate transcription at day O. Maximal induction of PPARy2 transcription in
the presence of functional SWI/SNF enzymes occurs on day 2 (Fig. 11.4). In contrast
starting on day 2 and continuing throughout the rest of the time course , the association
ofTBP , TFIIB , RNA polymerase II , and especially TFIIH is compromised in cells
expressing the dominant negative BRG1 (Fig. 11.50). Western blot analysis of these
GTFs and RNA polymerase II shows that the levels of these factors are not altered by
differentiation or by expression of the dominant negative BRG1 (data not shown). Thus,
on or about day 2 of differentiation , SWI/SNF function is necessary to maintain the
preinitiation complex on the PPARy2 promoter and to promote transcription.
Next , we asked if SWI/SNF complexes use the same mechanism to regulate
other adipogenic genes. We performed a series of ChiPs on the aP2 and adipsin
promoters during adipogenesis and determined that recruitment of one or more general
transcription factors was also compromised at the onset of gene expression (Fig. 11.6).
Examination of PPARy2promoter accessibilty and activation in differentiating
3T3-L 1 pre-adipocytes
Although forced differentiation of fibroblasts has been utilized for many years as
a model system and has been essential in the identification and characterization of
adipogenic regulatory proteins, we were concerned that the events leading to activation
of the PPARy2 promoter under conditions where the C/EBP(X activator was prematurely
expressed might not precisely reflectthe events that occurred during differentiation of a
committed pre-adipocyte cell. We therefore examined PPARy2 activation in
differentiating 3T3-L 1 pre-adipocytes.
Initially, we examined changes in PPARy2 promoter structure as reflected by
increases in nuclease accessibility. A schematic ofthe promoter is presented 
Fig. II. 7A. Examination of two Stul sites , an EcoN1 site and a Pstl site located between-
100 and -1000 on the PPARy2 promoter revealed a dramatic increase in accessibility in
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Figure 11.6. ChiP analysis of interactions on the aP2 and adipsin promoters as a
function of time of differentiation. B22 cells were infected with a retroviral vector
encoding C/EBPa, grown in the presence or absence of tetracycline , and differentiated.
One percent of input is shown for each experiment. It is shown the levels of interactions
with TBP , TFIIB , and TFIIH p89 and mRNA levels.
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Figure 11.7. Changes in PPARy2 promoter accessibility occur on day 1 of differentiation.
3T3-L 1 preadipocytes were induced to differentiate, and nuclei were harvested at the
indicated times for nuclease accessibility experiments. (A) Schematic of the PPARy2
promoter. The locations of relevant restriction enzyme sites are indicated, as are the
previously reported DNase I hypersensitive sites (HS1 and HS2) (34). Black squares
represent potential C/EBP binding sites. Black bars P1 and P2 indicate the fragments
used as Southern blot probes. (B to D) Restriction enzyme accessibility of EcoNI , Stul
: c?nd Pst!. The enzymes used for flanking digests are indicated in parentheses. (E)
Accessibility of DNase I.
this region on day 1 of the differentiation process (Figs. 11.7B-D), reflecting changes in
promoter structure. A previous report (Ren et aI. , 2002) indicated that two DNAse I
hypersensitive sites exist on the PPARy2 promoter in undifferentiated 3T3-L 1 cells (see
Fig. 11.7A): Our analysis indicated these DNAse I hypersensitive sites were difficultto
detect in undifferentiated, day 0 cells. However , by day 1 , they were clearly visible
indicating that these hypersensitive. sites are induced by differentiation (Fig. II. 7E).
Together the results clearly demonstrate a change in PPARy2 promoter structure on day
1 of 3T3-L 1 differentiation , prior to induction of PPARy2 gene expression.
Northern analysis of PPARy transcript levels revealed a robust induction of
expression on day 2 of 3T3- 1pre-adipocyte differentiation (Fig. 11.8A), in agreement
with prior studies (Tontonoz et aI. , 1994c). Thus , induction of the PPARy2 is temporally
distinct from changes in promoter accessibility.
Binding of C/EBP factors, hyperacetylated histones , RNA polymerase II and most
general transcription factors precede the onset PPARy2 induction
ChiP experiments to identify interactions of the C/EBP family of factors with the
PPARy2 promoter showed an induction of C/EBP~ and C/EBPo binding on days 1 and 2
of differentiation , respectively (Fig. 11.8B), largely consistent with the expression patterns
of these C/EBPs in differentiating 3T3-L 1 cells and with the ChiP results from the forced
fibroblast system (Fig. 11.5A). Thus , interaction of C/EBP~ correlated temporally with
changes in nuclease accessibility on the promoter. Over days 2 and 3 , C/EBP~ and 0
disappeared from the promoter , concurrent with the appearance of C/EBPa (Fig. 11.8B).
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Figure 11.8. (A) PPARyexpression levels in differentiating 3T3-L 1 preadipocytes. 3T3-
L 1 preadipocytes were induced to differentiate. PPARyexpression levels were analyzed
by Northern blottng. Ethidium bromide-stained 28S and 18S rRNA is shown asa
controL (B to E) ChiP analysis of interactions on the PPARy2 promoter as a function of
time of differentiation of 3T3-L 1 preadipocytes. 3T3-L 1 preadipocytes were induced to
differentiate and processed for ChiP assays at the indicated times. Portions of the
PPARy2 promoter or the ~-actin gene were amplified from each sample. (B) Levels of
interactions with C/EBPa, , and o. (C) Levels of interactions with tetra-acetylated H4
and K9- , K14-diacetylated H3. (D) Levels of interactions with TBP , TFIIB, TFIIH p89,
and Poll! phosphorylated on Ser-5 of the CTD. (E) Levels of interactions with Brg1
Brm, and Ini1. Inset: linearity controls for PCR amplifications. Each .ChIP was repeated
in three to five independent experiments. The data shown in parts B, C, and E derive
from a single differentiation experiment. ChiPs in part 0 derive from a different
differentiation experiment.
Thus in differentiating 3T3-L 1 cells, the C/EBP binding sites in the PPARy2 promoter
undergo a transition of factor occupancy from C/EBP~ to C/EBPa.
As in the C/EBP forced fibroblast differentiation experiments. ChiP analysis of
tetra-acetylated H4 indicated that levels were high prior to differentiation (Fig. 11.8C). In
contrast to the forced fibroblasts , di-aceylated H31evels were present on the PPARy2
promoter at day 0 , but increased on day 3 (Fig. 11.8C). This increase clearly occurred
after the onset ofPPARy2 expression but correlated with the transition from binding of
1 i;'
C/EBP~ and o to C/EBPa. Whether the change . in di-acetylated H3 levels is a cause or
effect of the transition to C/EBP binding has not been determined. Di-acetylated H3
was also present at relatively high levels on the control ~-actinsequences.
Examination of phosphorylated RNA polymerase II and associated general
transcription factors by ChiP showed that RNA polymerase II , TBP , and TFUB became
associated with the promoter on day 1 of differentiation , prior to expression of PPARy2
(Fig. 11.80). Collectively, these data agree with the results obtained with the fibroblast
differentiation model and indicate that much of the transcriptional machinery is present
on the promoter prior to the onset of gene activation.
PPARy2 expression is coincident with the binding of TFIIH and SWI/SNF
components to the promoter
In contrast to the other factors examined , the increase in association of TFIIH did
not occur until day 2 of 3T3-L 1 differentiation (Fig. 11.80). Similarly, association of the
SWI/SNF components Brg1 , Brm , and Ini1 occurred on day 2 (Fig. 11.8E), coincident with
the onset of PPARy2 transcription. Unlike RNA polymerase II and all of the general
; -
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transcription factors examined , the interaction of SWI/SNF subunits was transient , with
only background levels present on the promoter after day 4. The Ini1 subunit is common
to all SWI/SNF enzymes examined , but the Brg1 and Brm ATPases form distinct
SWI/SNF enzymes , indicating that at least two distinct forms of the enzyme are present
at the PPARy2 promoter at the onset of transcription. The data indicate that histone
hyperacetylation , changes in promoter structure , C/EBP activator binding, and
association of phosphorylated RNA polymerase II and multiple general transcription
factors with the PPARy2 promoter occur over the first 24 hours of adipocyte
differentiation but that these events are not sufficient to initiate transcription. PPARy2
expression is facilitated by association of TFIIH and SWI/SNF enzymes on day 2 of
differentiation.
A decrease in the rate of PPARy transcription correlates with the dissociation of
SWI/SNF enzyme components from the PPARy2 promoter
The ChiP experiments in Figure 11.8E clearly demonstrate that SWI/SNF
components were no longer stably associated with the PPARy2 promoter after day 4 of
differentiation , even though the general transcription factors and C/EBPa remained.
Analysis of stable mRNA levels indicated that PPARy mRNA was abundant on days 5-
(Figure 11.8A). Two possible explanations for these data exist. The promoter may
achieve a stable structure that is permissive for continued transcription in the absence of
SWI/SNF or the transcription of PPARy2 decreases or stops after day 4 and thePPARy
message observed on days 5-7 represents stable mRNAs produced on day 4 or earlier.
To distinguish between these possibilities , we performed a time course of nuclear
run-on experiments. Linearized plasmid DNA containing the PPARy2 cDNA or empty
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vector was immobilized on membranes and hybridized to radiolabeled run-on transcripts
produced by nuclei isolated from differentiating 3T3-L 1 cells on the days indicated. The
data demonstrated induction of PPARy transcription on day 2 , continued transcription on
day 4 , but little transcription on days 5-7 (Figure 11.9). Thus the rate of PPARy
transcription decreased between days 4 and 5 and correlated with the loss of SWI/SNF
enzyme components on the PPARy2 promoter(Fig. 11.8E). In contrast, the rate ofld1
transcription decreased as a function of differentiation (Fig. 11.9), in " agreement with
: previously published results from the differentiation of human preadipocyte cells (Moldes
et.al., 1997). We utilized non-specific hybridization to plasmid sequences and
hybridization to 3T3-L 1 genomic DNA as controls , as has been described (Cornelius et
aI. , 1990; Long and Pekala, 1996; Stephens and Pekala , 1991; Waite et at , 2001), since
we were unable to identify other genes that gave a constant rate of transcription over the
differentiation time course. The rates of Hprt , 36B4 , and Gapdh all decreased over the
seven day time course (Fig. 11.9 and data not shown).
We note that the immobilized template contained the entire PPARy2cDNA , thus
PPARy1 transcription would also have been detected. We were unable to detect run-on
signal when only the short, 121 bp portion of the cDNA unique to PPARy2(Zhu et aI.
1995) was used for the hybridizations (data not shown). However, PPARy mRNA at day
5 of 3T3- L 1 differentiation and beyond is predominantly expressed from the PPARy2
promoter (Saladin et aI. , 1999; Tontonoz et aI. , 1994a). Thus the data most likely reflect
a decrease in the rate of PPARy2 orin the rates of both PPARy2 and PPARy1
transcription.
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Figure 11.9. The rate of PPARy transcription decreases after day 4 of 3T3-L 1
differentiation. Nuclear run-on assays were performed on nuclei isolated from
differentiating 3T3-L 1 cells on the days indicated. Run-on transcripts were hybridized to
3T3-L 1 genomic DNA , linearized pBABE vector , linearized pBABE containing the
PPARy2 eDNA , or PCR products corresponding to Id1 or Hprt cDNAs.
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Discussion
PPARy is involved in adipocyte differentiation , insulin sensitivity and diabetes,
atherosclerosis and the control of cell proliferation in some cancer cells (reviewed in
(Berger and Moller , 2002; Rosen and Spiegelman , 2001 )). Consequently, its function
has been the subject of intense investigation. Relatively little however, is known about
the mechanisms controlling its expression. Here we utilized two different cellular models
for adipocyte differentiation to temporally describe the molecular interactions that occur
1 the promoter of the inducible PPARy2 gene during adipocyte differentiation, with
particular emphasis on the requirement for SWI/SNF chromatin remodeling enzymes.
Through use of a differentiation system driven by introduction of the adipogenic
regulator, C/EBPa, we demonstrate a requirement for SWI/SNF enzymes in the
activation the PPARy regulator as well as in the activation of adipogenic marker genes
expressed later during differentiation. Moreover , these experiments revealed that this
requirement for SWI/SNF enzymes was relatively late in the cascade of events leading
to PPARy2 activation. Activator binding, RNA polymerase II and associated general
transcription factors interactions at the promoter, and histone H3 and H4 acetylation
occurred prior to and independently of SWI/SNF function. Instead , the data revealed a
role for SWI/SNF enzymes in the function of the preinitiation complex components at the
promoter at the time of transcriptional activation. Preliminary results on aP2 and adipsin
promoters (Fig; 11.6) support the idea that a similar mechanism operates on genes
regulated by SWI/SNF.
Because of the inherent differences between forcing differe':tiation of fibroblasts
into the adipocyte lineage and genuine pre-adipocyte differentiation , we analyzed
differentiation of 3T3-L 1 pre-adipocytes and confirmed both the general order of events
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that occur during PPARy2 activation and a role for SWI/SNF enzymes in faciltating
preinitiation complex function. We expect that the differences exhibited by the two
systems reflects the ability of the C/EBPaactivator to recruit general transcription factors
and SWI/SNF enzymes (Pedersen et aI. , 2001) prematurely at the initiation of the forced
differentiation program. Despite the differences, itisimportarit to note the data from
both systems are consistent with a need for SWI/SNF enzymes to promote the function
of the preinitiation complex.
The order of events occurring in differentiating 3T3-L 1 cells is diagrammed
. schematically in Fig. 11.10. Acetylation of H4 occurs before the onset of differentiation
followed by concurrent changes in promoter accessibility, binding of the C/EBP~ and 3
activators , and assembly of polymerase II and most of the GTFs on day 1 of
differentiation. Subsequently, on day 2 , SWI/SNF enzymes and TFIIH associate with the
promoter, indicating that the SWI/SNF enzymes likely faciltate assembly of the pre-
initiation complex, thereby permittng PPARy2 transcription to commence. On day 3,
there is both an increase in the levels of H3 acetylation and a transition from binding of
C/EBP~ and 3 to binding of C/EBPa. Which event, if either is causal remains to be
determined. Following day 4 , the SWI/SNF enzymes disappear from the promoter and
the rate of PPARy transcription drops, indicating that the presence of SWI/SNF is
required for continued transcription.
The data from differentiating 3T3-L 1 pre-adipocytes indicate that both BRG1 and
BRM are present on the PPARy2 promoter, suggesting that both complexes are
contributing to function. Alternatively, the two complexes could be redundant in function
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Figure 11. 10. Schematic model of the temporal changes in factor interactions at the
PPARy2 promoter during 3T3-L 1 preadipocyte differentiation. Nucleosome positions are
presented for illustrative purposes only.
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and the presence of either SWI/SNF enzyme might be sufficient. Our studies using cell
lines that inducibly express dominant negative BRG1 or BRM also suggest that both
ATPases are required for PPARy2 activation and adipocyte differentiation. However
because the BRG1 and BRM SWI/SNF complexes share multiple subunits, ' it is possible
that expression of one mutant ATPase deleteriously affects both complexes by
sequestering subunits from the other, endogenous ATPase. Thus we cannot rigorously
state at present whether BRG1 , BRM or both are required for PPARy2 activation and
adipocyte differentiation.
One of the interesting results from our studies is the demonstration that the
C/EBP binding sites undergo a transition during the time course of differentiation from
binding C/EBP~ and to binding C/EBPa. Although the kinetics of expression for these
factors has long supported this idea,. this is the first documentation that such a transition
occurs at a promoter expressed during adipogenesis. These results differ from
previously published work that showed that C/EBPa and 8 , but not C/EBP~, could bind
to the C/EBP sites in the PPARy2 promoter in a gel shift study and could activate a
transiently transfected PPARy2 reporter plasmid (Elberg et aI. , 2000). The differences
between the studies may be attributed to the likelihood that the chromatin structure at
the genomic locus differs from that on antransfected template and undergoes changes
during the differentiation process that affect factor interactions.
Previous reports documenting the potential of C/EBPa and ~ to physically
interact with BRM in cells transfected with both the C/EBP isoform and BRM suggested
that these factors may recruit SWI/SNF enzymes (Kowenz-Leutz and Leutz , 1999;
Pedersen et aI. , 2001). Our temporal analysis of factor interactions on the PPARy2
promoter during C/EBPa driven differentiation strongly suggests that targeting of
; . . ,
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SWI/SNF by C/EBPa can occur. However, C/EBPa is prematurely present on the
promoter in this differentiation system; the temporal differences in the appearance of the
different C/EBP factors on the PPARy2 promoter in the differentiating 3T3-L 1 (Agalioti et
aI. , 2000) adipocytes suggest that in a more natural differentiation context , C/EBP and
o may target SWI/SNF enzymes , which then later recruit C/EBPa.
Changes in nuclease accessibility and the binding of C/EBP factors , RNA
polymerase II , and many of the GTFs on day 1 prior to the appearance of SWI/SNFi;' 
enzymes on the PPARy2 promoter indicate that other factors must cCintrolthe initial
accessibility of these promoter sequences. Changes in H4 acetylation did not correlate
with initial factor binding to the promoter. Changes in other histone modifications at the
PPARy2 promoter have not been tested but potentially could mediate factor accessibility.
Alternatively, a different ATP dependent remodeling enzyme(s) could alter chromatin
structure and promote activator binding prior to SWI/SNF function. This hypothesis is
supported by in vitro studies showing that ISWI containing chromatin remodeling
enzymes facilitated stable interaction of RARa:RXR on chromatin templates prior to
SWI/SNF enzyme mediated stimulation of transcription (Dilworth et aI. , 2000). Finally,
transcriptional regulators present on the promoter prior to differentiation, such as GAT 
2 and 3 (Tong et aI. , 2000) and KLF2 (Banerjee et aI., 2003), might influence chromatin
structure in a manner that promotes the transition to an actively transcribing gene.
Our analysis of general transcription factor interactions on the PPARy2 promoter
also revealed that serine 5 phosphorylated RNA polymerase II is present at the promoter
beforeTFIiH. TFIIH contains a kinase activity that is capable of phosphorylating the
RNA polymerase II CTD, however, the temporal order of factor appearance at the
PPARy2 promoter suggests that either a different kinase is responsible for the CTD
1 .
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phosphorylation or that TFIIH mediates CTD phosphorylation independently of promoter
. binding. Additionally, the presence of RNA polymerase II phosphorylated at serine 5 of
the CTD raises the possibility that the polymerase may be transcriptionally engaged at
day 1 , and that the inclusion of SWI/SNF enzymes and TFIIH on day 2 promotes release
of the polymerase and/or elongation. Multiple other genes are regulated at the level of
transcriptional elongation , including hsp70 , where elongation can be stimulated by
SWI/SNF enzymes in vitro and in vivo (Brown et aI. , 1996; Corey etal. , 2003).
The concurrent entry of SWI/SNF enzymes and TFIIH onto the PPARy2 promoter
in differentiating 3T3-L 1 cells suggests that SWI/SNF facilitates the interaction of TFIIH
with the rest of the pre- initiation complex. Such a role for SWI/SNF enzymes has not
previously been documented. However, the data presented here agree with and extend
findings from temporal analysesof other mammalian promoters that show that (1 ) some
form of histone hyperacetylation precedes association of SWI/SNF with the promoter
and (2) SWI/SNF enzymes work late in the activation of many genes, typically after
some , if not most, of the components driving transcription have associated with the
promoter (Agalioti et aI. , 2000; Lomvardas and Thanos , 2001; Martens et aI., 2003;
Soutoglou and Talianidis, 2002). Thus the data we present on PPARy2activation and
the preliminary results on aP2 and adipsinexpression during adipocyte differentiation
support a general model where SWI/SNF enzymes function subsequent to activator
binding by completing or stabilizing pre- initiation complex formation and/or by promoting
promoter clearance and elongation.
The work presented in this chapter was published in Journal of Molecular Endocrinology
(2006) volume 36: 139- 151. Data presented in figure 111. was generated by Hengyi
Xiao, Ph.
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ji - CHAPTER II
TEMPORAL RECRUITMENT OF CCAAT/ENHANCER-BINDING PROTEINS TO
EARLY AND. LATE ADIPOGENIC PROMOTERS IN VIVO
Abstract
The C/EBP family of transcriptional regulators is critically important for the activation of
adipogenic genes during differentiation. The C/EBP~ and 8 isoforms are rapidly induced
upon adipocyte differentiation and are responsible for activating the adipogenic
regulators C/EBPa and PPARy2, which together activate the majority of genes
expressed in differentiating adipocytes. However , mitosis is required following the
induction of adipogenesis, and the activation of C/EBPa and PPARy2 gene expression is
delayed until cell division is underway. Previous studies have used electromobilityshift
assays (EMSAs) to suggest that this delay is due at least in part to a delay between the
induction of C/EBP~ protein levels and the acquisition of DNA binding capacity by
C/EBP . Here we used in vivo chromatin immunoprecipitation (ChiP) analysis of the
C/EBPa, PPARy2, resistin, adiponectin, and leptin promoters to examine the kinetics of
C/EBP protein binding to adipogenic genes in differentiating cells. In contrast to prior
studies , we determined that C/EBP and 8 were bound to endogenous regulatory
sequences controlling the expression of these genes within 1-4 hours of adipogenic
induction. These results indicate that C/EBP~ and 8 bind not only to genes that are
induced early in the adipogenic process but also to genes that are induced much later
during differentiation , without a delay between induction of C/EBP protein levels and
rlo
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DNA binding by these proteins. We also showed that each of the genes examined
undergoes a transition in vivo 
from early occupancy by C/EBP~ and 3 to occupancy by
C/EBPa at times that correlate with the induction of C/EBPa protein levels
demonstrating the generalityof the transition during adipogenesis and indicating the.
binding of specific C/EBP isoforms does not correlate with timing of expression from
each gene. We conclude that C/EBP family members bind to adipogenic genes 
in vivo
in a manner that follows the induction of C/EBP protein synthesis.
' i;.
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Introduction
The major transcription factor families involved as key regulators of adipocyte
differentiation include the nuclear hormone receptor PPARyand the CCAAT/enhancer-
binding proteins (C/EBPs) (Campet aI. , 2002; Darlington et aI. , 1998; Fajas et aI. , 1998;
Lane et aI., 1999; MacDougald and Mandrup, 2002; Morrison and Farmer, 2000;
Rangwala and Lazar, 2000; Rosen et aI. , 2000). The C/EBP family members belong to
the basic- leucine zipper (bZIP) class of transcription factors , and bind to specific DNA
sequences as dimers with other C/EBPs (reviewed in (Lekstrom-Himes and
Xanthopoulos , 1998; Ramji and Foka, 2002)). When adipocyte differentiation is induced
in preadipocyte cell lines , C/EBP~ and () are rapidly and transiently induced (Cao eta!.,
1991; Yeh et aI. , 1995). These regulators act synergistically to modulate the expression
of C/EBPa and PPARy2 via interaction with the C/EBP regulatory elements present in
the proximal promoters of these genes (Christy et aI. , 1991; Clarke et aI. , 1997; Tang et
aI. , 1999; Zhu et aI. , 1995). Subsequently, C/EBPa and PPARy2 playa prominent role
regulating the expression of adipocyte genes necessary for the development of
functional , mature adipocytes (Fajas et aI. , 1998; Lin and Lane , 1994; Rosen et aI.
2000; Tontonoz et aI. , 1994c; Wu et aI. , 1999).
The essential role of the C/EBP proteins in adipocyte differentiation has been
established. Ectopic expression of C/EBP~ or C/EBPa is able to force non-adipogenic
cell lines to differentiate into adipocytes (Freytag et aI. , 1994; Wu et aI. , 1995b; Yeh et
aI. , 1995). In contrast , expression of antisense C/EBPa RNA in preadipocyte cell lines
prevents the differentiation program (Lin and Lane, 1992). Additionally, analysis of
promoter regions of adipogenic genes as well as studies of knockout mice have
demonstrated the involvement of this family of transcription factors in regulating
, "
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adipogenesis and other important physiological processes (reviewed in (Cornelius et a\.,
1994; Darlington et aI. , 1998; Gregoire et aI. , 1998; Lane et al. 1999; MacDougald and
Lane, 1995b; Ramji and Foka, 2002; Rangwala and Lazar, 2000; Tanaka et aI., 1997)).
Most regulatory sequences controlling the expression of adipocyte-specific genes
contain at least one functional C/EBP binding site , from which transactivation is
mediated by members of the C/EBP family (reviewed in (Cowherd et aI., 1999; Gregoire
et a\. , 1998; Hwang et aI. , 1997; Morrison and Farmer, 2000; Rangwala and Lazar,
: :2000)). Work on the PPARy2 and C/EBPa promoters has focused on the role of
C/EBP~ and () as primary inducers of the expression of key regulators. PPARyare
expressed by day 2 of the differentiation process, following one or two rounds of mitotic
clonal expansion. The induction of C/EBP~ and () protein levels, however, occurs almost
immediately after addition of differentiation inducers at the onset of differentiation (Cao
et aI. , 1991; Darlington et a\. , 1998; Tang and Lane, 1999; Yeh et aI. , 1995). Thus , even
though both C/EBP~ and () are expressed at high levels at the beginning of the.
differentiation program , the target genes C/EBPa and PPARy2 are not expressed until
nearly two days later (Lane et aI., 1999; Rosen et aI. , 2000). Previous work using
electrophoretic mobilty shift assay (EMSA) analysis (Tang and Lane, 1999) determined
that the lag in C/EBPa expression is due to a delay in acquisition of C/EBP~ and () DNA
binding activity, therefore pausing the transcriptional activation of the gene. The need
for such a delay fits well with the numerous observations that C/EBPa is anti-mitotic in
both pre-adipocytes as well other cell types (Lin et aI., 1993; Timchenko et aI. , 1996;
Umek et a\. , 1991; Wang et aI. , 2001).
The transcriptional activity of the C/EBP protein is regulated at several levels
including transcription , translation , association with other proteins , and posttranslational
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modification , which includes the regulation of the phosphorylated state by multiple
effectors. Multiple phosphorylation sites have been characterized on C/EBP~, some of
which result in attenuation or enhancement of DNA binding and transactivation activity
((Mahoney et-al. , 1992; Parket aI. , 2004a; Tang et aI. , 2005; Trautwein et aI. , 1993;
Trautwein et aI. , 1994) and references therein). At least some of these phosphorylation
events occur almost simultaneously with induction of C/EBP~ levels , and it has been
suggested. that phosphorylation causes a conformational change in C/EBP from a
repressor to an activator (Kowenz-Leutz et aI. , 1994).
We previously examined the temporal interactions of C/EBP family members
modified histones , and subunits of the SWI/SNF family of ATP dependent chromatin
remodeling enzymes at the PPARy2 promoter as afunction of adipocyte differentiation.
In that study, we used chromatin immunoprecipitation assays to determine that C/EBP~
was bound at the PPARy2 promoter at 24 and 48 hours following the initiation of the
differentiation program in both differentiating 3T3-L 1 cells and in fibroblasts forced to
differentiation into adipocytes by ectopic expression of C/EBPa (Salma et al. , 2004).
Continuation of these ChiP studies at earlier time points revealed that the C/EBP and 8
isoforms were found on the regulatory regions of numerous adipocyte specific genes in
differentiating 3T3-L 1 cells within a few hours of the onset of differentiation. These genes
included PPARy2, C/EBPa, and several genes expressed later in the differentiation
process. Thus the binding of C/EBP~ and 8 to adipogenic genes in cells correlates with
the kinetics of C/EBP~ and 8 expression. In addition , binding of C/EBP~ and 8 was
replaced at each of the loci by the binding of C/EBPa. C/EBPa binding was noted on
each promoter between 20 and 48 hours post-differentiation , indicating that it was
associating with promoters as soon as it was expressed and that binding did not strictly
correlate with the time at which the locus became transcriptionally active. We have
concluded that the binding of C/EBP transcription factors to regulatory sequences
controlling the expression of adipogenic genes in vivo occurs rapidly and without
significant delay following the induction of each isoform during adipogenic differentiation.
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Materials and methods
Cell lines and differentiation methods. 3T3-L 1 preadipocytes were purchased from
the American Type Culture Collection (ATCC), maintained in growth medium consisting
of Dulbecco s minimum essential medium containing 10% calf serum , and induced to
differentiate as described previously (Wu et aI. , 1995b). Cells were collected at 0 , 1 , 2
, 8, 12 , 16, 20, and 24 hours and then at 24 hour intervals for 7 days after addition of
differentiation cocktail (Salma et aI. , 2004) for Western blot, RT-PCR and ChiP analysis.
In experiments where 3T3-L 1 cells overexpressed C/EBP~, cells were infected with
pBABE retrovirus containing C/EBP~ or empty vector as described previously (Salma et
aI. , 2004; Tontonoz et aI. , 1994c). Generation of retrovirus was previously described
(Pear et aI., 1993; Salma et aI. , 2004). Samples were collected at 0 48 and 168
hours in the presence or absence of differentiation cocktail for Western blots, RT-PCR
and ChiP analysis.
Electrophoretic Mobilty Shift Assays (EMSA). Nuclear extracts isolated from 3T3-L 1
cells differentiated in the presence or absence of cocktail were prepared as described
(Hasegawa et aI. , 1997). The binding reaction contained 6 Ilg of nuclear extract and 5
fmolof labeled double stranded oligonucleotide probe corresponding to the region
from -343 to -306 bpfrom the mRNA start site in the mouse PPARy2 promoter. This
region contains a functional C/EBP binding site (Clarke et aI. , 1997; Zhu et aI. , 1995).
Binding reactions contained 10 mM Tris-HCI (pH 7. 5), 5% glycerol , 50 mM NaCI , 0. 5 mM
dithiothreitol 1 mM MgCI2 , and 0.5 mg/ml of Poly (dl-dC) Poly(dl-dC) in a volume of 10
Ill. Reactions were incubated for 30 minutes at room temperature and separated
electrophoretically on 4% non-denaturing polyacrylamide gels made with 0.5 x Tris-
11.
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Borate-EDT A buffer. Some reactionswere preincubatedfor 10 minutes with 1 III of IgG
or anti-C/EBP antibody (Santa Cruz , sc-7962) prior to addition of the labeled
oligonucleotides. The sequence of the oligonucleotide probe was: 5'
AAGCM TCMT A TTGMCMTCTCTGCTCTGGT M-
RNA analysis. RNA isolation and analysis by Northern blotting was described
previously(de la Serna et al. 2001c). Probes were derived from plasm ids containing
PARy (provided by B. Spiegelman) and 36B4 (obtained by RT-PCR) and labeled by
random priming. Washed blots were exposed to a Phosphorlmager (Molecular
Dynamics). For reverse transcriptase (RT)-PCR , total RNA (3 Ilg) was reverse
transcribed with Moloney murine leukemia virus RT (Invitrogen). cDNA was amplified by
PCRwithQIAGEN HotStart Taq master mix in the presence of 21lCi of (a P)dATP.
The sequences of the primers were as follows: 5' CCG GCC GCC TTCMC GAC-
and 5' CTC CTCGCG GGG CTC TTG TTT-3' for C/EBPa (288 bp product); 5'
CTG AGT TGT GTC CTG CT-3' and 5' TGC ACA CTG GCA GTG ACA-3' for resistin
(340 bp product); 5' GAT CM TGA CAT TTC ACACA-3' and 5' GGA CGC CAT CCA
GGC TCT CT-3' for leptin (281bp product); 5' CAG TGG ATC TGA CGA CAC CA-3' and
CGA ATG GGT ACA TTG GGA AC-3' for adiponectin (433bp product) and 5' CTC
CM GCA GAT GCA GCAGA-3' and 5' TCA ATG GTG CCT CTG GAG AT-3' for the
ribosomal phosphoprotein 36B4 (351 bp). The PCR conditions for leptinand 36B4 were:
, 15 minutes, fo)lowed by 24 cycles of: 95 C, 30s; 62 , 40s; 72 30 s and a final
round of extension for 5 minutes. The PCR conditions for adiponectin were the same
except that the number of cycles was 20. For resistin , the conditions were the same as
for leptin except that the annealing temperature was 58 C. For C/EBPa the PCR
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conditions were: 95 , 15 minutes, followed by 25 cycles of: 95 C, 50 s; 66 , 55 s;
, 50 s and a final round of extension for 5minutes.
Protein extracts and Western analysis. Isolation of protein and Western blotting have
been described (de la Serna et aI., 2001a). Antibodies utilized included the following
from Santa Cruz: C/EBPa (sc-61), C/EBP~ (sc-7962), C/EBP8 (sc-151) and Cydin A
(sc-596). Phosphatidylinositol (PI) 3-kinase antibody (06-496) was obtained from
Upstate.
Chromatin Immunoprecipitation. The ChiP procedure was adopted from the Upstate
protocol and was performed as described in (Salma et aI. , 2004). One-tenth of the
immunoprecipitated DNA and 1 % of the input DNA were analyzed by PCR. Antibodies
used included Santa Cruz antibodies: C/EBPa (sc-61), C/EBP~ (sc-7962), and C/EBP8
(sc-151). PCRs were performed with QIAGEN Hot Start Taq master mix in the presence
of 2 IlCi of(a-32P) dATP under the following conditions: a pre-heating at 94 C for 15
minutes , followed by 24-30 cycles of 94 C for 30 s , 62 C for 40 s (except for PPARy2
which was 49. C), 72 C for 30 s , followed by a 72 C extension for 5 minutes. PCR
products were resolved in 6-8% polyacrylamide-1 X Tris-borate-EDT A gels, dried , and
exposed to a Phosphorlmager. Primers used were the following: ~-actin, 5' (+31)
GCTTCTTTGCAGCTCCTTCGTTG-3' and 5' +135)TTTGCACA TGCCGGAGCCGTTGT-
3' (Rayman et aI. , 2002); PPARy2 promoter , 5' 413) TACGTTTATCGGTGTTTCAT-
and 5' 247) TCTCGCCAGTGACCC- ; upstream regionof PPARy2 promoter 5' 1871)
GGGCGTTAACACAATCCT-3' and 5' (- 1707) TCTCTTCCTCCTTCCCTTCC-
C/EBPa promoter, 5' ( 315) TGACTTAGAGGCTTAAGGA-3' and 5' (- 32)
, .
CGGGGACCGCTTTTATAGAG- ; resistin promoter, 5' 177)
CACCATGGTCCCTGGTGTTA-3' and 5' (+26) CTCAGTTCTGGGTATTAGCTC-
adiponectin promoter , 5' 272) ATTGTCCTTACCCTTGCCCC-3' and 5' 15) and, leptin
promoter 5' 323) GCCTTCTGTAGCCTCTTGCT-3' and 5' 22)
GCTCCATGCCCTGCCTGC- . Representative experiments from at leastthree
independent experiments are shown.
i;'
119
II,
"""
120
Results
In vitro binding of C/EBP~ at a C/EBP site in the PPARy2 promoter occurs as early
as 3 hours post-differentiation.
While investigating the role of C/EBP isoforms in the activation of adipogenic
genes , we examined in vitro binding of C/EBP~ at a C/EBP regulatory element present
in the PPARy2 promoter by EMSA during a short time course of 3T3-L 1 pre-adipocytes
induced to differentiate into adipocytes. We found that C/EBP~ present in nuclear
extracts prepared from cells differentiated for 3, 18 , and 24 hours was able to bind to a
C/EBP site in the PPARy2 promoter (Fig. 111.1 , lanes 3-5). Confirmation that the shifted
band in the EMSA was CIEBP~ was demonstrated by the appearance ofa supershifted
band upon addition of C/EBP~ antibody to the reaction while addition of purified IgG had
no effect (Fig. 111.1 , lanes 6 and 7). The results reveal that the C/EBP~ regulator has the
capacity to bind to DNA as early as 3 hours following the induction of differentiation. In
addition , we observed that the apparent level of C/EBP~ binding under the reaction
conditions used did not increase between 3 and 24 hours post-differentiation (Fig. 111.1 ,
lanes 3-5).
These results diverge somewhat from data published previously where the 
vitro binding activity of C/EBP~ was delayed until 12to 16 hours following thestimulation
of adipogenic differentiation (Tang and Lane, 1999). We note that the previous report
demonstrated that C/EBP~ binding could be observed at 4 hours post-differentiation but
that binding was significantly induced atthe 12-16 hour time points. Possibly, this
dissimilarity in results is due to differences in reaction conditions , or perhaps due to the
)1"1,, '
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Figure 111.1. In vitro binding of C/EBP to a C/EBP site in the PPARy2 promoter occurs
as early as 3 h following the induction of 3T3-L 1 adipocyte differentiation. EMSA was
performed using nuclear extracts prepared from preadipocytes (day 0) or from
differentiating preadipocytes at 1, 3, 18 , and 24 h after the addition of the differentiation
cocktail (lanes 1-5). The double-stranded , 32P end-labeled oligonucleotide probe
encoded the C/EBP binding site between -343 and -306 relative to the start site of
PPARy2 transcription. Supershift experiments were performed by adding purifiedlgG
from pre- immune serum (lane 6) or antibodies against C/EBP (lane 7).
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use of different oligonucleotide probes. In the previous study, EMSA was performed
using a C/EBP site from the C/EBPa promoter, while our experiment utilized a probe that
contained a C/EBP binding site from the PPARy2 promoter. Nevertheless , the results
presented in Figure 111.1 raised a question about the timing of C/EBP~ binding to
adipogenic regulatory sequences. To better address this issue, we decided to perform
ChiP experiments at different times following the induction of adipocyte differentiation in
3T3-L 1 cells in order to examine the binding of C/EBP isoforms in vivo.
Kinetics of C/EBPs expression in differentiating 3T3-L 1
Because the EMSA data presented in Figure 111. 1 indicated a potential difference
with previously published studies , we first performed a series of control experiments to
analyze the expression levels of C/EBP~, 0 and a during adipocyte differentiation of 3T3-
L 1 cells by Western blot in order to eliminate the possibility that our results might be due
to differences in the experimental handling of the differentiating 3T3-L 1 cells. It has
been well established that initiating differentiation of 3T3-L 1 preadipocytesactivates a
cascade of gene expression events. Among the initial events are the rapid induction of
C/EBP~ and 0, which are stimulated by components of the differentiation cocktail
followed by the induction of C/EBPa on the second day of differentiation (Wu et aI.
1996; Yeh et aI. , 1995). Western blot analyses corroborate that induced protein levels of
CIEBP~ and 0 were detectable at 1 hour, reached a maximum at 4 hour, and were
declining at 48 and 120 hours , respectively (Fig. 111.2). Expression of C/EBPa occurred
later; significant induction began at about 48 hours post-differentiation and expression
was maintained throughout the time course (Fig. 111.2).
i;'
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Figure 111.2. Western blot analysis of transcriptional and cell cycle regulators during
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C/EBP~
C/EBP()
C/EBPa
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differentiation of 3T3-L 1 cells. Protein extracts were prepared from differentiating cells at
the indicated times and the kinetics of protein expression for the indicated proteins were
determined bywestern blot analysis. PI-3K was used as a loading control.
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To corroborate that the cells began the mitotic expansion phase , we performed a
western blot with antibodies directed to cyclin A (Fig. 111.2). As was expected , cyclin A
levels were increased between 16-24 hours post-differentiation , indicating that the cells
had entered the cell cycle at16 hour and had exited by approximately 48 hour. All of the
data presented in Figure 111.2 indicate that the differentiation of the 3T3-L 1 cells occurred
as expected and confirm previously published results (Morrison and Farmer, 1999; Tang
et aI. , 2003a; Tang et aI. , 2003b). Thus we have demonstrated the integrity of the 3T3-
L 1 cells and the differentiation protocol used for this and subsequent experiments.
In vivo recruitment of C/EBPP, and a to the PPARy2 and C/EBPa promoters
during adipogenesis
The results presented in Fig. 111.1 show that C/EBP~ was able to bind to one of
the C/EBP binding sites on the PPARy2 promoter at times that correlated with the
induction of C/EBP~ levels. To determine whether binding occurs on endogenous
adipocyte promoters at early times after the induction of adipocyte differentiation , we
performed ChiP experiments and temporally analyzed binding, not only of C/EBP~, but
also of C/EBP and C/EBPa, to specific adipocyte promoters. First , we chose to
evaluate binding aUhe C/EBPa and the PPARy2 promoters , since these two essential
adipogenic regulators are expressed early during differentiation , on day2(Figs. 1I1.3A
and B).
Regulation ofthe C/EBPa and the PPARy2 promoters by C/EBP family members
has been previously characterized (Christy et aI. , 1991; Clarke et aI. , 1997; Elberg et aI.
2000; Tang et aI. , 1999; Tang and Lane, 1999; Tang et aI. , 2004; Yang and Chow, 2003;
Zhu et aI. , 1995). The C/EBPa proximal promoter contains a C/EBP regulatory element
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Figure 111.3. ChiP assays reveal that C/EBP~ binding to the PPARy2 and C/EBP
promoters occurs in vivo within 2 h of the induction of 3T3-L 1 adipocytedifferentiation.
ChiP assays were performed at the indicated time-points using the indicated antibodies
and amplified for the PPARy2 promoter (A , top panel), the C/EBPa promoter (B , top
panel), or the ~.,actin 5' untranslated region and coding region (C); 1 % of each input is
shown. A twofold titration (number of IJI indicated) of input from the 0 hsample is shown
on the left to demonstrate linearity of the PCR reactions. (A, bottom panel) Duplicate
samples were used to prepare RNA and a Northern blot showing the levels of PPARy
and 36B4 mRNA at each time-point is shown. (B , bottom panel) C/EBPa and 36B4
mRNA levels were determined by RT-PCR. Atwofold titration (number of IJI indicated) of
input reverse transcribed RNA from the day 7 sample is shown on the left to
demonstrate linearity of the PCR reactions. Ab, antibody.
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at -187 relative to the transcriptional start site that mediates transactivation by C/EBPs.
The PPARy2 promoter contains two previously characterized C/EBP recognition
elements at -340 bp and -327 bp relative to the transcriptional start site in addition to
other potential sites that diverge from the C/EBP consensus. As shown in Fig. 1I1.3A,
recruitment of C/EBP~ as well as C/EBPo at the C/EBP regulatory element on the
PPARy2 promoter was induced in a manner consistent with the protein expression
patterns of both proteins (Fig. 111.2), with binding of both proteins apparent 2 hours after
, i
the onset of differentiation. Subsequently, C/EBP~ and C/EBPo were replaced by
C/EBPa, which initiated binding to the promoter at 48 hours and was maintained
throughout the time course. These results confirm the transition of binding from
C/EBP~/o to C/EBPa at this promoter in vivo (Salma et aI. , 2004; Tang et aI. , 2004).
Analysis of the C/EBPa promoter revealed the same pattern found at the
PPARy2 promoter, except that binding occurred even earlier following differentiation
(Fig. 111.3B). C/EBP~ and C/EBPo were bound as early as 1 hour post-differentiation and
remained present until 48 hour and 120 hours respectively. Induction of C/EBPa binding
to the C/EBPa promoter began at 48 hrs as reported previously (Tang et aI. , 2004).
Therefore, the transition in binding of the C/EBP isoforms that was observed at the
PPARy2 promoter also occurred at the C/EBPa promoter.
The appearance and disappearance of binding of the different C/EBP isoforms at
the PPARy2 and C/EBPa promoters at different times post-differentiation indicate
specificity of binding. No antibody controls provide further evidence for specific binding
(Figs. 1I1.3A and B). As an additional control , we analyzed C/EBP factor interactions at
the ~-actin locus (Fig. 111.3C) and at sequences 1.8 kb upstream of the PPARy2 start site
11.1., "
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(data not shown). Neither ~-actin sequences nor sequences upstream of the PPARy2
promoter were immunoprecipitated by any of the antibodies used in the ChiP procedure.
In. vivo recruitment of C/EBP~, () and a to additional adipogenic gene promoters
during adipogenesis
We next examined if C/EBP~, 8 and a are recruited to the resistin , adiponectin
and leptin promoters. These adipocyte secreted peptides, collectively referred to as
adipocytokines, have generated considerable interest since they are important
regulators of body mass and theirmisregulation may playa role in obesity (Miner, 2004).
The proximal promoters of these genes contain C/EBP binding sites that are necessary
for expression. The resistin promoter contains a C/EBP site at '"56 relative to the
transcriptional start site , adiponectin contains two identified C/EBP sites at -775 and -
264 , and two potential binding sites at -117 and - , and leptin has three consensus
C/EBP binding sites at nucleotides -55, -211, and -292. The activity of these C/EBP
sites has been confirmed by reporter assays for each of these genes (de la Brousse et
aI. , 1996; Hartman et aI. , 2002; Hwang et aI. , 1996; Parket aI., 2004b).
Binding of C/EBP~ and 8 to the C/EBP site at the resistin proximal promoter was
evident at 2-4 hours post-differentiation and did not decline until after 48 hours (Fig.
IIIAA). A modest increase in binding of C/EBPa was observed from 20 to 48 hour, and
was further increased at 120 hour (Fig. 1I1.4A). These results indicate that C/EBP~ and 8
bind early after differentiation to the resistin promoter and suggest that all three C/EBP
isoforms play aTole regulating this adipocyte gene. It was previously demonstrated that
C/EBPa binds specifically to the C/EBP element on the resistin promoter that is essential
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Figure 11.4. ChiP assays show that C/EBP~ binding to the adipocytokine promoters
occurs in vivo within 4 h of the induction of 3T3-L 1 adipocyte differentiation. ChiP assays
were performed at the indicated time-points using the indicated antibodies and amplified
for the resistin promoter (A , top panel), the adiponectin promoter (B , top panel), or the
leptin promoter (C, bottom panel); 1 % of each input is shown. A twofold titration (number
of 1-1 indicated) of input from the day 0 sample is shown on the left to demonstrate
linearity of the PCRs. Duplicate samples were used to prepare RNA at each time-point
and mRNA levels for resistin (A, bottom panel), adiponectin (B , bottom panel), and leptin
(C, bottom panel) as determined by RT-PCR are shown. 36B4 mRNA levels are shown
as a control. A twofold titration (number of 1-1 indicated) of input reverse transcribed RNA
from the day 7 sample is shown on the left to demonstrate linearity of the PGRs. Ab,
antibody,
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\for expression (Hartmanetal. , 2002), however , a transition in binding of thes
regulators has not been previously demonstrated.
The adiponectin promoter contains two C/EBP sites at -775 and -264 and two potential
binding sites at -117 and -73, however, the C/EBP element at -264 and the potential
C/EBP sites at -117 and -73 confer promoter activity as defined in transient promoter
studies , EMSA, DNase I footprinting, and ChiP assays (Park et aI. , 2004b; Seo et aI.
2004). Consequently, we performed ChiPs in the region of the proximal promoter that
6bntains these C/EBP sites. The analysis of binding of C/EBP~, C/EBP8 and C/EBPa to
the adiponectin promoter showed a pattern nearly identical to that observed for the
resistin promoter, despite the fact that adiponectin expression initiated later than resistin
expression (Fig. 1I1.4B). CIEBP~ and 8 were bound to the promoter at 2 hours and
maintained until 48 hours. Definitive binding of C/EBPa was present at 48 hours
although a modest increase was noticed at 20-24 hours.
Finally, we assessed the recruitment of the C/EBP members on the leptin
promoter. The proximal promoter contains three consensus C/EBP binding sites.
DNase I footprint analysis , reporter gene assays, and EMSA studies have demonstrated
that one of these C/EBP sites, located at -53 relative to the transcriptional start site , is
functional (de la Brousse et aI. , 1996; Hwang et aI. , 1996; Mason et aI. , 1998).
However , because the C/EBP sites are near each other, we designed PCR primers to
amplify a region of the proximal promoter containing all three sites. The recruitment of
C/EBP~ occurred at 4 hours and remained relatively constant until 48 hours (Fig. IliAC).
In contrast , C/EBP8 was detectable from 12 hours to 48 hours. Binding of C/EBPa was
observed on the promoter at 20 hours , but was not robust until 120 hours post-
differentiation , which coincides with the start of leptin mRNA accumulation. These results
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indicate that C/EBP and 8 bind quickly after the induction of differentiation to
adipogenic promoters that are not expressed until much later in the differentiation
process. Furthermore, the transition fromC/EBP~ and 8 to C/EBPa binding on these
promoters also occurred prior to gene expression , suggesting that C/EBP factor
interations withadipogenic promoters is independent of the time at which gEme
expression is initiated.
Overexpression of C/EBP~ is not sufficient to promote C/EBP protein binding to
the PPA y2 promoter in differentiating 3T3-L 1 cells
The detection of C/EBP~ on adipogenic promoters in vivo within a few hours of
the onset of adipogenic stimulation caused us to evaluate whether over-expression of
C/EBP~ in 3T3-L 1 pre-adipocytes would be sufficient to induce binding of C/EBP~ to the
regulatory sequences examined. 3T3-L 1 pre-adipocytes were infected with a retroviral
vector expressing C/EBP~ and were allowed to reach confluence, but no differentiation
cocktail was added. Instead , cells were maintained in 10% calf serum as a confluent
plate, and C/EBP binding was assessed at 0, 4 , 24 , 48 and 168 hours. Despite the
ectopic expression of C/EBP~ (Fig. 111.5A), no binding of C/EBP~, 8, or a was observed
at the PPARy2 promoter, whereas control plates treated with differentiation cocktail
showed C/EBP~ and 8 binding to the PPARy2 promoter within 4 hours post-
differentiation and C/EBPa binding by 48 hours post-differentiation (Fig. 1I1.5B).
The data suggest that overexpression of C/EBP~ in cells is not sufficient to
promote C/EBP~ binding to adipogenic promoters in the absence of differentiation
cocktail. A potential caveat to this conclusion is that ectopic expression did not provide a
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Figure 11.5. Overexpression of C/EBP~ in undifferentiated 3T3-L 1 preadipocytes is not
sufficient to induce the binding of C/EBP factors at the PPARy2 promoter. Subconfluent
3T3-L 1 preadipocytes were infected with either pBABE retrovirus or pBABE retrovirus
encodingC/EBP . For differentiation , cells were placed in fresh media lacking or
containing the differentiation cocktail , and samples were harvested at the indicated times
for (A and C) Western blot analysis or (B and D) ChiP analysis. Ab antibody.
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high enough level of C/EBPB protein to surpass a threshold level of C/EBP~ protein
necessary to achieve binding. We note that the inoculum of pBABE-C/EBP~ retrovirus
used in these experiments is the same as we have previously used to trans-differentiate
fibroblast lines into adipocyte- like cells; thus the levels of C/EBP~ provided are sufficient
tp reprogram cells of a different lineage (Salma et aI. , 2004). However, to more directly
address this concern , we compared the levels of C/EBP~ protein present in uninfected
cells and in cells infected with pBABE-C/EBP~ or with the pBABE empty retrovirus that
I i;'
were differentiated in the presence or absence of differentiation cocktail for 4 hours. 
Western blot (Fig. 1I1.5C) demonstrates that cells infected with the C/EBP~ virus
contained greater levels of C/EBP~ protein in both the presence and absence of
differentiation cocktail (compare lane 2 to lane 3 and lane 5 to lane 6), as expected. We
also observed that C/EBP~ levels in vector infected cells that were differentiated in the
presence of cocktail are lower than C/EBP~ levels in the pBABE-C/EBP~ infected cells
that were differentiated in the absence of cocktail (compare lanes 4 and 3). The levels
of C/EBP~ protein in pBABE infected cells treated with differentiation cocktail were
sufficient to permit C/EBP~ binding to the PPARy2promoter , whereas higher levels of
C/EBP~ in the C/EBP~ infected cells differentiated in the absence of cocktail were not
(Fig. 111.50 , compare lanes 4 and 3). The results exclude the possibility that insufficient
levels of C/EBP~ were present in the cells not treated with differentiation cocktail. The
C/EBP~ protein undergoes a number of post-translational modifications that are
associated with the induction of adipogenesis; it is likely that such modifications are
induced by addition of the differentiation cocktail and are necessary to promote rapid
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binding to adipogenic gene regulatory sequences in vivo. Thus simpleoverexpression
of C/EBP is not sufficient to induce C/EBP~ binding in 3T3-L 1 pre-adipocytes.
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Discussion
The C/EBP family of transcription factors is widely expressed and is a key
regulator of a variety of target genes important in physiological events , including energy
metabolism , inflammation , hematopoiesis , cellular proliferation , and differentiation
(Darlington et aI. , 1998; Kovacs et aI. , 2003; Lekstrom-Himes and Xanthopoulos , 1998;
Ramji and Foka , 2002; Rosen et aI. , 2000). Of note is the essential role C/EBPfamily
members play during adipogenesis (reviewed in (Darlington et aI. , 1998; Lane et aI.
: 1999)). Almost immediately upon induction of adipogenesis , the C/EBP family members
~ ando are induced in a manner dependent on several signal transduction cascades that
result in phosphorylation of these proteins ((Bezy et aI. , 2005; Park et aI. , 2004a; Tang et
aI. , 2005) and references therein). However , the activation of the early adipogenic
regulators , PPARy2 and C/EBPa, which are dependent on c/EBP~ and 0, does not
occur until day 2 of the differentiation process. During the first two days, cells undergo
one or two rounds of mitosis , a process termed mitotic clonal expansion (Bernlohr et aI.
1985; Cornelius et aI. , 1994; MacDougald and Lane , 1995b). Thus , the transcriptional
activation potential of the C/EBP~ and 0 proteins are masked or repressed until clonal
expansion commences.
Over the past several years , data have accumulated that suggest that the binding
capacity of C/EBP~for its cognate binding site is delayed 12-20 hours post-induction of
adipocyte differentiation (Lane et aI. , 1999; Tang et aI. , 2005; Tang et aI. , 1999; Tang et
al. 2003a). This observation fits well with the need to delay expression of C/EBPa,
which has anti-mitotic properties (Lin et aI. , 1993; Timchehko et aI. , 1996; Umek et aI.
1991; Wang et aI. , 2001), until clonal expansion occurs. Moreover, the kinetics of DNA
binding activation fit well with the kinetics of other events that occur at his time , including
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the appearance of phosphorylated Rb and the localization of C/EBP~ to pericentric
heterochromatin , which contains numerous C/EBP bindingsitesin the satellite DNA
sequences (Tang and Lane, 1999). How this change in sub-nuclear distribution relates
to gene expression has not been well established, but the observation raises the
possibility that localization of proteins to specific nuclear compartments contributes to
the complexity of adipocyte gene regulation.
In the course of examining the activation of the PPARy2 promoter during
adipogenesis, we noted that in vitro binding of C/EBP to a C/EBP binding site in the
PPAR 2 promoter did not appear to change significantly between 3 and 24 hours post-
differentiation (Fig. 111.1). Given the wide range of variable conditions that can affect
protein binding in a gel shift assay, we initially did not view this as contradictory to the
existing models explaining the delay inactivation of C/EBPa and PPARy2 gene
expression. However, ChiP assays , which specifically detect in vivo protein:DNA
interactions at endogenous loci , clearly demonstrated that C/EBP~ and C/EBPo were
capable of binding to both the C/EBPa and the PPARy2 promoter at very early times
post differentiation. Moreover , C/EBP~ and 0 also could bind at early times to adipocyte
specific promoters that do not begin to transcribe until much later in the differentiation
process. Our results do not alter the original conclusion that mechanisms exist during
the time of mitotic clonal expansion to delay activation of C/EBPa and PPARy2 gene
expression and the target genes that they subsequently activate. Instead they indicate
that the rate- limiting step is not the interaction of the C/EBP~ protein with binding sites at
the endogenous target gene promoters.
Numerous possibilities to restrict the transcriptional activating properties of
C/EBP~ exist even if the protein is DNA bound. The exact isoform of C/EBP~ that is
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bound could influence the transcriptional potential. Interaction between C/EBP~and
repressor proteins (Ron and Habener, 1992; Tang et aI. , 1999) would not necessarily be
restricted to solution interactions; repression could occur via interactions at promoter
sequences as shown previously (Mo etal. , 2004). DNA-bound C/EBP could be and
likely is still subject to post-translational modifications , including phosphorylation
acetylation and sumoylation (Eaton and Sealy, 2003; Kim et aI. , 2002; Park et aI" 2004a;
Tang et aI. , 2005; Xu et aI., 2003), that may modulate transcriptional capacity. C/EBP~
, i
, bound locicouldremain transcriptionally silent because other activators , RNA
polymerase II , or RNA polymerase II-associated general transcription factors have not
been synthesized , are spatially restricted, have not yet undergone the appropriate post-
translational modification , or cannot bind in the absence of specific chromatin
modifications or alterations. In support of this last possibility, Wiper- Bergeron et 
(2003) showed that histone deacetylase 1 (HDAC1) could affect the acetylation status
of the C/EBPa promoter in a manner regulated by glucocorticoids (Wiper-Bergeron et
al. 2003). Finally; C/EBP~-bound loci may change position within the nucleus
becoming associated or disassociated with specific sub-nuclear structures such as
pericentric heterochromatin or splicing domains. None of these possibilities are mutually
exclusive , and it is likely that multiple mechanisms are acting cooperatively to control the
timing of expression for each individual target gene.
We also note that in other cell types , C/EBP~-mediated activation of
endogenous target genes can occur without induction of C/EBP~ levels or induction of
post-translational modifications. Lipopolysaccharide-mediated induction of C/EBP~
target genes in B cell-derived lines lacking C/EBP proteins could be accomplished by
constitutive expression of the bZIP domain of C/EBP~ (Hu et aI., 2000). More recently,
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C/EBP~ binding to and subsequent activation of target genes in lipopolysaccharide
stimulated macrophages were shown to occur prior to induction of C/EBP~ protein levels
and in the absence of induced C/EBP phosphorylation or nuclear translocation (Bradley
et aI., 2003). Thus different mechanisms likely control C/EBP~ function in different cell
types.
The in vivo binding capacity of C/EBP~ and b to adipogenic genes as early as 
hr post-differentiation seems likely to be modulated by components of the cocktail of
differentiation. ChiP assays performed with 3T3-L 1 over-expressing C/EBP~ in the
absence of differentiation inducers showed that this regulator is not recruited to the
PPARy2 and other promoters (Fig. 111.5). This result shows that the physical presence of
C/EBP~ alone is insufficient to be recruited to specific promoters. Further studies will be
required to determine the nature of modifications required for both C/EBP~ and b to
rapidly bind to adipogenic regulatory sequences following differentiation signaling as well
as the relative importance of C/EBP~ homodimers and C/EBP~ and b heterodimers.
Limited data on the binding of C/EBP~ and b to gene promoters other than
C/EBPa and PPARy2 exist. In differentiating 3T3-L 1 cells, C/EBP~ binds to theaP2
promoter between 24-72 hours post-differentiation (Tang et aI. , 2004), and a recent
report that shows both C/EBP and b on the adiponectin promoter in mouse adipose
tissue (Park et aI. , 2004b). These data raise the question of why C/EBP~ and bare
bound to such promoters when evidence strongly suggests that the genes are not
activated until later times when C/EBPa ha replaced C/EBP~ and b at these loci. We
speculate thatthe presence of C/EBP~ may be part of the process by which C/EBPa is
recruited to adipogenic promoters. Alternatively, or perhaps, additionally, all of the
/1,
140
adipogenic loci undergo structural changes at the onset of differentiation , and the
binding of C/EBP~ to these loci serves as a mark for subsequent gene activation.
The data also clearly demonstrate that the C/EBP binding sites on each of the
genes undergo a transition in binding from C/EBP~ and 8 to C/EBPa in vivo. 
We and
others previously demonstrated that this occurred on the PPARy2 promoter during
adipogenesis (Salma et aI. , 2004; Tanget aI. , 2004). From the data presented here, we
predict that this transition occurs on all adipocyte genes containing C/EBP binding sites
, i
'with similar kinetics , indicating the importance of the transition and a role for C/EBP~
and 8 in both early and late events of the differentiation program. We note that the
binding of C/EBP~ and 8 correlated with the induction of overall cellular levels of C/EBP~
and 8. Similarly, C/EBP~ and 8 were replaced on each promoter between 24 and 48
hours post-differentiation , the time at which C/EBPa protein levels begin to be induced.
Thus the binding of the specific C/EBP proteins to adipocyte specific genes in vivo 
does
not correlate with the time of target gene expression but instead occurs rapidly after the
induction of C/EBP protein levels.
/,.
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CHAPTER IV
GENERAL DISCUSSION
Role of SWI/SNF in adipogenesis
During cellular differentiation the expression of a group of genes is activated
sequentially to establish the tissue-specific phenotype. Gene activation requires that
specific transcription factors bind to the control regions to facilitate the interaction of
: additional factors , such as chromatin modifying enzymes that are involved in the
decondensation of the chromatin , which in turn facilitates the recruitment of the basal
transcription machinery to the core promoter to initiate transcription.
The major transcription factors that control the adipogenic process include the
C/EBP protein family and the nuclear hormone receptor PPARy, which act in concert to
regulate the expression of adipocyte-specifc genes. The action of both transcription
factors requires modification of the chromatin structure at the adipocyte specific loci
however, prior to this work , no studies of chromatin remodeling had been described.
The main focus of this thesis was to study the function of chromatin remodeling
enzymes , in particular the A TP-dependent chromatin remodeling enzymes , during
adipocyte differentiation. For these studies , we utilized cell lines that inducibly express
mutant versions of SWI/SNF enzymes (de La Serna et aI. , 2000). Adipocyte
differentiation was induced in these cells by forced expression of three main regulators
of adipogenesis, C/EBP~, C/EBPa or PPARy. The results of these studies, which were
presented in chapter II , clearly demonstrated that BRG1 and hBRM activities are
required in adipogenesis mediated by C/EBP~, C/EBPa or PPARy activators.
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Analysis of the expression of the late adipocyte genes aP2 andadipsin showed
that BRG1 or BRM are required for the induction of these genes. Fl,rthermore
overexpression of either C/EBPa or C/EBP~ activated PPARyexpression in a SWI/SNF
dependent way. These results revealed the requirements of SWI/SNF in both early
(inducing PPARy) and late (inducing aP2 and adipsin) gene activation. In contrast
dominant negative BRG1 or BRM did not affect the expression of endogenous C/EBP~
and C/EBP(), suggesting that SWI/SNF is not required for expression of these genes.
Another master regulator in adipogenesis is C/EBPa, which is regulated by other
members of the C/EBP family and by PPARy. However, the role for SWI/SNF in
C/EBPa expression could not be determined using the dominant negative cell lines that
over express C/EBP~ or PPARy because NIH-3T3 cells are deficient in C/EBPa (Wu et
aI. , 1998). Future studies wil address the role of SWI/SNF enzymes in the regulation of
C/EBPa by utilizing Swiss-3T3 cells , a cell line that expresses high levels of C/EBPa.
By silencing the expression of either BRG1 or BRM in Swiss-3T3 cells , using small
interfering RNA , we will determine if there is an effect on C/EBPa expression.
Mechanisms by which SWI/SNF activates PPARy2
Our next question was to understand how SWI/SNF activity regulates adipocyte
gene expression. Biochemical studies have indicated that SWI/SNF alters nucleosome
structure and may also promote the binding of transcription factors like GAL4 , and some
of the general transcription factors like TBPITFIIA (Cote et aI. , 1998; Cote et aI. , 1994;
Imbalzano et al. , 1994; Imbalzano et aI. , 1996; Kwon et aI. , 1994). Few studies have
addressed this question in differentiating cells by examining the temporal binding of
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different classes of chromatin remodeling enzymes , transcriptional regulators, and RNA
polymerase II factors to the promoter DNA during gene activation (Agalioti et aI.
, 2000;
Martens et aI. , 2003; Soutoglou and Talianidis , 2002). Using our unique cell lines that
inducibly express mutant SWI/SNF enzymes , we were able to specifically address the
role of SWI/SNF in facilitating promoter accessibility to various factors to adipogenic loci.
Because PPARy is the master regulator of adipocyte differentiation
, it has
become the focus of numerous studies (Rangwala and Lazar, 2004; Rosen and
: Spiegelman , 2001). The dependency ofPPARy2 expression on SWIISNF activity
prompted us to evaluate this promoter. The temporal analysis of the binding of various
classes of transcription factors to this promoter was analyzed by the chromatin
immunoprecipitaiton assay (ChiP). From the studies in cell lines that express dominant
negative BRG1 , iUs evidentthat SWI/SNF activity is required for the continuous stable
association of the preinitiation complex and/or for promoting promoter clearance and
elongation. Preinitiation complex formation was not affected by the presence of
dominant negative BRG1 in these cells , but interestingly, at the onset of transcription
coincidently with SWI/SNF binding, the assembly of RNA polymerase II
, and general
transcription factors fell apart. These observations strongly suggest the SWI/SNF may
faciltate promoter clearance.
In addition , SWI/SNF may be involved in facilitating preinitiation complex
formation since TFIIH is recruited to the PPARy2 promoter in 3T3-L 1 cells at the same
time as Brg1 , Brm and Ini1. The binding occurred at the onset of PPARy2 transcription.
Phosphorylated RNA polymerase II and associated general transcription factors
, TBP
and TFIIB are associated with the promoter by day one.
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Transcription in eukaryotes involves a coordinated cycle of events that consists
of assembly of the pre- initiation complex , initiation , promoter clearance elongation and
termination. Although , the transition between these events is poorly understood , the
hyperphosphorylation of the C-terminal domain (CTD) of RNA polymerase II triggers
promoter clearance and thereby defines the initiation to the elongation transition. It is
thought that the hyperphosphorylated CTD domain of RNA polymerase II disrupts the
links to the pre- initiation machinery and establishes new contacts with the elongation
factors , which leads to movement of RNA polymerase II through the chromatin (promoter
clearance) and transcript elongation (Svejstrup, 2004). Since the disassembly of the
preinitiationcomplex and RNA polymerase II occurred at the onset of transcription in
dominant negative BRG1 cells , it implies that SWI/SNF may facilitate promoter
clearance either by recruiting various factors or by facilitating RNA polymerase II to
move through chromatin. Further experiments will be required to explore this
mechanism.
Evidence from other reports also implies this mechanism when activities of ATP-
dependent chromatin remodeling enzymes are involved. Early studies on the hsp70
gene have suggested that the remodeling of nuclesomes near the promoter region by
SWI/SNF activities is crucial to release the paused polymerase and allow elongation to
proceed (Brown et aI. , 1996; Corey et aI. , 2003). Additional studies in Drosophila have
shown a high correlation between distribution of BRM and transcriptionally active
chromatin on the polytene chromosome of Drosophila. Interestingly, loss of BRM
function resulted in decreased association of RNA polymerase II with the salivary gland
chromosomes , suggesting a role of BRM in recruitment of the preinitiation complex and
RNA polymerase II (Armstrong et aI. , 2002). Recently, it was shown that the Drosophila
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trithorax group gene , kismet (kis), which is related to the members of the SWI/SNF and
CHD1 families , associates with transcriptionally active chromatin. Studies with non
functional Kis confirmed that the presence of elongating RNA polymerase II and the
elongation factors SPT6 and CHD1 are considerably reduced on polytene chromosomes
(Srinivasan et aI. , 2005).
Role of SWI/SNF regulating the expression of adipocyte specific genes
Subsequently, we asked if a similar mechanism as observed at the PPARy2
promoter also extends to other adipogenic genes that are regulated by SWI/SNF activity.
A series of ChiPs was performed on aP2 and adipsin promoters using dominant
negative cell lines overexpressing C/EBPa. Preliminary data showed that in the
presence of dominant negative BRG1 , the recruitment of one or more of the general
transcription factors , TFIIB , TFIIH , and/or TBP was compromised at the onset of gene
expression. That possibly explains the down regulation of both genes (Fig. 11.6). These
results support that this might be a general mechanism of SWI/SNF mediated
transcriptional activation.
SWI/SNF role in altering chromatin structure
Previous studies demonstrated that SWI/SNF alters chromatin structure
, as
evidenced by an increase in accessibility at the promoter regions. However
, our results
indicate that changes associated with chromatin structure at the PPARy2 promoter in
3T3-L 1 correlated neither with SWI/SNF recruitment nor with PPARy2 induction
indicating that factors other than SWI/SNF, such as ISWI complexes , may be involved in
this process. It is possible that a subtle change in the remodeling of a positioned
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nucleosome close to the start site at the promoter may require SWI/SNF function. This
could be evaluated by fine mapping of the nucleosome positions during differentiation.
Further investigations , using dominant negative BRG1 expressing cell lines , could clarify
this concern. Moreover, neither the overall acetylation status at the promoter regions nor
the binding sites of transcriptional factors was influenced by the presence of dominant
negative SWI/SNF. But this does not exclude the involvement of SWIISNF in some
other histone specific modifications.
In vitro analysis of 5WI/SNF mediated transcriptional activation
To determine if SWI/SNF enzymes playa critical role in the assembly,
stabilization , and functionofthe preinitiation complex at the PPARy2 promoter, whether
its activity is simply involved in remodeling of nucleosomes, or the combination of both , a
molecular approach such as in vitro transcription on DNA templates immobilized on
paramagnetic particles , could be considered for future experiments. By reconstituting the
transcriptional events such as initiation , elongation , and termination on a naked or
nucleosomal reconstituted template , this method allows an in depth analysis of the
factors involved in the transcription of a particular gene. These experiments potentially
will allow us to measure intermediates in PIC formation and elongation activity caused
by blocking the ATPase activity of SWI/SNF enzymes.
C/EBP transcription factors at the PPARy2 promoter
The analysis of the binding of the C/EBP family of transcription factors to the
PPARy2 promoter was important for several reasons. Many studies have supported the
essential role of C/EBP transcription factors in adipogenesis and in the regulation of
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PPARy2 expression (Clarke et aI. , 1997; Freytag et aI. , 1994; Lin and Lane, 1994; Wu et
aI. , 1995b; Yeh et aI. , 1995). Analysis of the murine PPARy2 promoter identified two
C/EBP recognition elements relative to the transcriptional start site that directly modulate
transcription of PPARy2 (Clarke et aI. , 1997; Elberg et aI. , 2000; Zhu et aI. , 1995).
Physical interaction between C/EBP factors and components of the SWI/SNF complex
and the general transcription factors is indicative of their possible role in recruitment of
these activities to the promoter to mediate transcriptional activation (Kowenz-Leutz and
I i.
, L:eutz , 1999; Nerlov and Ziff, 1995; Pedersen et aI. , 2001). Recently it has also been
demonstrated that the C/EBPs recruit different mediator complexes to thetarget gene
promoters depending on the phosphorylation status of the C/EBP~ MAPK site. The
differential interactions mediate gene transcription or repression (Mo et aI. , 2004).
By ChiP analysis we demonstrated the temporal and sequential recruitment of
C/EBP family members to PPARy2 promoter during differentiation of 3T3-L 1 cells, where
C/EBP~ and () bind first and then are substituted by C/EBPa. This binding pattern was
consistent with the expression pattern of these C/EBPs. The pattern of binding of
C/EBP~ and () did not change in C/EBP a overexpressing cells in the presence of
dominant negative BRG1 , although C/EBPa remained bound to the promoter duringthe
differentiation process.
Changes in chromatin structure measured by nuclease accessibility correlated
with binding of C/EBP~ and () and general transcription factors. Based on early reports
we propose that C/EBP~and () heterodimers are responsible for the recruitment of the
preinitiation complex to the promoter at very early time points following the initiation of
the differentiation program (Kowenz-Leutz and Leutz , 1999; Pedersen et aI. , 2001). In
that study, the authors demonstrated that the transactivation element (TEIII) in C/EBPa
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and the conserved region (CR1) of C/EBP~ function as SWI/SNF binding domains.
Ectopic expression of a C/EBPa mutant lacking TEIII in NIH-3T3 cells prevented
adipogenesis. Additionally, ectopic expression of C/EBPa mutants in TE I and TEll
interfered with TFIIB and TBP recruitment and consequently inhibited adipogenesis
(Kowenz-Leutz and Leutz , 1999; Pedersen et aI. , 2001). This observation suggests that
C/EBPa or C/EBP may recruit SWI/SNF and general transcription factors to promoters.
If this assumption is correct, then ectopic expression of C/EBP mutants in NIH-3T3 cells
as discussed above should prevent such an interaction , resulting in the absence of
SWI/SNF at the promoter and gene expression.
What causes the recruitment of SWI/SNF to the promoter? Does the transition in
binding of C/EBP factors from ~/b to a initiate SWI/SNF recruitment? or does C/EBPa
itself or in concert with C/EBP~ and/or b bring SWI/SNF activities to the promoter?
Alternatively, is a posttranslational modification of a C/EBP member at the promoter
required to bring SWI/SNF activity? There are still many questions that need to be
answered in order to really establish the role of the C/EBPs in adipogenesis (see below).
The scenario is complex since C/EBPs interact with a number of co activators and
repressors. In addition , C/EBP activity is controlled by a number of post-translational
modifications. Nevertheless , it is clear from these studies that C/EBP family members
playa pivotal role during PPARy2 activation , targeting to the promoter a series of
coactivators which in concert modulate its expression.
Another important aspects of the functional activity of C/EBP family members in
adipogenesis came from the studies of the double C/EBP~ and b knockout mice
C/EBP~(-/-) C/EBPb(-
/-). 
These mice had a decreased adipose tissue mass and levels
of some adipocyte markers were either completely inhibited or moderately down
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regulated , even though protein levels of the master regulators, PPARyand C/EBPa
were unaffected (Tanaka et aI. , 1997). These results are suggestive of a possible role of
C/EBP~ and C/EBP(5 in the regulation of late adipocyte genes. Likewise , we determined
by ChiP assays that C/EBP~ and (5 are recruited to a series of adipocyte genes,
including adipocyte transcription factors , and the results were presented in chapter III.
Kinetics of C/EBP protein binding to adipocyte genes during differentiation
We temporally analyzed , in a short time course of differentiation in3T3-L 1 cells
. the in vivo recruitment of C/EBP~ and (5 and a to the C/EBPa, PPARy, resistin
adiponectin and leptin promoters. C/EBPa and PPARy promoters were considered as
positive controls, since it was known that C/EBP factors interact in vivo with the C/EBP
sites of both promoters (Rochford et aI. , 2004; Salma et aI. , 2004; Tang et aI. , 2004). All
of the C/EBP isoforms a, ~ and (5 in this study playa role in regulating the expression of
PPARy2, C/EBPa , resistin , adiponectin , and leptin. Binding of each of the C/EBPs
undergoes a transition from C/EBP~ and (5 to a. This transitional binding may playa
pivotal role since it occurs in all of the adipocyte genes evaluated , including glut4 and
ap2 promoters. It occurs prior to gene expression and it is independent of the time at
which gene expression is initiated. The recruitment of the earlier expressed C/EBP~ and
(5 occurred as early as 1 hour and correlated with induction of these activators. The
same occurred with C/EBPa which is expressed later, between 24 to 48 hours.
Thus , from our results presented in chapter III , we conclude that C/EBP family
members , a, ~ and (5 bind to adipocyte genes in vivo in a manner that follows the
induction of C/EBP protein synthesis , without any delay, unlike previously published
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reports (Lane et aI., 1999; Tanget aI. , 2005; Tang and Lane , 1999; Tang et aI., 2003a).
A question that arises from these studies is whether overexpressionof any of these
proteins is sufficient to promote C/EBP binding to adipocyte gene promoters. When
C/EBP~ was overexpressedin 3T3-L 1 cells, no binding occurred on the PPARy2
promoter and other promoters in the absence of differentiation cocktail. Aswas
mentioned earlier, C/EBP~ undergoes a series of posttranslational modifications such as
phosphorylation , which are induced by the components of the differentiation cocktail
and these modifications modulate both its transcriptional activity and DNA binding
capacity. The same result was obtained when C/EBP~ was overexpressed in NIH-3T3
cells. In contrast , overexpression of C/EBPa in NIH-3T3 cells is sufficient to promote
binding to promoters , even in the absence of differentiation cocktail; however, gene
activation does not occur unless cocktail is added. Unlike C/EBP~, C/EBPa is only
phosphorylated at three sites during adipogenesis; these phosphorylations cause
conformational changes but do not affect transactivation activities and most likely DNA
binding capacity (Reviewed in (Otto and Lane , 2005)). Future experiments could
contemplate the analysis of such modifications and how differentially they modulate
each member of the family.
Binding of C/EBP~ and 0 on these promoters suggest a fundamental role for
these proteins at early time points during differentiation , including early and late
adipocyte genes. C/EBP and 0 interact with the same pattern of binding at regulatory
sequences in adipocyte genes other than C/EBPa and PPARy2. Our results could
explain the observations in the double knockout mice C/EBP~(-
/-).
C/CPBo(-/-) (Tanaka
et aI. , 1997). aP2 expression in these double knockout mice is down regulated indicating
that full induction requires the concerted activity of all of the members of the C/EBP
I. .
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family involved in adipogenesis. Mouse embryonic fibroblasts (MEFs) isolated from the
double mutant did not differentiate in culture since expression of PPARy2 andC/EBPa
did not occur. Interestingly, when PPARy2 was introduced into these C/EBP~(-
C/CPB8(-/-) fibroblasts , they differentiated in the presence of inducers. However
expression of C/EBPa, Glut4 , adipsin , and insulin receptor substrate 2 (IRS-2) was lower
than in the wild type MEFs. These results also suggested a role for C/EBP~ and8 in the
regulation of genes such as Glut4and IRS-2 that are involved in insulin-signaling
0 i;
. (Yamamoto et aI. , 2002). Therefore, full induction of these genes requires the concerted
activity of all of the C/EBP family members.
The binding of C/EBP~ and 8 at early time points from 1 to 48 hours before gene
induction seemed to be essential since it occurred on all of the adipocyte genes studied.
These proteins are on the promoter but there is no transcription. It is not clear why they
are on the promoter so early and for such a long period of time. What are they
regulating? What are the mechanisms during mitotic clonal expansion that cause the
delay of the activation of all of the genes studied? The answer to these questions would
increase our understanding of many aspects of the functional activity of these
transcription factors and the establishment of interaction with other proteins that in
concert modulate the whole adipogenic process. It is likely that crosstalk between the
cell cycle regulators and the factors controlling adipogenesis (Fajas , 2003) is established
through the CIEBP family members. It is well known that C/EBP~ during mitotic clonal
expansion (Tang et aI. , 2003a; Tang et aI. , 2003b; Zhang et aI. , 2004b) and the
recruitment of C/EBPa induces proliferation arrest and terminal differentiation (Muller et
aI. , 1999). Numerous proteins and signaling pathways that are active during the cell
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cycle stimulate or inhibit the activity of C/EBP proteins , perhaps by modulating the state
of phosphorylation , or acetylation.
We speculate that early association of C/EBP~ and () to the regulatory elements
of all of the genes evaluated may be functionally "marking " these genes for subsequent
gene activation. The requirements of the master regulator PPARy are crucial in this
process. A recent study showed that C/EBP~ binds to the C/EBPa promoter , but in the
absence of PPARy is associated with HDAC1 (Zuo et aI. , 2006). Under these conditions
C/EBPa expression did not take place unless PPARyand its ligand are present. PPARy
and ligand dislodge HDAC1 from the C/EBPa promoter releasing the repression state
(Zuo et aI. , 2006). It is possible that the presence of C/EBP~ and () at early time points
during differentiation recruits HDAC or other repressive activity to the promoters
awaiting" the expression of the master regulators. Then , repression is removed when
PPARy is present and expression commences.
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The peroxisome proliferator-activated receptor gamma (PPAR')) regulates adipogenesis , lipid metabolism
and glucose homeostasis, and roles have emerged for this receptor in the pathogenesis and treatment of
diabetes , atherosclerosis, and cancer. We report here that induction of the PPAR') activator and adipogenesis
forced by overexpression of adipogenic regulatory proteins is blocked upon expression of dominant-negative
BRGI or hBRM, the ATPase subunits of distinct SWI/SNF chromatin-remodeling enzymes. We demonstrate
: tliat histone hyperacetylation and the binding of C/EBP activators, polymerase II (Pol II), and general
transcription factors (GTFs) initially occurred at the inducible PPAR')2 promoter in the absence of SWI/SNF
function. However, the polymerase and GTFs were subsequently lost from the promoter in cells expressing
dominant-negative SWI/SNF, explaining the inhibition of PPAR')2 expression. To corroborate these data , we
analyzed interactions at the PPAR')2 promoter in differentiating preadipocytes. Changes in promoter struc-
ture, histone hyperacetylation, and binding of C/EBP activators, Pol and most GTFs preceded the inter-
action of SWI/SNF enzymes with the PPAR')2 promoter. However , transcription of the PPAR')2 gene occurred
only upon subsequent association of SWI/SNF and TFIIH with the promoter. Thus , induction of the PPAR'Y
nuclear hormone receptor during adipogenesis requires SWI/SNF enzymes to facilitate preinitiation complex
function.
Diferentiation of adipocytes, as with all differentiation
events, involves programmatic changes in gene expression pat-
terns. Genes specifically expressed in adipocytes must be acti-
vated; the concerted action of several transcriptional regula-
tors, including C/EBPa , C/EBPf3, and the nuclear hormone
receptor peroxisome proliferator-activated receptor gamma
(PP AR 'Y), controls these activation events via direct interac-
tion with PP AR 'Y and C/EBP binding sites in adipocyte-specific
gene-regulatory sequences (reviewed in references 14 , 33 , and
36). Each of these regulators is expressed with different kinet-
ics during adipocyte differentiation in culture , yet forced over-
expression of any is suffcient to initiate adipogenic differenti-
ation in fibroblast cells (17 51). Function of the PP AR')
regulator is especially critical , since many of the genes involved
in adipogenesis, as well as glucose homeostasis , are activated
by this nuclear hormone receptor. Since adipocyte-specific
genes are not expressed prior to differentiation , it is likely that
the regulatory sequences controlling the expression of these
genes are incorporated into a repressive chromatin structure
that is refractory to gene expression. Eukaryotic cells have
evolved two classes of enzymes that can alter chromatin struc-
ture to control accessibility to the transcriptional machinery.
These include histone-modifying enzymes, which posttransla-
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tionally modify the N- terminal and C-terminal domains
(CTDs) of the individual histone proteins that comprise the
nucleosome , and ATP-dependent chromatin-remodeling en-
zymes, which alter structure by disrupting the histone:DNA
contacts of the nucleosome, thereby altering nucleosome con-
formation and , in some cases, altering the position of the
histone octamer along the DNA (reviewed in references 28 , 42
and 46).
The mammalian SWI/SNF family of ATP-dependent chro-
matin-remodeling enzymes includes members containing ei-
ther the Brg1 or Brm ATPase. Although the mammalian SWl/
SNF enzymes share most of the same subunits, multiple forms
of these enzymes exist; these are distinguished by the ATPase
present, the presence of unique subunits, and/or the presence
of tissue-specific isoforms of common subunits (30 , 39 , 49).
In vitro analyses of hBRM- and different BRG1-containing
enzymes reveal many similarities in chromatin remodeling as-
says (39). In vivo , however , clear differences in function likely
exist. Brg1 knockout mice are embryonic lethal , and heterozy
gotes are predisposed to tumors (7). Brm knockout mice and
cells, in contrast , show only modest proliferation differences
compared to the wild type (35). Additionally, at the molecular
level , chromatin immunoprecipitation (ChIP) analyses have
revealed that Brg1 and Brm can be present on djjIerent pro-
moters (18, 40), supporting the idea of differential functions:
Collectively, the Jiterature reveals that Brg1 and/or Brm can
physically interact with a number of different transcriptional
reguJatory proteins , and these proteins have been localized by
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ChIP studies to the promoter sequences of a number of induc-
ible genes during transcriptional activation. In particular, pre,
vious work has indicated a requirement for or a contribution by
SWl/SNF enzymes for activation of cellular differentiation
genes. Myeloid, erythrocyte , enterocyte , muscle , and adipose
cell differentiation events have been linked to the presence of
functional SWl/SNF enzymes (2 , 12 , 19 , 32 , 40) and , in a more
limited number of cases , to the ability of SWl/SNF enzymes to
alter chromatin structure at or near inducible promoters. In
the case of adipogenesis, the factor C/EBPa , already known to
physically interact with the polymerase II (Pol II)-associated
general transcription factors TBP and TFIIB (29), was shown
to have the capability to interact with hBRM (32). Moreover
the domain mediating this interaction was critically required
for the ability of C/EBPa totransdifferentiate fibroblasts into
adipocyte- like cells. In vitro , the competency of PPAR'Y to
activate in vitro transcription templates assembled into chro,
matin was dependent on a specific BRG1-containing SWl/SNF
enzyme (22). However, the nature of the role that SWl/SNF
enzymes play in facilitating adipogenic gene expression re,
mains to be determined.
Here we explore the functional role of SWl/SNF enzymes
during adipocyte differentiation by examining the activation of
the PPAR'Y regulator itself. PPAR'Y mRNA is expres sed from
two distinct promoters that give rise to two distinct isoforms
termed PPAR'Yland PPAR'Y2 (52). We focused on PPAR'Y2
expression because in differentiating preadipocytes, PPAR'Y2 is
highly induced and is the predominant isoform in differenti,
ated adipocytes (38, 44), while in undifferentiated and differ,
entiated fibroblasts , PPAR'Y1 expression was not observed (see
below). We found that the SWl/SNF enzymes are critically
required for transdifferentiation of fibroblasts along the adipo,
genic pathway. Temporal analyses of factor binding to the
PPAR'Y2 promoter revealed that the BRG1,based SWI/SNF
enzymes did not facilitate activator binding to the promoter
but instead promoted preinitiation complex (PIC) function.
Examination of PP AR'Y2 activation during differentiation of
committed preadipocyte cells confirmed that changes in chro-
matin structure, activator binding, and assembly of multiple
components of the. PIC did not require SWl/SNF function.
Nevertheless, activation of PPAR'Y2 transcription did not oc,
cur until SWl/SNF and TFIIH subsequently were brought to
the promoter. Thus, using two different cellular models for
adipocyte differentiation, we demonstrate that activation of the
PPAR'Y regulator critically depends upon SWI/SNFenzymes
most likely by facilitating PIC formation and function.
MATERIAS AND METHODS
Plasmids. The retrovirus encoding mouse PPAR-y2 (45) and cDNAs encoding
rat C/EBP" (20) and mouse C/BPJ3 (8) were kindly provided by Bruce
Spiegelman. C/EBP" and C/EBPJ3 were subcloned into pBabe-Puro (27).
Cell lines and differentiation methods. The derivation and maintenance of the
cell lines that express dominant-negative human BRGI (B22 and B24), domi-
nant-negative hBRM (H17), and the Tet-VP16 regulator (Tet-VPI6) were de-
scribed previously (11). To infect cell lines, BOSC23 cells were cultured in
100-mm-diameter dishes and transfected at 80% confluence by FUGENE
(Roche) with 10 fLg of pBabe-PPAR-y2 , pBabe-C/EBP" , pBabe-C/EBPJ3, or the
empty vector as described previously (31). Viral supernatants were harvested
48 h after transfection. Dishes (60 mm) ofB22 , B24, H17, or Tet-VPI6 cells at
50% confluence were infected with virus in Dulbecco s modified Eagle s medium
(DMEM) containing 10% calf serum , 4 fLg of polybrene/ml , and 2 fLg of tetra-
cycline/ml in a final volume of 5 ml. The corresponding cell lines were split 1:3
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48 h after infection and placed under selection with 2 fLg of puromycin/ml in the
presence of tetracycline. Subsequently, each virally infected cell line was split 1:4
into media containing or lacking tetracycline. After 96. hthe medium was
changed. Plates designated to be undifferentiated received and continued to be
maintained in DMEMplus 10% calf serum in the presence or absence of
tetracycline , while the plates designated for differentiation received DMEM plus
10% fetal calf serum plus cocktail containing 0.5 mM methylisobutylxanthine
(Sigma), 1 fLM dexamethasone (Sigma), 5 fLg of insulin/ml , and 10 fLM troglita-
zone (Biomol) in the presence or absence of tetracycline for 48 h. The cells were
subsequently maintained in DMEM plus 10% fetal ' calf serum with 5 fLg of
insulin/ml and refed every 2 days for up to 8 days.
3T3-Ll preadipocytes were purchased from the American Type Culture Col-
lection , maintained in growth medium consisting of DMEM containing 10% calf
serum , and induced to differentiate as described previously (50).
Oil Red 0 staining. Sixty-millimeter-diameter dishes were washed twice with
phosphate-buffered saline (PBS) and fixed with 10% buffered formalin for 30
min. The formalin was aspirated, and the cells were stained for 1 h in freshly
diluted Oil Red a solution (Sigma), prepared by mixing six parts Oil Red a stock
solutioi1(0.5% Oil Red Oil in isopropanol) and four parts distiled water. The
stain was removed , and cells were washed three times with distilled water and
photographed.
RNA analysis. RNA isolation and analysis by Northern blotting was described
previously (13). Probes were derived from plasmids containing PPAR'), aP2 , or
adipsin cDNA (provided by B. Spiegelman) and were labeled by random prim-
ing. Washed blots were exposed to a PhosphorImager (Molecular Dynamics).
For reverse transcriptase (RT)-PCR, total RNA (3 fLg) was reverse transcribed
with Moloney murine leukemia virus RT (Invitrogen). cDNA was amplified by
PCR with Taq polymerase (Invitrogen; 2.5 U/reaction), 0.2 mM deoxynucleoside
triphosphates, 8 ng of each primer/fLl , and either 1 mM (C/EBP,,), 1.5 mM
(PPAR')), or 2.5 mM hypoxanthine phosphoribosyltransferase (HPRT) MgCl
The initial denaturation step was at 95 C for 5 min and was followed by 25 cycles
(PPAR') and C/EBP,,) or 27 cycles (HPRT). A cycle for PPAR') PCR consisted
of denaturation for 30 s, annealing for 40 s at 68 , and extension at for
30 s. For C/EBP" , it consisted of denaturation for 50 s , annealing for 55 s at 66
and extension at for 50 s. The final round of extension was for 5 min. The
sequences of the primers were as follows: 5' GCATGGTGCCICGCTGATG
and 5' AGGCCTGTIGTAGAGCTGGGT- .for PPAR')2 (340- bp prod-
uct), and5' CCGGCCGCCICAACGAC-3' and CTCCTCGCGGGGCTC
ITGTI-3' for C/EBP", (288- bp product). HPRT and PPAR')1 RT-PCRs were
described previously (13 , 52).
Nuclear run"on analysis was performed as described previously by Schubeler
and Bode (http://juergenbode.gmxhome.de/t01176.htm) on nuclei isolated from
-4 x 10 differentiating 3T3-Ll preadipocyte cells that were collected at days 0
, 4 , 5 , 6, and 7 after induction of differentiation. Hybond N + membranes
(Amersham) were prepared for hybridization as described previously (3). Im-
mobilized DNAs included 0.1 fLg of genomic DNA from 3T3-Ll preadipocytes
3 fLg of EcoRI-linearized pBABE and pBABE-PP AR')2 , or 3 fLg of PCR product
corresponding to nucleotides 181 to 531 of the mouse 36B4 eDNA, to nucleo-
tides 111 to 641 of mouse Gapdh or to Hprl. The HPRT PCR product has been
described (B),
Protein extracts and Western analysis. Isolation of protein and Western blot-
ting have been described (11). Antibodies utilized included C/EBPJ3 (Santa Cruz
sc-7962), M2 anti-FLAG (Sigma), and phosphatidylinositol (PI) 3-kinase (06-
496; Upstate). Determination of the total Brgllevels (see Fig. 4) was performed
by scanning multiple film exposures and quantifying in ImageQuant (Molecular
Dynamics).
Accessibilty assays. Restriction enzyme and DNase I accessibility assays were
performed as described previously (12), except that buffer M contained 0.15 mM
spermine and 0.5 mM spermidine. DNase I was purchased from Promega.
Probes PI and P2 were PCR fragments corresponding to - 1579 to - 1187 and
105 to + 138 from the mouse PP AR')2 promoter (52).
ChIPs. The ChIP procedure was adopted from the Upstate protocol. Cells at
the indicated time points were fied by adding 37% formaldehyde to a final
concentration of 1 % and incubated at 37 C for 10 min. Cross- linking was stopped
by addition of glycine to a final concentration of 0. 125 M. Cells were washed
twice with cold PBS and collected in 1 ml of PBS containing protease inhibitors.
. After centrifugation , the pellet of cells was resuspended in sodium dodecyl
sulfate (SDS) lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCI (pH 8.1))
containing protease inhibitors and incubated on ice for 10 min. Celllysates were
sheared extensively by sonication (Ultrasonic processor from Cole and Parmer;
3-mm tip at 80 W) on ice to obtain fragments from 200 to 600 bp, as revealed by
ethidium bromide staining of aliquots run on agarose gels. Samples were cen-
trifuged to pellet debris , and an aliquot was taken for gel analysis and inputs. One
''''
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hundred micrograms of soluble .chromatin was diluted 10 times with IP buffer
(0,0 % SDS, 1. % Triton X-100, 1.2 mM EDTA , 16.7 mM Tris (pH 8.1), 167 mM
NaCl) containing protease inhibitors and precleared for 3 h at 4 C with 50%
sJurry of protein A, G, or Lin Tris-EDT A (TE) (depending on the isotype of the
antibody used) in the presence of 20 ILg of sonicated salmon sperm DNA and 1
mg of bovine serum albumin/ml. After incubation; the beads were pelleted, and
the supernatantwas immunoprecipitated with antibodies of interest (see below)
at 4 C overnight. Immune complexes were collected with 50% slurry of protein
, G, or L containing 20 ILg of sonicated salmon sperm DNA and 1 mg of bovine
serum albumin/ml in 1E by incubation at 4 C for 1 h. Sepharose. beads were
washed sequentially for 5 min at 4 C with wash 1 (0. 1 % SDS , 1 %Triton X-100,
2 mM EDTA, 20 mM Tris-HCI (pH 8.1), 150 mM NaCl), wash 2 (wash 1
containing 500 mM NaCI), and wash 3 (0.25 M LiCl, 1%.NP- , 1% sodium
deoxycolate, 1 mM EDTA, 10 mM Tris-HCl (pH 8.1)), and finally were washed
twice with TE (pH 8.0). Immune complexes were eluted from the beads with 1 %
SDS in TE (pH 8.0), and protein-DNA cross- links were reversed by adding 200
mM NaCl and heating at 65 C overnight. Afer treatment with proteinase K, the
samples were purified with the QIAquick PCR purification kit (QIAGEN).
One-tenth of the immunoprecipitated DNA and 1 % of the input DNA were
analyzed by PCR.
Antibodies used included Brg1 , Brm , and Ini1 (11), diacetylated (K9K14) H3
(06-599; Upstate), Tetra-acetylated H4 (06-866; Upstate), Pol II CI-Ser-5P ,
(Covance), and the following Santa Cruz antibodies: QEBPa (sc-9314), QEBPJ3
(sc-7962), C/EBPS (sc-151), TFIIB (sc-274), TBP (sc-273), andTFIIH (sc-293).
When Pol p ,antibody was used , 10 mM NaF was added to all buffers. PCRs were
performe , Wih QIAGEN HotStart Taq master mix in the presence of 2 uCiof
(a- P)dATP under the following conditions: 94 , 15 min , followed by 26 cycles
(J3-actin) or 27 cycles (PPAR,,2) of 94 C for 30 s, and then either 65 C for 40 s
(J3-actin) or 49. C for 40 s(PPAR,,2), followed by for 30 s, followed by a
not extension for 5 min. PCR products were resolved in 8% polyacrylamide-1 x
Tris-borate-EDTA gels, dried , and exposed to a PhosphoImager. Primers used
were the following: J3-actin, 5' (+31)GCIcmGCAGCfCCICGTTG-
and 5 ' (+135)TIGCACATGCCGGAGCCGTTGT- ; and PPAR,,2 pro-
moter, 5' 413) TACGTIATCGGTGTICAT-3' and 5' 247) TCfCGC
CAGTGACCC- . Experiments utilizing Pol II or GTF antibodies were also
performed using primers spanning - 216 to - 20 of the PPAR,,2 promoter with
identical results. 
RESULTS
SWI/SNF enzymes are required for differentiation of fibro-
blasts along the adipogenic pathway. We previously described
the B22 and H17 fibroblast cell lines that utilize the tet-regu-
latory system to inducibly express an ATPase-deficient , FLAG-
tagged human allele of BRGI (B22) or an ATPase-deficient
FLAG-tagged human allele of BRM (HI7). The parent for
these cell lines, termed Tet-VPI6 , inducibly expresses only the
tet-VPl6 transactivator and thus serves as a control for our
experiments. The mutant BRGI and hBRM proteins ex-
pressed in B22 and .H17 cells are competent to associate with
other endogenous subunits of SWI/SNF chromatin-remodeling
enzymes and can act as dominant negatives with regard to
different inducible gene activation events (11 , 12).
To determine the requirement for BRGl- and hBRM-based
SWI/SNF enzymes in adipogenesis, we forced the differentia-
tion of these cells in the presence (dominant negative off) or
absence (dominant negative on) of tetracycline by infection
with a retroviral vector encoding the PPAR'Y nuclear hormone
receptor or the C/EBPa or C/EBPf3 activator. Cells infected
with empty retroviral vector served as a control. Cells then
were split into medium containing or lacking tetracycline for
96 h and subsequently were cultured for 7 days in the presence
or absence of a differentiation regimen that included exposure
to a differentiation cocktail (see Materials and Methods) con-
taining troglitazone , a synthetic PPAR'Y ligand. Adipocyte dif-
ferentiation was shown by staining with Oil Red 0 , a lipophilic
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dye. In our hands, approximately 15 to 20% of the PPAR'Y-
infected cells stained with Oil Red 0, which is similar to pre-
vious data for unmodified NIH 3T3 cells infected with PPAR'Y
(45). Tet-VPI6 control cells stained positively when infected
with the PP AR'Y retrovirus but not when infected with the
empty vector (data not shown), and differentiation into adipo-
cytes was dependent on exposure to the differentiation cocktail
(Fig. 1). The presence or absence of tetracycline made no
difference , as expected. In contrast, B22 and H17 cells infected
with the PPAR'Y retrovirus and cultured in the absence of
tetracycline did not differentiate (Fig. 1), suggesting that the
. expression of dominant-negative BRGI or hBRM interfered
with the differentiation process. The same results were ob-
tained for cells infected with either the C/EBPa or the C/EBPf3
virus (data not shown).
SWI/SNF enzymes are required for the activation of adipo-
genic genes as well as for activation of PPAR'Y. We analyzed
the mRNA levels of two adipogenic marker genes, aP2 and
adipsin , in cells expressing PPAR'Y, CIEBPa , or CIEBPf3. Cells
infected with the PP AR'Y retrovirus and cultured in the pres-
ence of tetracycline and differentiation cocktail expressed both
genes, while cells cultured in the absence of tetracycline pro-
duced dominant-negative BRGI and inhibited the expression
of both genes (Fig. 2A, rightpanei). Expressionof PPAR'Y in
each of the samples was monitored by RT-PCR (Fig. 2B , right
panel), and induction of dominant-negative BRGI was moni-
tored by FLAG expression (Fig. 2C, right panel). Other exper-
iments demonstrated thatthe related B24 celUine, which also
inducibly expresses dominant-negative BRGl , and H17 cells,
which inducibly express dominant-negative hBRM, similarly
inhibited expression of adipogenic marker genes in the pres-
ence of dominant-negative protein (data not shown). Control
Tet-VPI6 cells infected with PPAR'Y-encoding virus showed.
accumulation of both aP2 and adipsin mRNAs , regardless of
the presence or absence of tetracycline (Fig. 3, lanes 9 and 10).
The results demonstrate that expression of dominant-negative
BRGI or hBRM interfered with the differentiation process by
preventing expression of adipogenic genes. Since BRGI and
hBRM have been found only in cells in a large-molecular-
weight complex associated with the other SWI/SNF subunits
presumably adipogenesis is also dependent on the activity of
the SWI/SNF chromatin-remodeling enzymes.
Adipogenesis also can be induced in culture via ectopic
expression of the ceIJular transcription factor C/EBPa or
C/EBPf3 (17 51). When B22 cells were infected with ret-
rovirus expressing either C/EBPa or C/EBPf3, a similar block
to aP2 and adipsin gene expression was observed in the pres-
ence of dominant-negative BRGl , though in cells expressing
C/EBPa , the aP2 and adipsin mRNA levels were reduced 85 to
90% and were not completely absent (Fig. 2A, left panel),
Expression levels of C/EBPa (Fig. 2B, left panel), CIEBPf3,
and dominant-negative BRG1 (Fig. 2C, left panel) in these
samples were monitored by RT-PCR or Western blotting. Sim-
ilar results were obtained in H17 cells expressing dominant-
negative hBRM (data not shown). As anticipated , Tet-VP16
ceIJs infected with CjEBPa- or CIEBPf3-encoding virus ex-
pressed both aP2 and adipsin mRNAs in both the presence and
absence of tetracycline (Fig. 3 , lanes 13 to 14 and 17 to 18).
Thus, SWI/SNF chromatin-remodeling enzymes also are re-
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FIG. 1. Expression of dominant-negative BRGI or hBRM blocks the ability of PPAR'Y2 to induce adipogenesis in fibroblast cells. B22 and HI7
cells , which inducibly express ATPase-deficient, dominant-negative BRGI or hBRM, respectively, upon removal of tetracycline, or Tet-VPI6 cells,
which induce only the Tet-VPI6 regulator, were infected with a retroviral vector encoding PPAR'Y2, grown in the presence or absence of
tetracycline , and differentiated for 7 days in the presence or absence of differentiation cocktail (see Materials and Methods). Cells were fied
stained with Oil Red 0, and photographed.
quired for activation of the adipogenic gene program by
C/EBPa or C/EBPI3.
Interestingly, cells induced to differentiate via expression of
C/EBPa or C/EBPI3 activated PPAR'Y expression in a SWI/
SNF-dependent manner (Fig. 2B, left panel). This suggests
that during differentiation promoted by C/EBPa or C/EBPI3,
induction of PPAR'Y-one of the earliest steps in differentia-
tion-is dependent on the activity of BRGI or BRM. This
explains the significant decrease in aP2 and adipsin expression
in these cells. However, the data presented here also indicate
that SWI/SNF enzymes playa broader role in adipogenesis
than just promoting induction of PPAR'Y, because when the
induction of PPAR'Y is bypassed by providing PPAR'Y via ret-
roviral infection, expression of the downstream adipogenic
marker genes remained SWI/SNF dependent (Fig. 2, right
panels). Thus, the data indicate that SWI/SNF enzymes are
required for both early and late gene activation events during
adipocyte differentiation.
Kinetics of PPARy2 expression in dilferentiating cells. To
further analyze the molecular events controlling activation of
the adipogenic pathway, we initiated differentiation by infect-
ing cells with C/EBPa, since we could observe that nearly 70%
of cells differentiated for 1 week would accumulate lipid drop-
lets (data not shown). RT-PCR analysis of PPAR'Y2 mRNA
levels in cells grown in the presence of tetracycline showed a
detectable accumulation on day 1 of differentiation, with ro-
bust levels present from days 2 to 7 (Fig. 4). Low levels of
PPAR'Y2 transcripts were observed in cells grown in the ab-
sence of tetracycline. We could not detect PPAR'Yl mRNA in
these cells. Western analyses confirmed that C/EBPa was
present at equivalent levels in each sample (Fig. 4). Analysis of
FLAG-tagged-protein levels indicated that expression of the
mutant BRGI protein occurred in all samples grown in the
absence of tetracycline. Reprobing of this blot for total Brgl
levels revealed only a 1.5- to 2. fold increase in levels of Brgl
in the cells expressing the dominant-negative BRG1. This sug-
gests that the levels of mutant Brgl are only a fraction of the
total Brgl present in the cells, yet they stil function as domi-
nant-negative proteins. Alternatively, expression of the Brgl
mutant reduces expression from the endogenous locus, per-
haps for the purpose of maintaining a specific overall level of
Brgl protein. In either case, the results indicate that high levels
of Brgl overexpression are not occurring in the differentiating
cells.
VOL. 24 , 2004
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FIG. 2. Expression of dominant-negative BRGI blocks the ability of PPAR"(2, C/EBPa , or C/EBPfI to induce adipogenesis in fibroblast cells.
B22 cells were infected with retroviral vectors encoding PPAR"(2, C/EBPa , or C/EBPfI, grown in the presence or absence of tetracycline , and
differentiated for 7 days in the presence or absence of differentiation cocktail. Samples in lanes marked Adipocyte were taken from 3T3-
preadipocytes differentiated for7 days. (A) Northern blot showing levels of aP2 and adipsin mRNA. Ethidium bromide staining of rRNA is shown
as a control. (B) RT-PCR showing levels of PP ARoy2 and C/EBPa mRNA. HPRT mRNA levels are shown as a control. (C) Western blot showing
levels of FLAG-tagged dominant-negative BRGI , CIEBPfI, and PI3-kin e. 
Histone hyperacetylation and binding of C/EBP factors to
the PPAR')2 promoter are independent of Brgl- based SWI/
SNF activity. The mouse PP ARy2 promoter has been defined
but not well characterized functionally. Of interest , however, is
the presence of multiple C/EBP binding sites in the promoter
includingtwo half-consensus sites around - 325 reJative to the
mRNA start site that contribute to activation of PP ARy2 re-
porter genes (16). To temporally analyze factor interactions at
the endogenous PPAR"(2 promoter, we performed ChIP ex-
periments and amplified either PP AR"(2 promoter sequences
or j3-actin sequences as a control. Because we forced differen-
tiation by ectopically expressing C/EBPa before inducing dif-
ferentiation , we were not surprised to see interaction of
C/EBPa with the PPAR"(2 promoter at the initiation of the
differentiation process and throughout the time course. This
observation likely reflects and explains the capacity of C/EBPa
to initiate the adipogenic gene expression program in nonadi-
pogenic cells. The presence of dominant-negative BRG1 had
no or little effect on C/EBPa interactions (Fig. SA). In differ-
entiating adipocytes, there is a temporal order to expression of
the C/EBP family members , where C/EBPj3 and C/EBPo are
rapidly induced and then are shut off over the first few days of
differentiation. Subsequently, C/EBPa is induced at about day
2 to 3 and is maintained during differentiation (reviewed in
reference 21). We therefore examined interactions of C/EBPj3
and C/EBPo with the PPAR"(2 promoter. Somewhat surpris-
ingly, both C/EBPj3 and C/EBPo showed a robust induction of
occupancy of the promoter at days 1 to 2 of differentiation
despite the presence of ectopic C/EBPa and regardless of the
presence of dominant-negative BRG1 (Fig. SA). Thus, there
appears to be a preference durIng the early stages of differen-
tiation for interaction with C/EBPj3 and C/EBPo. In addition
binding of these factors does not require functional SWI/SNFenzymes. - 
There are a muJtitude of histone modifications and other
ATP-dependent chromatin-remodeling activities that may me-
diate C/EBP factor binding in the presence of mutant SWI/
SNF enzymes. We examined diacetylation of histone H3 on
lysines 9 and 14 as well as tetra-acetylation of H4 (Fig. SB).
Levels of tetra-acetylated H4 were high at the beginning of the.
differentiation process and remained constant throughout. In
contrast, there was induction of diacetylated H3 at day 1
concurrent with occupancy of the promoter by the C/EBPj3
and C/EBPo factors. Acetylation of H3 and H4 was unaffected
by the presence of dominant-negative BRGl.
C/EBP factors initate recruitment of SWI/SNF and Pol
II-associated GTFs to the promoter. Previous work has dem-
onstrated that both C/EBPa and C/EBPj3 can physically inter-
act with the SWI/SNF component hBRM in cells overexpress-
ing both proteins (19 , 32). Additionally, C/EBPa interacts with
the Pol II-associated general transcription factors (GTFs)
TFIIB and TBP (29). These data have been used to argue that
the C/EBP factors can recruit SWI/SNF and GTFs to facilitate
transcription. ChIP experiments with the FLAG-tagged
ATPase-deficient BRG1 produced in B22 cells revealed that
the mutant ATPase, when expressed, was present on the
PPAR"(2 promoter as early as day 0 and maximally from day 1
through day 7 of differentiation (Fig. SC). Thus, the presence
of C/EBPa may be recruiting SWI/SNF to the promoter at or
before the onset of differentiation , possibly reflecting the abil-
p. 
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FIG. 3. PPAR'Y2 , C/EBPa , and C/EBPf3 induce adipogenesis in Tet-VPI6 control fibroblasts. Tet-VPI6 cells were infected and manipulated
as described for Fig. 2. (A) Northern blot showing levels ofaP2 and adipsin mRNA. Ethidium bromide staining of rRNA is shown as a control.
(B) RT-PCR showing levels of PPAR-y2 and C/EBPa mRNA. HPRT niRNA is shown as a control. (C) Western blot showing levels of
FLAG-tagged dominant-negative BRG1 , C/EBPf3, and PI3-kinase.
ity of these proteins to physically interact. ChIP analysis of
Brgl and the SWI/SNF component Inil revealed kinetics of
promoter occupancy that were similar to each other and to
FLAG-tagged mutant BRGl. Promoter occupancy in cells not
expressing the dominant-negative BRGI (plus tetracycline)
differed in that interaction of SWI/SNF components peaked at
day 2, which coincides with full induction of PPARy2 tran-
scription (Fig. 4). The observed interaction of the mutant
BRGI with the promoter on day 0 may be due to the modest
overexpression of total Brgl in the cells expressing mutant
BRGl(Fig. 4). 
Analyses of phosphorylated RNA Pol II and its associated
Days
Telracyclll'e
PPAR mRNA
PPARyt mRNA
HPRT
CIEBPn
eRG1
PI3 kinase
FIG. 4.. Expression levels of adipogenic regulators during differentiation of fibroblast cells along the adipogenic pathway. B22 cells were infected
with a retroviral vector encoding C/EBPa grown in the presence or absence of tetracycline , and differentiated. Expression levels of adipogenic
regulators are given as a function of time of differentiation. PPAR'Y2 and PPAR'Yl transcript levels were measured by RT- PCR. HPRT levels are
shown as a control. The lane marked C is a positive control from day 7 differentiated 3T3-Ll preadipocytes. C/EBPa total Brgl, dominant-
negative, FLAG-tagged BRG1 , and PI3-kinase levels were measured by Western blotting.
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FIG. 5. ChIP analysis of interactions on the PPARy2 promoter as
a function of time of differentiation. B22 cells were infected with a
retroviral vector encoding C/EBPa , grown in the presence or absence
of tetracycline , and differentiated. One percent of input is shown for
each experiment. Portions of the PPAR)'2 promoter or the l3-actin 5'
un translated region and coding sequence were amplified from each
sample. (A) Levels of interactions with C/EBPa , -13, and -0. (B) Levels
of interactions with tetra-acetylated H4 and K9- , K14-diacetylated H3.
(C) Levels of interactions with total BrgI , dominant-negative, FLAG-
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GTFs , TBP, TFIIB, and TFIIH , indicated that each of these
factors is present on the PPARy2 promoter on day 0, and
occupancy in the presence of the dominant-negative SWI/SNF
complex is essentially unaffected on days 0 and 1 (Fig. 5D).
Thus, SWI/SNF function is not required to assemble these
factors onto the promoter in the presence of ectopic C/EBPa.
However , the presence of the C/EBP factors , Brg1-based SWI/
SNF enzyme , and these GTFs on the promoter are not suff-
cient to initiate transcription at day O. Maximal induction of
PP ARy2 transcription in the presence of functional SWI/SNF
enzymes occurs on day 2 (Fig. 4). In contrast , starting on day 2
and continuing throughout the rest of the time course, the
association of TBP, TFIIB, Pol II, and especially TFIIH is
compromised in cells expressing the dominant-negative BRG1
(Fig. 5D). Western blot analysis of these GTFs and Pol II
shows that the levels of these factors are not altered by differ-
entiation or by expression of the dominant-negative BRG1
(data not shown). Thus , on or about day 2 of differentiation
SWI/SNF function is necessary to maintain the PIC on the
PPAR"(2 promoter and to promote transcription.
Examination ofPPAR'Y2 promoter accessibilty andactiva-
tion in differentiating 3T3-Ll preadipocytes. Although forced
differentiation of fibroblasts has been utilized for many years as
a model system and has been essential in the identification and
characterization of adipogenicregulatory proteins, we were
concerned that the events leading to activation of the PPAR"(2
promoter under conditions where the C/EBPa activator was
prematurely expressed might not precisely reflect the events
that occurred during differentiation of a committed preadipo-
cyte cell. We therefore examined PPAR"(2 activation in differ-
entiating 3T3-Ll preadipocytes.
InitiaJly, we examined changes in PPAR"(2 promoter struc-
ture as reflected by increases in nuc1ease accessibility. A sche-
matic of the promoter is presented in Fig. 6A. Examination of
two StuI sites, an EcoNI site , and a Pst! site located between
100 and - 1000 on the PP AR "(2 promoter revealed a dra-
matic increase in accessibility in this region on day 1 of the
differentiation process (Figs. 6B to D), reflecting changes in
promoter structure. A previous report (34) indicated that two
DNase I hypersensitive sites exist on the PPAR"(2 promoter in
undifferentiated 3T3-Ll ceJls (Fig. 6A). Our analysis indicated
these DNase I hypersensitive sites were diffcult to detect in
undifferentiated , day a cells. However, by day 1 , they were
clearly visible , indicating that that these hypersensitive sites are
induced by differentiation (Fig. 6E). Together, the results
c1early demonstrate a change in PP AR"(2 promoter structure
on day 1 of 3T3-Ll differentiation, prior to induction of
PPAR"(2 gene expression.
Northern analysis of PP AR"( transcript levels revealed a
robust induction of expression on day 2 of 3T3-Ll preadipo-
cyte differentiation (Fig. 7A), in agreement with prior studies
tagged BRGl , and Inil. (D) Levels of interactions with TBP , TFIIB
TFIIH p89 , and Pol II phosphorylated on Ser-5 of the CTD. Inset:
linearity controls for PCR amplifications. Each ChIP was repeated in
two to five independent experiments. The data shown in parts A, B
and C derive from a single differentiation experiment. ChIPs in part D
derive from a different differentiation experiment.
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FIG. 6. Changes in PPAR-y2 promoter accessibility occur on day I of differentiation. 3T3-Ll preadipocytes were induced to differentiate , and
nuclei were harvested at the indicated times for nuclease accessibility experiments. (A) Schematic of the PP AR-y2 promoter. The locations of
relevant restriction enzyme sites are indicated, as are the previously reported DNase I hypersensitive sites (HSI and HS2) (34). Black sql1ares
represent potential C/EBP binding sites. Black bars PI and P2 indicate the fragments used as Southern blot probes. (B to D) Restriction enzyme
accessibility of EcoNI , StuI , and Pst!. The enzymes used for flanking digests are ,indicated in parentheses. (E) Accessibility of DNase I.
(45). Thus, induction of the PPAR'Y2 is temporally distinct
from changes in promoter accessibility. 
Binding of C/EBP factors , hyperacetylated histones, Pol 
and most GTFs precedes the onset ofPPAR')2 induction. ChIP
experiments to identify interactions of the C/EBP family of
factors with the PPAR'Y2 promoter showed an induction of
C/EBPI3 and C/EBPo binding on days 1 and 2 of differentia-
tion , respectively (Fig. 7B), largely consistent with the expres-
sion patterns of these C/EBPs in differentiating 3T3-Ll cells
and with the ChIP results from the forced fibroblast system
(Fig. SA). Thus, interaction of C/EBPI3 correlated temporally
with changes in nuclease accessibility on the promoter. Over
days 2 and 3 , C/EBPI3 and -0 disappeared from the promoter
concurrent with the appearance of C/EBPa (Fig. 7B). Thus , in
differentiating 3T3-Ll cells, the C/EBP binding sites in the
PP AR'Y2 promoter undergo a transition of factor occupancy
from C/EBPI3 to C/EBPa.
As in the C/EBPa forced fibroblast differentiation experi-
ments , ChIP analysis of tetra-acetylated H4 indicated that lev-
els were high prior to differentiation (Fig. 7C). In contrast to
the forced fibroblasts , levels of diacetylated H3 were present
on the PPAR'Y2 promoter at day Obut increased on day 3 (Fig.
7C). This increase clearly occurred after the onset ofPPAR'Y2
expression but correlated with the transition from binding of
C/EBPI3 and -0 to C/EBPa. Whether the change in diacety-
lated H3 levels is a cause or effect of the transition to C/EBPa
binding has not been determined. Diacetylated H3 was also
present at reJatively .high levels on the control l3-actin se-
quences.
Examination of phosphorylated Pol II and associated GTFs
by ChIP showed that Pol II , TBP , and TFIIB became associ-
ated with the promoter on day 1 of differentiation , prior to
expression of PP AR'Y2 (Fig. 7D). Collectively, these data agree
with the results obtained with the fibroblast differentiation
model and indicate that much of the transcriptional machinery
is present on the promoter prior to the onset of gene activa-
tion.
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FIG. 7. (A) PPAR,, expression Jevels in differentiating 3T3-Ll preadipocytes. 3T3-Ll preadipocytes were induced to differentiate. PPAR,,
expression levels were analyzed by Northern blotting. Ethidium bromide-stained 28S and I8S rRNA is shown as a control. (B tp E) ChIP analysis
of interactions on the PPAR,,2 promoter as a function of time of differentiation of 3T3-Ll preadipocytes. 3T3-Ll preadipocytes were induced to
differentiate and processed for ChIP assays at the indicated times. Portions of the PP AR ,,2 promoter or the l3-actin gene were amplified from each
sample. (B) Levels of interactions with CIEBPe. -13, and -0. (C) Levels of interactions with tetra-acetylated H4 and K9-, KI4-diacetylated H3.
(D) Levels of interactions with TBP , TFIIB , TFIIH p89 , and Pol II phosphorylated on Ser-5 of the CTD. (E) Levels of interactions with Brgl , Brm
and Inil. Inset: linearity controls for PCRamplifications. Each ChIP was repeated in three to five independent experiments. The data shown in
parts B, C, and E derive from a single differentiation experiment. ChIPs in part D derive from a different differentiation experiment.
PPAR')2 expression is coincident with the binding ofTFIIH
and SWI/SNF components to the promoter. In contrast to the
other factors examined , the increase in association of TFlIll
did not occur until day 2 of 3T3-Ll differentiation (Fig. 7D).
Similarly, association of the SWI/SNF components Brgl , Brm
and Inil occurred on day 2 (Fig. 7E), coincident with the onset
of PP AR')2 transcription. Unlike the case with Pol II and all of
the GTFs examined , the interaction of SWI/SNF subunits was
transient, with only background levels present on the promoter
after day 4. The Inil subunit is common to all SWI/SNF en-
zymesexamined , but the Brgl and Brm ATPases form distinct
SWI/SNF enzymes, indicating that at least two distinctforms of
the enzyme are present at the PPAR')2 promoter at the onset
of transcription. The data indicate that histone hyperacetyla-
tion , changes in promoter structure, C/EBP activator binding,
and association of phosphorylated Pol II ' and multiple GTFs
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FIG. 8. The rate of PP AR") transcription decreases after day 4 of
3T3-LI differentiation. Nuclear run-on assays were performed on nu-
clei isolated from differentiating 3T3-Ll cells on the days indicated.
Run-on transcripts were hybridized to 3T3-Ll genomic DNA, linear-
ized pBABE vector, linearized pBABE containing the PPAR")2
cDNA, or PCR products corresponding to Idl or Hprt cDNAs.
with the PPARy2 promoter occur over the first 24 h of adipo-
cyte differentiation but that these events are not suffcient to
initiate transcription. PPAR-y2 expression is facilitated by as-
sociation of TFIIH and SWI/SNF enzymes on day 2 of differ-
entiation.
A decrease in the rate of PPAR') transcription correlates
with the dissociation of SWI/SNF enzyme components from
the PPAR')2 promoter. The ChIP experiments shown in Fig.
7E clearly demonstrate that SWI/SNF components were no
longer stably associated with the PP AR-y2 promoter after day
4 of differentiation , even though the GTFs and C/EBPa re-
mained. Analysis of stable mRNA levels indicated that PPAR-y
mRNA was abundant on days 5 to 7 (Fig. 7A). Two possible
explanations for these data exist. The promoter may achieve a
stable structure that is permissive for continued transcription
in the absence of SWI/SNF, or the transcription of PPAR-y2
decreases or stops after day 4 and the PPAR-y message ob-
served on days 5 to 7 represents stable mRNAs produced on
day 4 or earlier.
To distinguish between these possibilities , we performed a
time course of nuclear run-on experiments. Linearized plasmid
DNA containing the PPAR-y2 cDNA or empty vector was
immobilized on membranes and hybridized to radiolabeled
run-on transcripts produced by nuclei isolated from differen-
tiating 3T3-Ll cells on the days indicated. The data demon-
strated induction of PPAR-y transcription on day 2 , continued
transcription on day 4, but little transcription on days 5 to 7
(Fig. 8). Thus, the rate of PP AR-y transcription decreased
between days 4 and 5 and correlated with the loss of SWI/SNF
enzyme compo'nents on the PPAR-y2 promoter (Fig. 7E). In
contrast, the rate of Id1 transcription decreased as a function
of differentiation (Fig. 8), in agreement with previously pub-
lished results from the differentiation of human preadipocyte
cells (26). We utilized nonspecific hybridization to plasmid
sequences and hybridization to 3T3-Ll genomic DNA as con-
trols, as has been described (10, 24, 41 , 47), since we were
unable to identify other genes that gave a constant rate of
transcription over the differentiation time course. The rates for
Hprt 36B4 , and Gapdh all decreased over the 7-day time
course (Fig. 8 and data not shown).
We note that the immobilized template contained the entire
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PPAR-y2 cDNA; thus, PPAR-y1 transcription would also have
been detected. We were unable to detect run-on signal when
only the short , 121-bp portion of the cDNA unique to PPAR-y2
(52) was used for the hybridizations (data not shown). How-
ever, PPAR-y mRNA at day 5 of 3T3-Ll differentiation and
beyond is predominantly expressed from the PPAR-y2 pro-
moter (38 , 44). Thus, the data most likely reflect a decrease in
the rate of PPAR-y2 orin the rates of both PPAR-y2 and
PPAR-y1 transcription.
DISCUSSION
PPAR-y is involved in adipocyte differentiation , insulin sen-
sitivity and diabetes , atherosclerosis, and the control of cell
proliferation in some cancer cells (reviewed in references 5 and
37); Consequently, its function has been the subject of intense
investigation. Relatively little, however, is known about the
mechanisms controlling its expression. Here we utilized two
different cellular models for adipocyte differentiation to tem-
porally describe the molecular interactions that occur at the
promoter of the inducible PPAR-y2 gene during adipocyte dif-
ferentiation , with particular emphasis on the requirement for
SWI/SNF chromatin-remodeling enzymes. Through use of a
differentiation system driven by introduction of the adipogenic
regulator, C/EBPa , we demonstrate a requirement for SWI/
SNF enzymes in the activation of the PPAR-y regulator as well
as in the activation of adipogenic marker genes expressed later
during differentiation. Moreover , these experiments revealed
that this requirement for SWI/SNF enzymes was relatively late
in the cascade of events leading to PPAR-y2 activation. Acti-
vator binding; Pol II and associated GTF interactions at the
promoter , and histone H3 and H4 acetylation occurred prior to
and independently of SWI/SNF function. Instead, the data
revealed a role for SWI/SNF enzymes in the functiQo of the
PIC components at the promoter at the time of transcriptionalactivation. 
Because of the inherent differences between forcing differ-
entiation of fibroblasts into the adipocytelineage and genuine
preadipocyte differentiation, we analyzed differentiation of
3T3-Ll preadipocytes and confirmed both the general order of
events that occur during PP AR-y2 activation and a role for
SWI/SNF enzymes in facilitating PIC function. We expect that
the differences exhibited by the two systems reflect the ability
of the C/EBPa activator to recruit GTFs and SWI/SNF en-
zymes (32) prematurely at the initiation of the forced differ-
entiation program. Despite the differences , it is important to
note that the data from both systems are consistent with a need
for SWI/SNF enzymes to promote the function of the PIC.
The order of events occurring in differentiating 3T3-Ll cells
is diagrammed schematically in Fig. 9. Acetylation of H4 oc-
curs before the onset of differentiation , followed by concurrent
changes in promoter accessibility, binding of the C/EBPj3 and
0 activators, and assembly of Pol II and most of the GTFs on
day 1 of differentiation. Subsequently, on day 2, SWI/SNF
enzymes and TFIIH associate with the promoter, indicating
that the SWI/SNF enzymes likely facilitate completion of the
preinitiation complex, thereby permitting PPAR-y2 transcrip-
tion to commence. On day 3 , there is both an increase in the
levels of H3 acetylation and a transition from binding of
C/EBPj3 and -0 to binding of C/EBPa. Which event, if either
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FIG. 9. Schematic model of the temporal changes in factor interactions at the PPAR'Y2 promoter during 3T3-LI preadipocyte differentiation.
Nucleosome positions are presented for ilustrative purposes only.
is causal remains to be determined. Following day 4 , the SWI/
SNF enzymes disappear from the promoter and the rate of
PPAR-y transcription drops, indicating that the presence of
SWI/SNF is required for continued transcription.
The data from differentiating 3T3-Ll preadipocytes indicate
that both BRG1 and BRM are present on the PPAR-y2 pro-
moter, suggesting that both complexes are contributing to
function. Alternatively, the two complexes could be redundant
in function , and the presence of either SWI/SNF enzyme might
be suffcient. Our studies using cell lines that inducibly express
dominant-negative BRG1 or BRM also suggest that both
ATPases are required for PPAR-y2 activation and adipocyte
differentiation. However, because the BRG1 and BRM SWI/
SNF complexes share multiple subunits, it is possible that ex-
pression of one mutant ATPase deleteriously affects both com-
plexes by sequestering subunits from the other, endogenous
ATPase. Thus, we cannot rigorously state at present whether
BRG1 , BRM , or both are required for PPAR-y2 activation and
adipocyte differentiation.
One of the interesting results from our studies is the dem-
onstration that the C/EBP binding sites undergo a transition
during the time course of differentiation from binding C/EBP
and -8 to binding C/EBPa. Although the kinetics of expression
for these factors has long supported this idea, this is the first
documentation that such a transition occurs at a promoter
expressed during adipogenesis. These results differ from pre-
viously published work that showed that C/EBPa and - , but
not C/EBP , could bind to the C/EBP sites in the PPAR-y2
promoter in a gel shift study and could activate a transiently
transfected PPAR-y2 reporter plasmid (16). The differences
between the studies may be attributed to the likelihood that
the chromatin structure at the genomic locus differs from that
on a transfected template and undergoes changes during the
differentiation process that affect factor interactions.
Previous reports documenting the potential of C/EBPa and
to physically interact with BRM in cells transfected with
both the C/EBP isoform and BRM suggested that these factors
may recruit SWI/SNF enzymes (19, 32). Our temporal analysis
of factor interactions on the PPAR-y2 promoter during
C/EBPa-driven differentiation strongly suggests that targeting
of SWI/SNF by C/EBPa can occur. However, C/EBPa is pre-
maturely present on the promoter in this differentiation sys-
tem; the temporal differences in the appearance of the differ-
ent C/EBP factors on the PPAR-y2 promoter in the
differentiating 3T3-Ll adipocytes suggest that in a more natu-
ral differentiation context, C/EBP and -8 may target SWI/
SNF enzymes, which then later recruit C/EBPa.
Changes in nuclease accessibility and the binding of C/EBP
factors, Pol II, and many of the GTFs on day 1 prior to the
appearance of SWI/SNF enzymes on the PPAR-y2 promoter
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indicate that other factors must control the initial accessibility
of these promoter sequences. Changes in H4 acetyJation did
not correlate with initial factor binding to the promoter.
Changes in other histone modifications at the PPAR')2 pro-
moter have not been tested but potenfially could mediate fac-
tor accessibility. Alternatively, a different ATP-dependent re-
modelingenzyme(s) could alter chromatin structure and
promote activator binding prior to SWI/SNF function. This
hypothesis is supported by in vitro studies showing that ISWI
containing chromatin-remodeling enzymes facilitated stable
interaction of RARa:RXR on chromatin templates prior to
SWI/SNF enzyme-mediated stimulation of transcription (15).
Finally, transcriptional regulators present on the promoter
prior to differentiation , such as GATA-2 and -3 (43) and KLF2
(4), might influence chromatin structure in a manner that pro-
motes the transition to an actively transcribing gene.
Our analysis of GTF interactions on the PPAR')2 promoter
also revealed that serine 5-phosphorylated Pol II is present at
the promoter before TFIIH. TFIIH contains a kinase activity
that is capable of phosphorylating the Pol II CTD; however
the temporal order of factor appearance at the PPAR')2 pro-
moter suggests that either a different kinase is responsibJe for
the CTD phosphoryJation or TFIIH mediates CTD phosphor-
ylation independently of promoter binding. Additionally, the
presence of PoJ II phosphorylated at serine 5 of the CTD raises
the possibility that the poJymerase may be transcriptionally
engaged at day 1 and that the inclusion of SWI/SNFenzymes
and TFIIH on . day 2 promotes release of the polymerase
and/or elongation. Multiple other genes are regulated at the
JeveJ of transcriptional elongation , including hsp70 where
elongation can be stimulated by SWI/SNF enzymes in vitro and
in vivo (6 , 9).
The concurrent entry of SWI/SNF enzymes and TFIIH onto
the PP AR')2 promoter in differentiating 3T3- Ll cells suggests
that SWI/SNF facilitates the interaction of TFIIH with the rest
of the preinitiation complex. Such a role for SWI/SNF enzymes
has not previousJy been documented. However , the data pre-
sented here agree with and extend findings from temporal
analyses of other mammalian promoters that show the follow-
ing: (i) some form of histone hyperacetylation precedes asso-
ciation of SWI/SNF with the promoter, and (ii) SWI/SNF en-
zymes work late in the activation of many genes, typically after
some , if not most , of the components driving transcription have
associated with the promoter (1 , 23 , 25 , 40). Thus , the data we
present on PP AR')2 activation during adipocyte differentiation
support a general model where SWI/SNF enzymes function
subsequent to activator binding by completing or stabilizing
preinitiation complex formation and/or by promoting pro-
moter clearance and elongation.
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Abstract
The CCAAT/enhancer-binding protein (C/EBP) family of transcriptional regulators is critically important for the
activation of adipogenic genes during differentiation. The C/EBPP and /) isoforms are rapidly induced upon adipocyte
differentiation and are responsible for activating the adipogenic regulators C/EBPa and peroxisome proliferator
activated receptor (PPAR)y2, which together activate the majority of genes expressed in differentiating adipocytes.
However, mitosis is required following the induction of adipogenesis , and the activation of C/EBPa and PPARy2 gene
expression is delayed unti cell division is underway. Previous studies have used electromobility shift assays to suggest
that this delay is due , at least in part, to a delay between the induction of C/EBPP protein levels and the acquisition of
DNA binding capacity by C/EBPp. Here we used in vivo chromatin immunoprecipitation analysis of the C/EBPa
PPARy2 , resistin, adiponectin, and leptin promoters to examine the kinetics of C/EBP protein binding to adipogenic
genes in differentiating cells. In contrast to prior studies, we determined that C/EBPP and /) were bound to endogenous
regulatory sequences controlling the expression of these genes within 1-4 h of adipogenic induction. These results
indicated that C/EBPP and /) bind not only to genes that are induced early in the adipogenic process but also to genes
that are induced much later during differentiation , without a delay between induction of C/EBP protein levels and DNA
binding by these proteins. We also showed . that each of the genes examined undergoes a transition in vivo from early
occupancy by C/EBPP and /) to occupancy by C/EBPa at times that correlate with the induction of C/EBPa protein
levels , demonstrating the generality of the transition during adipogenesis and indicating that the binding of specific
C/EBP isoforms does not correlate with timing of expression from each gene. We have concluded that C/EBP family
members bind to adipogenic genes in vivo in a manner that follows the induction of C/EBP protein synthesis.
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Introduction
The major transcription factor families involved as key
regulators of adipocyte diferentiation include the
nuclear hormone receptor peroxisome proliferator
activated receptor (PP AR)y. and the CCAA T / enhancer-
binding proteins (C/EBPs) (Darlington et al. 1998 , Fajas
et al. 1998 , Lane et al. 1999 , Morrison & Farmer 2000
Rangwala & Lazar 2000 , Rosen et al. 2000 , Camp et al.
2002 , MacDougald & Mandrup 2002). The C/EBP
family members belong to the basic leucine zipper
(bZIP) class of transcription factors , and bind to specific
DNA sequences as dimers with other C/EBPs (reviewed
by Lekstrom-Himes & Xanthopoulos 1998 , Ramji &
Foka 2002). When adipocyte differentiation is induced in
preadipocyte cell lines , C/EBP and 8 are rapidly and
transiently induced (Cao et al. 1991 , Yeh et al. 1995).
These regulators act synergistically to modulate the
expression ofC/EBPa and PPARy2 via interaction with
the C/EBP regulatory elements present in the proximal
promoters of these genes (Christy et al. 1991 , Zhu et al.
1995 , Clarke et al. 1997 , Tang et al. 1999). Subsequently,
C/EBPa and PPARy2 playa prominent role regulating
Journal of Molecular Endocrinology (2006) 36, 139-151
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the expression of adipocyte genes necessary for the
development of functional, mature adipocytes (Lin &
Lane 1994, Tontonoz et al. 1994, Fajas et al. 1998 , Wu
et al. 1999 , Rosen et al. 2000).
The essential role of the C/EBP proteins in adipocyte
differentiation has been established, Ectopic expression
of C/EBP or C/EBPa is able to force non-adipogenic
cell lines to differentiate into adipocytes (Freytag et al.
1994, Wu et al. 1995 , Yeh et al. 1995). In contrast
expression of antisense C/EBPa RNA in preadipocyte
cell lines prevents the diferentiation program (Lin &
Lane 1992). Additionally, analysis of promoter regions of
adipogenic genes as well as studies of knockout mice
have demonstrated the involvement of this family of
transcription factors in regulating adipogenesis and
other important physiological processes (reviewed by
Cornelius et al. 1994, MacDougald & Lane 1995
Tanaka et al. 1997 , Darlington et al. 1998 , Gregoire et al.
1998 , Lane et al. 1999 , Rangwala & Lazar 2000 , Ramji
& Foka 2002).
Most regulatory sequences controlling the expression
of adipocyte-specifc genes contain at least one func-
tional C/EBP binding site , from which transactivation
001: 10.1677/jme. 01918
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is mediated by members of the C/EBP family (reviewed
by Hwang et at. 1997 , Gregoire et al. 1998 , Cowherd
etal. 1999 , Morrison & Farmer 2000, Rangwala &
Lazar 2000). Work on the PPARy2 and C/EBPu
promoters has focused on the role of C/EBP and
as primary inducers of the expression of key
regulators. PPARy2 and C/EBPu are expressed by day
2 of. the diferentiation process , following one or two
rounds of mitotic clonal expansion. The induction of
C/EBP and 8 protein levels , however , occurs almost
immediately after addition of differentiation inducers at
the onset of diferentiation (Cao et al. 1991 , Yeh et al.
1995 , Darlington et al. 1998 , Tang & Lane 1999). Thus
even though both C/EBP and 8 a e expressed at high
levels at the beginning of the diferentiation program
the target genes C/EBPu and PPARy2 are not
expressed until nearly 2 days later (Lane et al. 1999
Rosen et al. 2000). Previous work using electrophoretic
mobility shift assay (EMSA) analysis (Tang & Lane
1999) clc;termined that the lag in C/EBPu expression is
due to delay in acquisition of C/EBP and 8 DNA
binding activity, therefore pausing the transcriptional
activation of the gene. The need for such a delay fits well
with the numerous observations that C/EBPu 
anti-mitotic in both preadipocytes as well other cell types
(Umek et al. 1991 , Lin et al. 1993 , Timchenko et al. 1996
Wang et at. 2001).
The transcriptional activity of the C/EBP protein is
regulated at several levels, including transcription
translation, association with other proteins, and post-
translational modification, which includes the regulation
of the phosphorylated state by multiple effectors.
Multiple phosphorylation sites have been characterized
on C/EBP , some of which result in attenuation or
enhancement of DNA binding and transactivation
activity (Mahoney et al. 1992 , Trautwein et at. 1993
1994, Park et al. 2004a Tang et al. 2005 and references
therein). At least some of these phosphorylation events
occur almost simultaneously with induction of C/EBP
levels, and it has been suggested that phosphoryla-
tion causes a conformational change in C/EBP that
transforms it from a repressor . to an activator
(Kowenz- Leutz et al. 1994).
Vve previously examined the temporal interactions of
C/EBP family members, modified histones , and subunits
of the SWI/SNF family of ATP-dependent chromatin
remodeling enzymes at the PP AR 1'2 promoter as a
function ofadipocyte differentiation (Salma et al. 2004).
In that study, we used chromatin immunoprecipitation
(ChIP) assays to determine that C/EBP was bound at
the PPARy2 . promoter at 24 and 48 h following the
initiation of the diferentiation program in both
diferentiating 3T3-Ll cells and in fibroblasts forced to
diferentiation into adipocytes by ectopic expression 
C/EBPu (Salma et at. 2004). Continuation of these ChIP
studies at earlier time-points revealed that the C/EBP
Journal of Molecular Endocrinology (2006) 36, 139- 151
and 8 isoforms were found on the regulatory regions of
numerous adipocyte-specifc genes in diferentiating
3T3-LI cells within a few hours of the onset of
diferentiation. These genes included PPARy2
C/EBPu, and several genes expressed later in the
diferentiation process. Thus the binding of C/EBP
and 8 to adipogenic genes in cells correlates with the
kinetics of C/EBP and 8 expression. In addition
binding of C/EBP and 8 Was replaced at each of the
loci by the binding of C/EBPu. C/EBPu binding was
noted on each promoter between 20 and 48 
post-differentiation, indicating that it was associating
with promoters as soon as it was expressed and that
binding did not strictly correlate with the time at which
the locus became transcriptionally active. We have
concluded that the binding of C/EBP transcription
factors to regulatory sequences controlling the expres-
sion of adipogenic genes in mlJO occurs rapidly and
without signifcant delay following the induction of each
isoform during adipogenic differentiation.
Materials and methods
Cell lines and differentiation methods
3T3-Ll preadipocytes were purchased from the
American Type Culture Collection (Manassas, VA
USA), maintained in growth medium consisting of
Dulbecco s minimum essential medium containing 10%
calf serum, and induced to differentiate as described
previously 0i\u et at. 1995). Cells were collected at 0 , 1
, 4, 8 , 12 , 16 , 20 , and 24h and then at 24-h intervals
for 7 days after addition of differentiation cocktail
(Salma et at. 2004) for western blot, RT-PCR, and ChIP
analysis. In experiments where 3T3-Ll cells over-
expressed C/EBP , cells were infected with pBABE
retrovirus containing C/EBP or empty vector as
described previously (Tontonoz et al. 1994, Salma et al.
2004). The generation of the retrovirus has been
described previously (Pear et al. 1993 , Salma et al. 2004).
Samples were collected at 0 , 4, 24, 48 , and 168 h in the
presence or absence of diferentiation cocktail for
western blots , RT PCR, and ChIP analysis.
EMSAs
Nuclear extracts isolated from 3T3-Ll cells diferen-
tiated in the presence or absence of cocktail were
prepared as described (Hasegawa et al. 1997). The
binding reaction contained 6 flg nuclear extract and
5 fmol 32P-Iabeled double-stranded oligonucleotide
probe corresponding to the region from -343 to -306 bp
from the mRNA start site in the mouse PPARy2
promoter. This region contains a functional C/EBP
binding site (Zhu et al. 1995 , Clarke et al. 1997). Binding
reactions contained 10mM Tris-HCI (PH 7'5), 5%
www,endocrinology-journals.org
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glycerol , 50 mM NaCl, O' 5 mM dithiothreitol, 1 
MgC1 , and 0,5 mg/ml Poly (dI-dC) ina volume of
10 Ill. Reactions were incubated for 30 min at room
temperature and separated electrophoretically on 4%
non-denaturing polyacrylamide ' gels made with
0,5 x Tris-borate-EDTA buffer. Some reactions were
pre incubated for 10 min with 1 III IgG or anti-C/EBP
antibody (Santa Cruz Biotechnology, Santa Cruz , CA
USA; s(;-7962) prior to addition of the labeled
oligonucleotides. The sequence of the oligonucleotide
probe was: 5' TAAGCAATCAATATTGAACAA
TCTCTGCTCTGGT AA-
RNA analysis
RNA isolation and analysis by northern blotting have
been described previously (de la Serna et al. 2001b).
Probes were derived from plasmids containing PPARy
(provided by B Spiegelman, Dana Farber Cancer
Institute, Boston, MA, USA) and the ribosomal
phosphoprotein 36B4 (obtained by RT-PCR) and
labeled by random priming. Washed blots were exposed
to a PhosphorImager (GE Healthcarem Chalfont St.
Giles , UK). For RT-PCR; total RNA (3 Ilg) was reverse
transcribed with Moloney murine leukemia virus RT
(Invitrogen). cDNA was amplified by PCR with
QIAGEN HotStart Taq master mix in the presence of
2 IlCi (a32PJdATP. The sequences of the primers were
as follows: 5' CCG GCC GCC TTC AAC GAC-3' and
CTC CTC GCG GGG CTC TTG TTT-3' for
C/EBPa (288 bp product); 5' -GAA CTG AGT TGT
GTC CTG CT-3' and 5' TGC ACA CTG GCA GTG
ACA-3' for resistin (340 bp product); 5' GAT CAA
TGA CAT TTC ACA CA-3' and 5' GGA CGC CAT
CCA GGC TCT CT-3' for leptin (281 bp product);
CAG TGG ATC TGA CGA CAC CA-3' and
CGA ATG GGT ACA TTG GGA AC-3' for
adiponectin (433 bp product); and 5' CTC CAA GCA
GAT GCA GCA GA-3' and 5' TCA ATG GTG CCT
CTG GAG AT-3' for the ribosomal phosphoprotein
36B4 (351 bp). The PCR conditions for leptin and 36B4
were: 95 oC for 15 min, followed by 24 cycles of: 95 o
for 30 s; 62 oC for 40 s; 72 oC for 30 s , and a final round
of extension for 5 min. The PCR conditions for
adiponectin were the same , except that the number of
cycles was 20. For resistin , the conditions were the same
as for leptin except that the annealing temperature was
58 oc. For C/EBPa, the PCR conditions were: 95 oc for
15 min , followed by 25 cycles of: 95 oc for 50 s; 66 o
for 55 s; 72 oc for 50 s , and a final round of extension
for 5 min.
Protein extracts and Western analysis
Isolation of protein and western blotting have been
described (de la Serna et al. 2001 a). Antibodies utilized
www.endocrinology-journals .org
included the following from Santa Cruz BiotechilOlogy:
C/EBPa (sc-61), C/EBP (sc-7962), C/EBP6(sc- 151),
and cyclin A (sc-596). Phosphatidylinositol 3-kinase
(PI-3K) antibody (06-496) was obtained from Upstate
(Charlottesville , VA, USA).
ChIP
The ChIP procedure was adopted from the Upstate
protocol and was performed as described by Salma et al.
(2004). . One-tenth of the immunoprecipitated DNA and
1 % of the input DNA were analyzed by PCR.
Antibodies used included Santa Cruz antibodies:
C/EBPa (sc-61), C/EBP (sc-7962), and C/EBP6
(sc- 151). PCRs were performed with QIAGEN Hot
Start Taq master mix in the presence of 2 IlCi
(a- 2PJdATP under the following conditions: a pre-
heating at 94 oc for 15 min, followed by 24-30 cycles of
94 oc for 30s, 62 oc for 40 s (except for PPARy2 which
was 49,5 oC), 72 oG for 30 s, followed by a 72 o
extension for 5 min. . PCR products were resolved in
8% polyacrylamide-1 x Tris-borate-EDTA gels
dried , and exposed to a PhosphorImager. Primers used
were the following: -actin, 5' ( + 31) GCTTCTTTGCA
GCTCCTTCGTTG-3' and 5' (+ 135) TTTGCACAT
GCCGGAGCCGTTGT- 3' (Rayman et al. 2002);
PPARy2 promoter, 5' (- 413) TACGTTTATCGGT
GTTTCAT-3' and 5' ( 247) TCTCGCCAGTGA
CCC- ; upstream region of the PPARy2 promoter, 5'
(- 1871) GGGCGTTAACACAATCCT-3' and 5'
( - 
1707) TCTCTTCCTCCTTCCCTTCC- ; C/EBPa
promoter 5' (- 315) TGACTTAGAGGCTTAA
GGA-3' and 5' (-32) CGGGGACCGCTTTTATAG
AG- ; resistin promoter, 5' (- 177) CACCATGGTC
CCTGGTGTTA-3' and 5' (+26) CTCAGTTCTGGG
TATTAGCTC- ; adiponectin promoter, 5' (- 272)
ATTGTCCTTACCCTTGCCCC-3' and 5' ( 15);
and leptin promoter , 5' (- 323) GCGTTCTGTAGCC
TCTTGCT-3' and 5' (' - 22) GCTCCATGCCCTG
CCTGC . Representative experiments from at least
three independent experiments are shown.
Results
In vitro binding of C/EBP at aC/EBP site in the
PPAR"(2 promoter occurs as early as 3 h
post-differentiation
't\hile investigating the role of C/EBP isoforms in the
activation of adipogenic genes , we examined in vitro
binding of C/EBP at a C/EBP regulatory element
present in the PP AR y2 promoter by EMSA during a
short time-course of 3T3-L1 preadipocytes induced to
differentiate into adipocytes. We found that C/EBP
present in nuclear extracts prepared from cells
differentiated for 3 , 18 , and 24 h was able to bind to a
Journal of Molecular Endocrinology (2006) 36, 139-151
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Figure 1 /n vitro binding of C/EBP to a C/EBP site in the
PPARy2 promoter occurs as early as 3 h following the
induction of 3T3-L 1 adipocyte differentiation. EMSA was
performed using nuclear extracts prepared from preadipocytes
(day 0) or from differentiating preadipocytes at 1 , 3, 18 , and
24 h after the addition ofthe differentiation cocktail (lanes 1-5).
The double-stranded, 32p end- labeled oligonucleotide probe
encoded the C/EBP binding site between -343 and -306
relative to the start site of PPARy2 transcription. Supershift
experiments were performed by adding purified IgG from
pre- immune serum (lane 6) or antibodies against C/EBP
(lane 7).
C/EBP site in the PPARy2 promoter (Fig. 1 , lanes 3-5).
Confirmation that the shifted band in the EMSA was
C/EBP was demonstrated by the appearance of a
supershifted band upon addition of C/EBP antibody to
the reaction while addition of purified IgG had no effect
(Fig. 1 , lanes 6 and 7). The results revealed that the
C/EBP regulator has the capacity to bind to DNA as
early as 3 h following the induction of diferentiation. In
addition, we observed that the apparent level of
C/EBP binding under the reaction conditions used did
not increase between 3 and 24 h post-differentiation
(Fig. 1 , lanes 3-5).
These results diverged somewhat from data published
previously where the in vitro binding activity of C/EBP
was delayed until 12-16 h following the stimulation of
adipogenic differentiation (Tang & Lane 1999). We note
that the previous report demonstrated that C/EBP
binding could be observed at 4 h post-differentiation but
that binding was signifcantly induced at the 12- 16 h
time-points. This dissimilarity in results is possibly due to
diferences in reaction conditions , or perhaps to the use
of different oligonucleotide probes. In the previous study
(Tang & Lane 1999), EMSA was performed using a
C/EBP site from theC/EBPa promoter, while our
Journal of Molecular Endocrinology (2006) 36, 139-151
experiment utilized a probe that contained a C/EBP
binding site from the PPAR y2 promoter. Nevertheless
the results presented in Fig. 1 raised a question about the
timing of C/EBP binding to adipogenic regulatory
sequences. To better address this issue , we decided to
perform ChIP experiments at different times following
the induction of adipocyte differentiation in 3T3- L 1 cells
in order to examine the binding of C/EBP isoforms
zn VlVO.
Kinetics of C/EBP expression in differentiating
3T3-L 1
Since the EMSA data presented in Fig. 1 indicated a
potential diference from previously published studies
we first performed a series of control experiments to
analyze the expression levels of C/EBP , and (l
during adipocyte differentiation of 3T3-Ll cells by
western blot in order to eliminate the possibility that our
results might be due to differences in the experimental
handling of the differentiating 3T3-Ll cells. It has been
well established that initiating diferentiation of 3T3-
preadipocytes activates a cascade of gene expression
events. Among the initial events are the rapid induction
of C/EBP and 0 , which are stimulated by components
of the differentiation cocktail, followed by the induc-
tion of C/EBPa on the second day of differentiation
(Yeh et al. 1995 , Wu et al. 1996). Western blot analyses
corroborated that induced protein levels of C/EBP and
o were detectable at 1 h , reached a maximum at 4 h
and were declining at 48 and 120 h respectively (Fig. 2).
Expression of C/EBPa occurred later; significant
induction began at about 48 h post-differentiation and
expression was maintained throughout the time-course
(Fig. 2).
To corroborate that the cells began the mitotic
expansion phase , we performed a western blot with
antibodies directed to cyclin A (Fig. 2). As was expected
cyelin A levels were increased between 16-24 h
post-differentiation , indicating that the cells had entered
the cell cycle prior to 16 h and had exited by
approximately 48 h. An of the data presented in Fig. 2
indicate that the differentiation of the 3T3-Ll cells
occurred as expected and confirm previously published
results (Morrison & Farmer 1999 , Tang et al. 2003a b).
Thus we have demonstrated the integrity of the 3T3- Ll
cells and the diferentiation protocol used for this and
subsequent experiments.
In vivo recruitment of C/EBP
, ()
, and to the
PPARy2 and C/EBPa promoters during adipogenesis
The results presented in Fig. 1 show that C/EBP was
able to bind to C/EBP binding sites on the PPARy2
promoter at times that correlated with the induction of
C/EBP levels. To determine whether binding occurs
WWW. endocrinology-journals .org
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Figure 2 Western blot analysis of transcriptional and cell cycle regulators during differentiation of 3T3-L 1 cells. Protein extracts
were prepared from differentiating cells at the indicated times and the kinetics of protein expression for the indicated proteins were
determined by western blot analysis. Pl 3K was used as a loading control.
on endogenous adipocyte promoters at early times after
the induction of adipocyte differentiation , we performed
ChIP experiments and temporally analyzed binding, not
only of C/EBPP, but also of C/EBP8 and C/EBPa
specifc adipocyte promoters. First, we chose to evaluate
binding at the C/EBPaand the PPARy2 promoters
since these two essential adipogenic regulators are
expressed early during differentiation , on day 2 (Fig. 3A
and B).
Regulation of the C/EBPa and the PPARy2
promoters by C/EBP family members has been
characterized previously (Christy et al. 1991 , Zhu et al.
1995 , Clarke et al. 1997 , Tang & Lane 1999 , Tang et al.
1999 , 2004 , Elberg et al. 2000 , Yang & Chow 2003). The
C/EBPa proximal promoter contains a C/EBP
regulatory element at - 187 relative to the transcrip-
tional start site that mediates transactivation by C/EBPs.
The PPARy2 promoter contains two previously
characterized C/EBP recognition elements at - 340 bp
and - 327 bp relative to the transcriptional start site in
addition to other potential sites that diverge from the
C/EBP consensus. As shown in Fig. 3A, recruitment of
C/EBPP as well as C/EBP8 at the C/EBP regulatory
element on the PPARy2 promoter was induced in a
manner consistent with the protein expression patterns
of both proteins (Fig. 2), with binding of both proteins
apparent 2 h after the onset of differentiation. Subse-
quently, C/EBPP and C/EBP8 were replaced by
C/EBPa which initiated binding to the promoter at
48 h and was maintained throughout the time-course.
These results confirmed the transition of binding from
C/EBPP/8 to C/EBPa at this promoter in vivo (Salma
et al. 2004, Tang et al. 2004).
Analysis of the C/EBPa promoter revealed the same
pattern found at the PP AR y2 promoter, except that
binding occurred even earlier following differentiation
(Fig. 3B). C/EBPP and C/EBP8 were bound as early as
1 h post-differentiation and remained present until 48 h
www.endocrinology-journals.org
and 120 h respectively. Induction of C/EBPa binding to
the C/EBPa promoter began at 48 as reported
previously (Tang et al. 2004). Therefore , the transition in
binding of the C/EBP isoforms that was observed at the
PPARy2 promoter also occurred at the C/EBPa
promoter.
The appearance and disappearance of binding of the
different C/EBP isoforms at thePPARy2 and C/EBPa
promoters at different . times post-diferentiation indicate
specificity of binding. No antibody controls provide
further evidence for specific binding (Fig. 3A and B). As
an additional control, we analyzed C/EBP factor
interactions at the p-actin locus (Fig. 3C) and at
sequences 1.8 kb upstream of the PPARy2 start site(data not shown). Neither p-actin sequences nor
sequences upstream of the PP AR y2 promoter were
immunoprecipitated by any of the antibodies used in the
ChIP procedure.
In vivo recruitment of C/EBPp, b, and to additional
adipogenic gene promoters during adipogenesis
Vve next examined if C/EBPP, 8 , and are recruited to
the resistin, adiponectin, and leptin promoters. These
adipocyte-secreted peptides , collectively. referred to 
adipocytokines, have generated considerable interest
since they are important regulators of body mass and
their misregulation may playa role in obesity (Miner
2004). The proximal promoters of these genes contain
C/EBP binding sites that are necessary for expression.
The resistin promoter contains a C/EBP site at - 56
relative to the transcriptional start site, adiponectin
contains two identified C/EBP sites at -775 and - 264
and two potential binding sites at - 117 and - 73 , and
leptin has three consensus C/EBP binding sites at
nucleotides - 55, - 211 , and - 292. The activity of
these C/EBP sites has been confirmed by reporter assays
Journal of Molecular Endocrinology (2006) 36, 139-151
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for each of these genes (de la Brousseet al. 1996 , Hwang
et al. 1996 , Hartman et al. 2002 , Park et at. 2004b).
Binding of C/EBP and 8 to the C/EBP site at the
resistin proximal promoter was. evident at 2-4 h
post-differentiation and did not decline. until after 48 h
(Fig. 4A). A modest increase in binding of C/EBPa was
observed from 20 to 48 h , and was further increased at
120 h (Fig. 4A). These results indicate that C/EBPP and
8 bind early after differentiation to the resistin promoter
and suggest that all three C/EBP isoforms playa role
regulating this adipocyte gene. It was previously
demonstrated that C/EBPa binds specifcally to the
C/EBP element on the resistin promQter that is essential
for expression (Hartman et al. 2002); however, a
transition in binding of these regulators has not been
previously demonstrated.
The adiponectin promoter contains two C/EBP sites
at - 77 Sand - 264 and two potential binding sites
at - 117 and - 73; however, the C/EBP element at
- 264 and the potential C/EBP sites at - 117 and
- 73 confer promoter activity as defined in transient
. promoter studies , EMSA, DNase I footprinting, and
ChIP assays (Park et al. 2004b Seo et al. 2004).
Consequently, we performed ChIPs in the region of the
proximal promoter that contains these C/EBP sites. The
analysis of binding of C/EBP C/EBP8 and C/EBPa
to the adiponectin promoter showed a pattern nearly
identical to that observed for the resistin promoter
despite the fact that adiponectin expression initiated
later than resistin expression (Fig. 4B). C/EBP and 8
were bound to the promoter at 2 h and maintained until
8 h. Definitive binding of C/EBPa was present at 48 h
although a modest increase was noticed at 20-24 h.
Finally, we assessed the recruitment of the C/EBP
members on the leptin promoter. The proximal
promoter contains three consensus C/EBP binding sites.
DNase I footprint analysis, reporter gene assays , and
EMSA studies have demonstrated that one of these
C/EBP sites, located at S3 relative to the transcrip-
tional start site , is functional (de la Brousse et al. 1996
Hwang et al. 1996 , Mason et al. 1998). However , because
the C/EBP sites are near each other, we designed PCR
primers to amplify a region of the proximal promoter
containing all three sites. The recruitment of C/EBP
occurred at 4 h and remained relatively constant until
48 h (Fig. 4C). In contrast C/EBP8 was detectable from
12 h to 48 h. Binding of C/EBPa was observed on the
promoter at 20 h, but was not robust until 120h
post-diferentiation, which coincides with the start 
leptin mRNA accumulation. These results indicate that
C/EBP and 8 bind quickly after the induction of
differentiation to adipogenicpromoters that are not
expressed until much later in the diferentiation process.
Furthermore , the transition from C/EBP and 8 to
C/EBPa binding on these promoters also occurred prior
to gene expression, suggesting that C/EBP factor
interations with adipogenic promoters is independent of
the time at which gene expression is initiated.
Overexpression of C/EBP is not sufficient to
promote C/EBP protein binding to the PPARy2
promoter in differentiating 3T3-L 1 cells
The detection of C/EBP on adipogenic promoters
in vivo within a few hours of the onset of adipogenic .
stimulation caused us to evaluate whether over-
expression of C/EBP in 3T3-Ll preadipocytes would
be suffcient to induce binding of C/EBP to the
regulatory sequences examined. 3T3-L1 preadipocytes
were infected with a retroviral vector expressing
C/EBP and were allowed to reach confluence , but no
differentiation cocktail was added. Instead, cells were
maintained in 10% calf serum as a confluent plate , and
C/EBP binding was assessed at 0, 4, 24, 48, and 168 h.
Despite the ectopic expression of C/EBP (Fig. ' SA), no
binding of C/EBP , 8 , or was observed at the
PPARy2 promoter, whereas control plates treated with
differentiation cocktail showed C/EBP and 8 binding
to the PPARy2 promoter within 4 h post-diferentiation
and C/EBPa binding by 48 h post-diferentiation
(Fig. SB).
The data suggested that overexpression of C/EBP
cells is not suffcient to promote C/EBP binding to
adipogenic promoters in the absence of differentiation
cocktail. A potential caveat to this conclusion is. that
ectopic expression did not provide a high enough level of
C/EBP protein to surpass a threshold level of C/EBP
protein necessary to achieve binding. VVe note that the
inoculum of pBABE-C/EBP retrovirus used in these
experiments is the same as we have previously used to
trans-diferentiate fibroblast lines into adipocyte-like
cells; thus the levels of C/EBP provided are suffcient
to reprogram cells of a diferent lineage (Salma et al.
2004). However, to more directly address this concern
we compared the levels of C/EBP protein present in
Figure 3 ChiP assays reveal that C/EBP binding to the PPARy2 and C/EBPa promoters occurs in vivo within 2 h of the induction
of 3T3-L 1 adipocyte differentiation. ChiP assays were performed at the indicated time-points using the indicated antibodies and
amplified for the PPARy2 promoter (A, top panel), the C/EBPa promoter (B, top panel), or the -actin 5' untranslated region and
coding region (C); 1 % of each input is shown. A twofold titration (number of I indicated) of input from the 0 h sample is shown on
the left to demonstrate linearity of the PCR reactions. (A , bottom panel) Duplicate samples were used to prepare RNA and a
Northern blot showing the levels of PPARy and 36B4 mRNA at each time-point is shown. (B , bottom panel) C/EBPa and 36B4
mRNA levels were determined by RT-PCR. A twofold titration (number of I indicated) of input reverse transcribed RNA from the day
7 sample is shown on the left to demonstrate linearity of the PCR reactions. Ab , antibody.
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Figure 5 Overexpression 6f C/EBP in undifferentiated 3T3-L 1 preadipocytes is not sufficient to induce the binding of C/EBP
factors at the PPARy2 promoter. Subconfluent 3T3-L 1 preadipocytes were infected with either pBABE retrovirus or pBABE
retrovirus encoding C/EBP . For differentiation , cells were placed in fresh media lacking or containing the differentiation cocktail
and samples were harvested at the indicated times for (A and C) Western blot analysis or (B and D) ChiP analysis. Ab , antibody.
uninfected cells and in cells infected with pBABE-
EBP or with the pBABE empty retrovirus that were
differentiated in the presence or absence of diferentia-
tion cocktail for 4 h. A western blot (Fig. 5C)
demonstrates that cells infected with the C/EBP virus
contained greater levels of C/EBP protein in both the
presence and absence of diferentiation cocktail (com-
pare lane 2 with lane 3 and lane 5 with lane 6), as
expected. We also observed that C/EBP levels in
vector-infected cells that were differentiated in the
presence of cocktail were lower than C/EBP levels in
the pBABE-C/EBP infected cells that were diferen-
tiated in the absence of cocktail (compare lanes 4 and 3).
The levels of C/EBP protein in pBABE-infected cells
treated with differentiation cocktail were suffcient to
permit C/EBP binding to the PPARy2 promoter
whereas higher levels of C/EBP in the C/EBP
infected cells differentiated in the absence of cocktail
were not (Fig. 5D , compare lanes 4 and 3). The results
exclude the possibility that insuffcient levels of C/EBP
were present in the cells not treated with differentiation
cocktail. The C/EBP protein undergoes a number of
post-translational modifications that are associated with
the induction of adipogenesis; it is likely that such
modifications are iriduced by addition of the differentia-
tion cocktail and are necessary to promote rapid binding
to adipogenic gene regulatory sequences in vivo. Thus
simple overexpression of C/EBP is not suffcient to
induce C/EBP binding in 3T3-Ll preadipocytes.
Discussion
The C/EBP family of transcription factors is widely
expressed and is a key regulator of a variety of target
genes important in physiological events, including
energy metabolism , inflammation , hematopoiesis , cellu-
lar proliferation, and diferentiation (Darlington et al.
1998, Lekstrom- Himes & Xanthopoulos 1998, Rosen
et al. 2000 , Ramji & Foka 2002, Kovacs et al. 2003). Of
note is the essential role C/EBP family members play
during adipogenesis (reviewed by Darlington et al. 1998
Lane et al. 1999). Almost immediately upon induction 
adipogenesis , the C/EBP family members and 0 are
induced in a manner dependent on several signal
transduction cascades that result in phosphorylation of
Figure 4 ChiP assays show that C/EBP binding to the adipocytokine promoters occurs in vivo within 4 h of the induction of 3T3-L 1
adipocyte differentiation. ChiP assays were performed at the indicated time-points using the indicated antibodies and amplified for
the resistin promoter (A , top panel), the adiponectin promoter (B , top panel), or the leptin promoter (C, bottom panel); 1 % of each
input is shown. A twofold titration (number of IJI indicated) of input from the day 0 sample is shown on the left to demonstrate
linearity of the PCRs. Duplicate samples were used to prepare RNA at each time-point and mRNA levels for resistin (A , bottom
panel), adiponectin (B, bottom panel), and leptin (C , bottom panel) as determined by RT-PCR are shown. 36B4 mRNA levels are
shown as a control. A twofold titration (number of IJI indicated) of input reverse transcribed RNA from the day 7 sample is shown 
the left to demonstrate linearity of the PCRs. Ab ,. antibody.
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these proteins (Parket al. 2004a Bezy et al. 2005 , Tang
et at. 2005 and references therein). However, the
activation of the early adipogenic regulators , PP AR y2
and C/EBPa which are dependent onC/EBP and 8
does not occur until day 2 of the diferentiation process.
During the first 2 days , cells undergo one or two rounds
of mitosis, a process termed mitotic clonal expansion
(Bernlohr et at. 1985 , Cornelius et at. 1994, MacDougald
Lane 1995). Thus, the transcriptional activation
potential of the C/EBP and 8 proteins are masked or
repressed until clonal expansion commences.
Over the past several years data have accumulated
that suggest that the binding capacity of C/EBP for its
cognate binding site is delayed 12-20 h post-induction of
adipocyte diferentiation (Lane et at. 1999 , Tang & Lane
1999 , Tang et at. 2003b 2005). This observation fits well
with the need to delay expression of C/EBPa which ha
anti-mitotic properties (Umek et al. 1991 , Lin et al. 1993
Timchenko et at. 1996 , Wang et at. 2001), until clonal
expansi9,n occurs. Moreover, the kinetics of DNA
binding activation fit well with the kinetics of other
events that occur at this time , including the appearance
of phosphorylated Rb and the localization of C/EBP
pericentric heterochromatin, which contains numerous
C/EBP binding sites in the satellite DNA sequences
(Tang & Lane 1999). Flow this change in sub-nuclear
distribution relates to gene expression has not been well
established , but the observation raises the possibility that
localization of proteins to specifc nuclear compartments
contributes to the complexity of adipocyte gene
regulation.
In the course of examining the activation of the
PP AR y2 promoter during adipogenesis , we noted that
in vitro binding of C/EBP to a C/EBP binding site in
the PP AR y2 promoter did not appear to change
significantly between 3 and 24 h post-differentiation
(Fig. 1). Given the wide range of variable conditions that
can afect protein binding in a gel shift assay, we initially
did not view this as contradictory to the existing models
explaining the delay in activation of C/EBPa and
PP AR y2 gene. expression. However . ChIP assays, which
specifically detect in vivo protein:DNA interactions at
endogenous loci, clearly demonstrated that C/EBP and
C/EBP8 were . capable of binding to both the C/EBPa
and the PP AR y2 promoter at very early times
post-diferentiation. Moreover, C/EBP and 8 could
also bind at early times to adipocyte specifc promoters
that do not begin to transcribe until much later in the
differentiation process. Our results do not alter the
original conclusion that mechanisms exist during the
time of mitotic clonal expansion to delay activation of
C/EBPa and PPARy2 gene expression and the target
genes that they subsequently activate. Instead, they
indicate that the rate-limiting step is not the interaction
of the C/EBP protein with binding sites at the
endogenous target gene promoters.
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Numerous possibilities to restrict the transcriptional
activating properties of C/EBP exist even if the protein
is DNA bound. The exact isoform of C/EBP that is
bound could influence the transcriptional potential.
Interaction between C/EBP and repressor proteins
(Ron & Habener 1992 , Tang et al. 1999) would not
necessarily be restricted to solution interactions;
repression could occur via interactions at promoter
sequences as shown previously (Mo et at. 2004).
DNA-bound C/EBP could be and likely is still subject
to post-translational modifcations including phos-
phorylation, acetylation , and sumoylation (Kim et at.
2002, Eaton & Sealy 2003 , Xu et at. 2003 , Park et at.
2004a Tang et al. 2005), that may modulate
transcriptional capacity. C/EBP bound loci could
remain transcriptionally silent because other activators
RNA polymerase II (pol 11)- or pol II-associated general
transcription factors have not been synthesized, are
spatially restricted, have not yet undergone the
appropriate post-translational modification, or. . cannot
bind in the absence of specifc chromatin modifcations
or alterations. In support of this last possibility,
Wiper- Bergeron et at. (2003) showed that histone
deacetylase 1 (HDAC 1) coulclaffect the acetylation status
of the C/EBPa promoter in a manner regulated by
glucocorticoids. Finally, C/EBP bound loci may
change position within the nucleus , becoming associated
or disassociated with specific sub-nuclear structures such
as pericentric heterochromatin or splicing domains.
None of these possibilities are mutually exclusive , and it
is likely that multiple mechanisms are acting co-
operatively to control the timing of expression for each
individual target gene.
'Ve also note that , in other cell types, C/EBP
mediated activation of endogenous target genes can
occur without induction of C/EBP levels or induction
of post-translational modifications. Lipopolysaccharide-
mediated induction of C/EBP target genes . in B
cell-derived lines lacking C/EBP proteins could be
accomplished by constitutive expression of the bZIP
domain of C/EBP (Hu et at. 2000). More recently,
C/EBP binding to and subsequent activation of target
genes in lipopolysaccharide-stimulated macrophages
were shown to occur prior. to induction of C/EBP
protein levels and in the absence of induced C/EBP
phosphorylation or nuclear translocation (Bradley et al.
2003). Thus different mechanisms likely control
C/EBP function in differelit cell types.
The in vivo binding capacity of C/EBP and 8 to
adipogenic genes as early as 1 h post-differentiation
seems . likely to be modulated by components of the
diferentiation cocktail. ChIP assays performed with
3T3-Ll over-expressing C/EBP in the absence of
differentiation inducers showed that this regulator is not
recruited to the PPARy2 (Fig. 5). This result shows that
the physical presence of C/EBP alone is insuffcient to
www.endocrinology-journals .org
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be recruited to specific promoters. Further studies will be
required to determine the nature of modifcations
required for both C/EBP and 0 to rapidly bind to
adipogenic regulatory sequences following diferentia-
tion signaling as well as the relative importance of
C/EBP homodimers and C/EBP and 0 heterodimers.
Limited data on the binding of C/EBP and 0 to
gene promoters other than C/EBPa and PPARy2 exist.
In diferentiating 3T3-Ll cells, C/EBP binds to the
aP2 promoter between 24-72 h post-differentiation
(Tang et al. 2004), and a recent report shows both'
C/EBP and 0 on the adiponectin promoter in mouse
adipose tissue (Park et al. 2004b). These data raise the
question of why C/EBP and 0 are bound to such
promoters when evidence strongly suggests that the
genes are not activated until later times when C/EBPa
has replaced C/EBP and 0 at these loci. We speculate
that the presence of C/EBP may be part of the process
by which C/EBPa is recruited to adipogenic promoters.
Alternatively, or perhaps additionally, all of the
adipogenic loci undergo structural changes at the onset
of diferentiation , and the binding of C/EBP to these
loci serves as a mark for subsequent gene activation.
The data have also clearly demonstrated that the
C/EBP binding sites on each of the genes undergo a
transition in binding from C/EBP and 0 to C/EBPa
in vivo. We and others have previously demonstrated that
this occurred on the PP AR y2 promoter during
adipogenesis (Salma et ai. 2004 , Tang et al. 2004). From
the data presented here , we predict that this transition
occurs on all adipocyte genes containing C/EBP binding
sites with similar kinetics , indicating the importance of
the transition and a role forC/EBP and 0 in both early
and late events of the differentiation program. VVe note
that the binding of C/EBP and 0 correlated with the
induction of overall cellular levels of C/EBP and o.
Similarly, C/EBP and 0 were replaced on each
promoter between 24 and 48 h post-diferentiation . the
time at which C/EBPa protein levels begin to be
induced. Thus the binding of the specific C/EBP
proteins to adipocyte specifc genes in vivo does not
correlate with the time of target gene expression but
instead occurs rapidly after the induction of C/EBP
protein levels.
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